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ABSTRACT 
Ischemia /reperfusion injury (IRI) is a major cause of acute kidney injury (AKI) that is 
associated with high morbidity and mortality. Macrophages (Mcp) are multifunctional 
cells involved in the initiation, progression and resolution of kidney inflammation 
response. The enzyme hemeoxygenase -1 (HO -1) is upregulated in response to cell 
stress and metabolises heme- containing proteins to carbon monoxide (CO) and 
bilirubin that possess anti -apoptotic and anti -oxidant properties. Previous work has 
shown that Mcp can be used as therapeutic vectors with the administration of bone 
marrow -derived macrophages (BMDM) overexpressing HO -1 being protective in 
murine renal IRI (Ferenbach et al., 2010). However, these studies used primary 
BMDM that are inherently heterogeneous with the genetic manipulation achieved by 
adenoviral transduction that is not suitable for use in patients. Previous work has 
shown that pure Mq populations may be generated from murine and human 
embryonic stem cells (ESC) in vitro, providing an essentially limitless source of Mcp 
that can be derived from genetically manipulated cells. This project has adopted an 
ESC approach to develop anti -inflammatory ESC -derived macrophages (ESDM) 
overexpressing HO -1 for therapeutic use in experimental models of AKI. We 
successfully generated Mq from ESC and demonstrate that ESDM are comparable 
to BMDM in all properties that we tested. ESDM are large mononuclear cells and 
express Mcp cell surface markers (F4/80 high CD11bh'9h CD11ch'9h MHC class Ill°W) 
ESDM are phagocytic and produce pro -inflammatory mediators when activated by 
lipopolysaccharide and interferon -y (LPS and IFNy). 
ESC were then genetically manipulated to overexpress HO -1 under the control of 
the constitutive pCAG promoter. Our results suggest that a high level of constitutive 
HO -1 overexpression in ESC impacts on ESC number, self -renewal and Mcp 
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differentiation. Thus, we decided to generate ESC that overexpress HO -1 under an 
inducible promoter using the A2lox.cre system. HO -1 inducible ESC exhibited 
significant HO -1 up- regulation and generated F4 /80h'9h CD11bh'9h CD11cult MHC Ill°" 
ESDM. However, HO -1 inducibility by doxycycline (Dox) was lost following both 
ESDM differentiation and RA induced differentiation of ESC. A similar loss of Dox- 
induced gene expression following ESDM differentiation or RA induced cell 
differentiation was found in ESC expressing a control eGFP transgene under the 
control of the same inducible promoter. 
In view of the difficulties encountered using the inducible systems, a 
pharmacological approach using treatment with the potent HO -1 inducer 
hemearginate (HA) was used to upregulate HO -1 expression in ESDM. HA 
treatment significantly upregulated HO -1 expression by ESDM. HA treatment 
modulated ESDM phagocytosis and the production and gene expression of both 
pro- and anti -inflammatory mediators (NO, TNFa, IL -10 and IL -6) following LPS and 
IFNy stimulation. Intravenous injection of fluorescently labelled ESDM directly after 
inducing renal IRI resulted in the localisation of the ESDM to solid organs and 
preferential homing to the injured kidney at the 1 hour time point indicating their 
potential for use in cell therapy. 
In conclusion, we were able to generate functional Mcp from ESC. The differentiation 
of ESC to My resulted in the loss of inducible gene expression and pharmacological 
HO -1 induction was used. HA treated ESDM present promising anti -inflammatory 
properties in vitro and home to the injured kidney in a model of murine IRI in vivo. 
Further experiments are still needed to determine if HA treated ESDM exert anti - 
inflammatory properties in vivo. However, our findings are a strong platform for 
future studies of the translational potential of using modified ESDM in cell therapy. 
4 




It would not have been possible to write this thesis without the help and support of 
the kind people around me, to only some of whom, in no specific order, it is possible 
to give particular mention here. 
I would like to express my utmost gratitude to my supervisor, Professor Jeremy 
Hughes for his continuous support during my PhD. 
Dear Jeremy, for your "half full glass" vision of Life, patience with all my doubts, 
infectious enthusiasm, and immense knowledge, I shout Thank you! Merci! 
Diolch! Meeting you was pure serendipity! And today, at the end of my PhD 
journey, I can tell that you're the Best supervisor I could have had. 
I would also like to thank Professor Lesley Forrester and Dr David Kluth for their 
encouragement and insightful comments. 
Thanks to Dr Richard Axton, Helen Taylor and Julie Wilson for their precious help. 
Ms Rachel Victoria Richardson and Ms Joena Bal for their eager contribution. 
Dear Spike, if it wasn't for you, I'd never have landed in Edinburgh! 
Chère Grande Chef, Nathalie, si tu n'étais pas aussi sympa /bavarde, je n'aurais 
jamais atterri à Edimbourg! 
I acknowledge the Medical Research Council UK that provided me with financial 
support for this research through an MRC PhD Studentship. 
À ma Famille... 
BONNE ANNÉÉÉÉE aux Assumani! Mon irremplaçable Marraine, Mon 
beau(dineux) Tonton et mes couz : Zaïna, Antoine et Marie -So ! 
À Luc & Nicole 
À Anne & Fred & Antoine 
Mais aussi à... 
My dear friends, Catherine and Lindsay, You ROCK! Can't describe how happy I am 
we found each other! Edinburgh wouldn't be Edinburgh without you. Love you to 
bits! See you around the world! xxx 
Marie d'être la plus géniale des potes, Fred & Sarah et Mathieu & Perrine pour les 
soupers /encouragements /..., Andréa -surtout de m'avoir présenté Fran, Mahmoud 
for your unconditional Luv, Nathalie Caron & ses filles de m'avoir sorti de mon trou, 
Brenda & Beano Hughes for being so welcoming while I was writing the last lines of 
this work, my fellow PIG lab mates especially Katie, Jillian, Alicja and Al Dane for 
the stimulating discussions and for all the fun we've had in the last three years +. 
Ryanair, Skype, Facebook, and all the mice who gave their life to Science... 
6 
Et puis surtout... 
À Papoun & Mutti, 
Merci pour la liberté que vous m'avez accordée, pour cette éducation maintes fois 
critiquée, pour ces mots qui m'ont souvent poussée, parfois freinée... Merci d'avoir 
contribué à faire de moi qui je suis aujourd'hui et surtout de m'encourager à aimer 
cette personne. Je vous aime. 
À Malté, 
Pour ton humeur changeante, qui me permet de savourer intensément tes câlins 
spontanés, tes « ma sceuuuur », tes sourires,... Grandir à tes côtés ma sceur, c'est 
grandir tout court. Je t'aime et je suis fière de la femme que tu deviens. 
À Gilles, 
Je craquerais bien pour l'occasion, mais il ne faut pas exagérer non plus! Gilles tu 
es, et Gilles tu resteras, rien que pour moi! Pti frère, mes voyages, la solitude, les 
doutes... Tu sais que ça a été très dur. Mais rien que pour les liens que la distance 
a resserrés entre nous, je recommencerais ! C'est apaisant de (enfin) me sentir 
proche de toi, je t'aime. 
7 
A toi, mon Fran... 
8 




TABLE OF CONTENTS 9 
FIGURES 17 
TABLES 24 
LIST OF ABBREVIATIONS 25 
CHAPTER 1. INTRODUCTION 29 
1.1 THE KIDNEY 29 
1.1.1 Anatomy of the kidney 29 
1.1.2 Kidney vasculature 32 
1.2 RENAL FAILURE 35 
1.2.1 Pathophysiology of ischaemic acute kidney injury 38 
1.2.1.1 Proximal tubule alterations and injury 40 
1.2.1.2 Haemodynamic changes 40 
1.2.1.3 Cellular death 41 
1.2.1.4 Microvascular alterations 42 
1.2.1.5 Inflammatory response 44 
1.3 THE HEMEOXYGENASE SYSTEM 48 
1.3.1 Hemeoxygenase -1 and the kidney 52 
1.3.1.1 Hemeoxygenase -1 in ischaemic acute kidney injury 53 
1.3.2 Strategies of hemeoxygenase -1 up- regulation as therapy in models of renal inflammation 
54 
1.3.2.1 Pharmacological induction of hemeoxygenase-1 54 
1.3.2.2 HO -1 gene therapy 58 
9 
1.3.3 Kidney gene therapy 62 
1.3.4 Alternatives to direct targeting of HO -1 64 
1.4 MACROPHAGES 65 
1.4.1 Macrophages cell therapy in renal inflammation and ischaemic acute kidney injury 68 
1.4.2 Macrophages as vector for HO -1 therapy in renal inflammation and ischaemic acute 
kidney injury 70 
1.5 EMBRYONIC STEM CELLS 71 
1.5.1 Embryonic stem cell derived macrophages 73 
1.6 HYPOTHESIS 76 
1.7 AIMs 76 
CHAPTER 2. MATERIAL AND METHODS 77 
2.1 MATERIALS AND REAGENTS 77 
2.2 EMBRYONIC STEM CELLS 77 
2.2.1 E141V cell line 77 
2.2.2. A2lox.cre cell line 77 
2.2.3 Embryonic stem cell self -renewal- alkaline phosphatase activity assay 80 
2.2.4 Retinoic acid - embryonic stem cell differentiation assay 83 
2.2.5 Embryonic stem cell cryopreservation 83 
2.3 PREPARATION OF MACROPHAGES, DENDRITIC CELLS AND MONOCYTES 83 
2.3.1 Preparation of L929- Conditioned Medium 83 
2.3.2 Preparation of embryonic stem cell- derived macrophages 84 
2.3.3 Preparation of bone marrow derived macrophages 88 
2.3.4 Preparation of bone marrow derived dendritic cells 88 
2.3.5 Purification of bone marrow monocytes 89 
2.4 CHARACTERISATION OF MACROPHAGES 90 
2.4.1 Cytospin followed by Diff- -quick staining 90 
2.4.2 Immunohistochemistry analysis of cells 90 
2.4.3 Flow cytometry 91 
10 
2.4.4 Phagocytosis assay 94 
2.4.4.1 Flow cytometry analysis of phagocytosis of fluorescent latex beads 94 
2.4.4.2 Preparation of apoptotic thymocytes 95 
2.4.4.3 Fluorescent microscopy analysis of phagocytosis of apoptotic thymocytes 95 
2.4.5 Macrophage activation: LPS and IFNy stimulation 98 
2.4.5.1 Nitric oxide measurement 98 
2.4.5.2 Enzyme Linked Immunosorbent Assay 100 
2.5 INDUCTION OF HEMEOXYGENASE-1 EXPRESSION 101 
2.5.1 Pharmacological induction of hemeoxygenase -1 expression 101 
2.5.2 Genetically engineered induction of hemeoxygenase -1 expression 101 
2.5.2.1 Constitutive overexpression of hemeoxygenase -1 under the pCAG promoter 101 
2.5.2.2 Tetracycline inducible system: using the A2lox.cre embryonic stem cell line 102 
2.6 DETECTION OF HEMEOXYGENASE -1 PROTEIN 102 
2.6.1 Western blotting 102 
2.6.2 Flow cytometry analysis of intracellular hemeoxygenase -1 expression 105 
2.7 DETECTION OF HEMEOXYGENASE -1 GENE EXPRESSION 105 
2.7.1 RNA extraction 105 
2.7.2 DNase treatment 106 
2.7.3 Reverse transcriptase PCR 106 
2.7.4 Quantitative real time PCR 107 
2.8 MURINE MODEL OF RENAL ISCHAEMIA /REPERFUSION INJURY 1 09 
2.8.1 Characterisation of ischaemic injury 110 
2.8.1.1 Assessment of renal histology 110 
2.8.1.2 Immunohistochemistry of tissue sections 112 
2.8.1.3 Assessment of renal function 114 
2.9 IN VIVO LOCALISATION OF EMBRYONIC STEM CELL -DERIVED MACROPHAGES 114 
2.9.1 PKH26 dye labelling of macrophages 114 
2.9.2 Localisation of macrophages following renal ischaemia /reperfusion injury 116 
2.10 STATISTICAL ANALYSIS 116 
11 
CHAPTER 3. DERIVING AND PHENOTYPING EMBRYONIC STEM CELL -DERIVED 
MACROPHAGES 117 
3.1 INTRODUCTION 117 
3.2 PHENOTYPING EMBRYONIC STEM CELL -DERIVED MACROPHAGES 118 
3.2.1 Embryonic stem cell- derived macrophages exhibit a macrophage -like morphology 118 
3.2.2 Embryonic stem cell- derived macrophages express macrophage cell surface markers 122 
3.2.3 Embryonic stem cell -derived macrophages phagocytose latex beads 127 
3.2.4 Embryonic stem cell- derived macrophages respond to a pro -inflammatory stimulus 133 
3.3 ANALYSIS OF EMBRYONIC STEM CELL -DERIVED MACROPHAGE DIFFERENTIATION 135 
3.3.1 Phenotyping the embryonic stem cell- derived macrophage progenitor cells isolated from 
embryoid body culture supernatants. 135 
3.3.1.1 Embryonic stem cell- derived macrophage progenitor cells acquire a macrophage -like 
morphology with maturity 136 
3.3.1.2 Embryonic stem cell -derived macrophage progenitor cells do not express the stem cell marker 
Oct4 139 
3.3.1.3 Embryonic stem cell- derived macrophage progenitor cells express the macrophage cell surface 
markers F4/80 and CD1lb 139 
3.3.1.4 Embryonic stem cell- derived macrophage progenitor cells are phagocytic 149 
CHAPTER 4. CONSTITUTIVE AND INDUCIBLE OVEREXPRESSION OF 
HEMEOXYGENASE -1 IN EMBRYONIC STEM CELLS AND EMBRYONIC STEM CELL - 
DERIVED MACROPHAGES 153 
4.1 INTRODUCTION 153 
4.2 CONSTITUTIVE OVER EXPRESSION OF HEMEOXYGENASE -1: THE PCAG SYSTEM 154 
4.2.1 Embryonic stem cells constitutively overexpress hemeoxygenase -1 under the exogenous 
pCAG promoter 154 
4.2.2 Random integration ofpCAG -HO -1 adversely affects the ability of embryonic stem cells to 
self -renew 156 
4.2.3 Random integration of the pCAG -HO -1 plasmid can affect the differentiation of embryonic 
stem cell- derived macrophages 160 
12 
4.3 SUMMARY 1 165 
4.4 TETRACYCLINE INDUCIBLE OVER- EXPRESSION OF HEMEOXYGENASE -1: THE A2LOX.CRE CELL 
LINE INDUCIBLE SYSTEM. 166 
4.4.1 Hemeoxygenase -1 inducible embryonic stem cells overexpress hemeoxygenase -1 following 
doxycycline treatment 166 
4.4.2 Inducible Hemeoxygenase -1 expression has no effect on the self -renewal properties of the 
inducible embryonic stem cells 169 
4.4.3 The generation of hemeoxygenase-1 inducible embryonic stem cell- derived macrophages 
from the genetically modified stem cell line 169 
4.4.3.1 Hemeoxygenase -1 inducible embryonic stem cell- derived macrophages exhibit a large 
mononuclear cell morphology 171 
4.4.3.2 Hemeoxygenase -1 inducible embryonic stem cell- derived macrophages express macrophage 
cell surface markers 174 
4.4.3.3 Inducible hemeoxygenase -1 embryonic stem cell- derived macrophages do not overexpress 
hemeoxygenase -1 following doxycycline treatment 174 
4.5 INVESTIGATING THE LOSS OF HEMEOXYGENASE -1 INDUCIBILITY IN GENETICALLY MODIFIED 
HEMEOXYGENASE -1 INDUCIBLE EMBRYONIC STEM CELL -DERIVED MACROPHAGES. I7ó 
4.5.1 Increasing the dose of Doxycycline does not restore inducible hemeoxygenase-I 
expression in embryonic stem cell derived macrophages 178 
4.5.2 The ability of Dox to induce hemeoxygenase -1 overexpression is diminished during 
macrophage differentiation 180 
4.5.3 The loss of inducibility is specific to the A2lox.cre cell line and not related to the 
hemeoxygenase -1 cDNA insert. 182 
4.5.4 The loss of Dox inducibility is not specific to process of cellular differentiation to 
macrophages 188 
4.6 SUMMARY 199 
CHAPTER 5. PHARMACOLOGICAL INDUCTION OF HEMEOXYGENASE -1: HEME 
ARGINATE TREATMENT OF ESDM. 200 
5.1 INTRODUCTION 200 
13 
5.2 HEME ARGINATE MODULATES THE POTENTIAL OF EMBRYONIC STEM CELLS TO UNDERGO SELF - 
RENEWAL 200 
5.3 HEME ARGINATE SIGNIFICANTLY UPREGULATES THE EXPRESSION OF HEMEOXYGENASE -1 BY 
EMBRYONIC STEM CELL -DERIVED MACROPHAGES 203 
5.4 STUDY OF THE EFFECT OF HEME ARGINATE EXPOSURE UPON THE PHENOTYPE OF EMBRYONIC 
STEM CELL -DERIVED MACROPHAGES 205 
5.4.1 The duration of heme arginate exposure has an impact on the level of expression of 
hemeoxygenase -1 by Embryonic Stem Cell -Derived Macrophages 208 
5.4.2 The effect of heme arginate treatment upon the phenotype of embryonic stem cell -derived 
macrophages 
5.4.1.1 Heme arginate does not influence the yield of embryonic stem cell- derived macrophages 
5.4.1.2 Heme arginate treated embryonic stem cell- derived macrophages exhibit a macrophage -like 
morphology 
5.4.1.3 Exposure to heme arginate during embryonic stem cell- derived macrophage differentiation 
modulates expression of CD11b and CD11c 
5.4.1.4.Heme arginate treated macrophages are significantly more phagocytic 








5.4.1.5.1 Heme arginate treated embryonic stem cell- derived macrophages produce less nitric 
oxide following treatment with LPS and IFNy 224 
5.4.1.5.2 Prolonged HA exposure significantly downregulates iNOS gene expression following 
stimulation with LPS and IFNy 225 
5.4.1.5.3 Prolonged heme arginate exposure significantly downregulates TNFa production by 
embryonic stem cell -derived macrophages following LPS and IFNy stimulation 228 
5.4.1.5.4 Heme arginate has no impact on TNFa gene expression by embryonic stem cell - 
derived macrophages following LPS and IFNy stimulation 228 
5.4.1.5.5 Embryonic stein cell- derived macrophages treated with heme arginate for 24h produce 
significantly more IL -10 following LPS and IFNy stimulation 231 
14 
5.4.1.5.6 Prolonged heme arginate exposure significantly downregulates IL -10 gene expression 
by embryonic stem cell- derived macrophages following LPS and IFNy stimulation 231 
5.4.1.5.7 Heme arginate exposure of embryonic stem cell- derived macrophages downregulates 
IL -6 and IL -113 mRNA expression following LPS and IFNy stimulation but does not modulate 
IL -12 mRNA expression 234 
5.5 SUMMARY 236 
CHAPTER 6. DEVELOPMENT OF A MODEL OF ACUTE KIDNEY INJURY IN 129/P2 
MICE AND THE LOCALISATION OF EMBRYONIC STEM CELL DERIVED 
MACROPHAGES IN VIVO 237 
6.1 INTRODUCTION 237 
6.2 THE SEVERITY OF ACUTE KIDNEY INJURY IN 129/P2 MICE IS INFLUENCED BY GENDER AND 
DURATION OF ISCHAEMIA. 238 
6.2.1 The severity of acute tubular necrosis is dependent on gender and the duration of the 
ischaemic period 240 
6.2.2 The severity of renal failure is dependent on mouse gender and the duration of the 
ischaemic insult. 244 
6.2.3 The number of F4/80 positive interstitial macrophages in the medulla of 129/P2 mice is 
dependent on gender 248 
6.2.4 Medullary influx of F4/80 positive macrophages is not evident in 129/P2 mice 24 hours 
following renal ischaemia reperfusion 248 
6.3 IN VIVO LOCALISATION OF EMBRYONIC STEM CELL DERIVED MACROPHAGES 251 
6.3.1 Embryonic stem cell -derived macrophages localise to solid organs one hour post renal 
ischaemia reperfusion injury 251 
6.3.2 Control and heme arginate treated embryonic stem cell- derived macrophages 
preferentially home to the injured kidney one hour post renal ischaemia reperfusion injury 253 
6.4 SUMMARY 256 
CHAPTER 7. DISCUSSION & FUTURE WORK 257 
7.1 DERIVING AND PHENOTYPING EMBRYONIC STEM CELL -DERIVED MACROPHAGES. 257 
15 
7.2 CONSTITUTIVE AND INDUCIBLE OVEREXPRESSION OF HEMEOXYGENASE -1 IN EMBRYONIC STEM 
CELLS AND EMBRYONIC STEM CELL -DERIVED MACROPHAGES. 260 
7.3 PHARMACOLOGICAL INDUCTION OF HEMEOXYGENASE -1: HEME ARGINATE TREATMENT OF 
ESDM 264 
7.4 DEVELOPMENT OF A MODEL OF ACUTE KIDNEY INJURY IN 129/P2 MICE AND THE LOCALISATION 
OF EMBRYONIC STEM CELL DERIVED MACROPHAGES IN VIVO 268 
8. CONCLUSION 271 
16 
Figures 
FIGURE 1: STANDARD NOMENCLATURE FOR STRUCTURES OF THE NEPHRON. 31 
FIGURE 2: RENAL VASCULATURE 34 
FIGURE 3: LOCALISATION OF ACUTE KIDNEY INJURY CAUSES. 37 
FIGURE 4: KEY EVENTS ASSOCIATED WITH RENAL ISCHEMIA /REPERFUSION INJURY. 39 
FIGURE 5: INTERACTION OF HEMOXYGENASE -1 WITH THE SUBSTRATE HEME RESULTS IN THREE END 
PRODUCTS: CARBON MONOXIDE (CO), BILIRUBIN AND FEZ +THAT STIMULATES THE 
UPREGULATION OF FERRITIN 49 
FIGURE 6: POTENTIAL ROUTES OF GENE DELIVERY TO THE KIDNEY 63 
FIGURE 7: CYTOKINES PRODUCED BY IMMUNE CELLS CAN GIVE RISE TO DISTINCT MURINE Mcp 
POPULATIONS .... 67 
FIGURE 8: EMBRYONIC STEM CELLS ORIGINATE AS INNER MASS CELLS WITHIN A BLASTOCYST 72 
FIGURE 9: THE A2LOX.CRE EMBRYONIC STEM CELL LINE. 79 
FIGURE 10: MICROSCOPIC EXAMINATION OF ALKALINE PHOSPHATASE ACTIVITY ASSAY. 82 
FIGURE 11: METHOD FOR THE DIFFERENTIATION OF EMBRYONIC STEM CELLS INTO MACROPHAGES. 86 
FIGURE 12: REPRESENTATIVE PICTURES OF CELLS GENERATED DURING THE EMBRYONIC STEM CELL - 
DERIVED MACROPHAGE DIFFERENTIATION. 87 
FIGURE 13: VISUAL ASSESSMENT OF MACROPHAGE PHAGOCYTOSIS OF APOPTOTIC THYMOCYTES UNDER 
FLUORESCENT MICROSCOPE 97 
FIGURE 14: GRIESS REACTION ASSAY FOLLOWING LPS AND IFN -y ACTIVATION OF MACROPHAGES 99 
FIGURE 1 5 : THE OUTER STRIPE OF THE OUTER MEDULLA (OS OM) IS ONE OF FOUR KIDNEY REGIONS. 1 1 1 
FIGURE 16: PKH26 LABELLED EMBRYONIC STEM CELL -DERIVED MACROPHAGES. 115 
FIGURE 17: EMBRYONIC STEM CELL -DERIVED MACROPHAGES EXHIBIT A MACROPHAGE -LIKE 
MORPHOLOGY 119 
FIGURE 18: EMBRYONIC STEM CELL -DERIVED MACROPHAGES EXHIBIT SIMILAR SIZE BUT HIGHER 
GRANULARITY THAN BONE MARROW DERIVED MACROPHAGES 121 
FIGURE 19: DAY 7 EMBRYONIC STEM CELL -DERIVED AND BONE MARROW DERIVED MACROPHAGES 
EXHIBIT COMPARABLE EXPRESSION OF F4/80 AND CD 1 1 B BY FLOW CYTOMETRY. 123 
17 
FIGURE 20: FLOW CYTOMETRIC ANALYSIS OF F4/80, CD11B, CD11C AND MHC CLASS II EXPRESSION 
OF DAY 7 ESDM, BMDM AND BMDC 125 
FIGURE 21: EMBRYONIC STEM CELL -DERIVED MACROPHAGES AND BONE MARROW DERIVED 
MACROPHAGES EXHIBIT COMPARABLE CELL SURFACE EXPRESSION OF F4/80, CD 11 B, CD 11 C 
AND MHC II. 126 
FIGURE 22: FLOW CYTOMETRIC ANALYSIS OF THE PHAGOCYTOSIS OF FLUORESCENT GREEN LATEX 
BEADS BY F4/80 POSITIVE MACROPHAGES. 129 
FIGURE 23: EMBRYONIC STEM CELL -DERIVED MACROPHAGES AND BONE- MARROW- DERIVED 
MACROPHAGES EXHIBIT COMPARABLE PHAGOCYTOSIS OF FLUORESCENT LATEX BEADS. 130 
FIGURE 24: MICROSCOPIC ANALYSIS OF FLUORESCENT GREEN LATEX BEAD PHAGOCYTOSIS BY CELL 
TRACKER ORANGE LABELLED EMBRYONIC STEM CELL -DERIVED AND BONE MARROW DERIVED 
MACROPHAGES. 131 
FIGURE 25: PERCENTAGE PHAGOCYTOSIS AND PHAGOCYTIC INDEX OF EMBRYONIC STEM CELL -DERIVED 
AND BONE MARROW DERIVED MACROPHAGES FOLLOWING INCUBATION WITH FLUORESCENT 
LATEX BEADS 132 
FIGURE 26: EMBRYONIC STEM CELL -DERIVED MACROPHAGES ARE ACTIVATED BY LPS /IFNy 
STIMULATION AND RELEASE NITRIC OXIDE. 134 
FIGURE 27: QUALITATIVE ASSESSMENT OF CELL MORPHOLOGY BY LIGHT MICROSCOPY. 137 
FIGURE 28: MATURATION OF EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS 138 
FIGURE 29: EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS AND EMBRYONIC STEM 
CELL -DERIVED MACROPHAGES DO NOT EXPRESS THE STEM CELL MARKER OCT4. 140 
FIGURE 30: EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS EXPRESS F4/80 141 
FIGURE 31: EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS (EPC) EXPRESS 
CD11B. 142 
FIGURE 32: DAY 14 AND DAY 16 EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS 
HARVESTS PRODUCE THE HIGHEST CELL YIELDS. 144 
FIGURE 33: EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS EXHIBIT DUAL 
EXPRESSION OF THE MACROPHAGE CELL SURFACE MARKERS F4/80 AND CD I 1B THAT INCREASES 
WITH CELL MATURITY. 146 
18 
FIGURE 34: EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS EXHIBIT EXPRESSION 
OF THE CELL SURFACE MARKER CD 11 C THAT INCREASES WITH CELL MATURITY 147 
FIGURE 35: COMPARISON OF THE CELL SURFACE EXPRESSION OF F4/80, CD 11 B, CD 11 C AND MHC 
CLASS II BY BONE MARROW MONOCYTES, D14 AND D16 EMBRYONIC STEM CELL -DERIVED 
MACROPHAGE PROGENITOR CELLS AND EMBRYONIC STEM CELL -DERIVED MACROPHAGES. 148 
FIGURE 36: EMBRYONIC STEM CELL -DERIVED MACROPHAGE PROGENITOR CELLS ARE ABLE TO 
PHAGOCYTOSE GREEN FLUORESCENT BEADS. 150 
FIGURE 37: STABLE EMBRYONIC STEM CELL LINES OVEREXPRESSING HEMEOXYGENASE -1 UNDER THE 
CONSTITUTIVE PCAG PROMOTER 155 
FIGURE 38: GENERAL STEM CELL CONDITION IS IMPAIRED FOLLOWING INSERTION OF A PCAG -HO -1 
VECTOR INTO THE GENOME OF THE CELLS. 158 
FIGURE 39: THE RANDOM INTEGRATION OF PCAG -HO -1 REDUCES EMBRYONIC STEM CELL SELF - 
RENEWAL ABILITY AND PROMOTES CELL DIFFERENTIATION 159 
FIGURE 40: A VARIABLE NUMBER OF ADHERENT CELLS ARE GENERATED BY THE EMBRYONIC STEM 
CELL -DERIVED MACROPHAGE PROTOCOL FOLLOWING GENETIC MODIFICATION OF EMBRYONIC 
STEM CELLS. 162 
FIGURE 41: CELL MORPHOLOGY OF DAY 7 EI4IV, HO -1/2 AND HO -1/5 EMBRYONIC STEM CELL - 
DERIVED MACROPHAGES 163 
FIGURE 42: FLOW CYTOMETRIC ANALYSIS OF CELL SURFACE MARKER EXPRESSION OF DAY 7 
EMBRYONIC STEM CELL -DERIVED MACROPHAGES DERIVED FROM E14 IV AND HO -1/2 CELL 
LINES. 164 
FIGURE 43: USE OF THE A2LOX.CRE EMBRYONIC STEM CELL LINE TO GENERATE HO -1' "D EMBRYONIC 
STEM CELLS. 167 
FIGURE 44: DOXYCYCLINE INDUCES HEMEOXYGENASE -1 OVEREXPRESSION IN THE INDUCIBLE 
EMBRYONIC STEM CELLS 168 
FIGURE 45: INDUCIBLE HEMEOXYGENASE -1 EXPRESSION HAS NO EFFECT ON THE SELF -RENEWAL 
PROPERTIES OF THE INDUCIBLE EMBRYONIC STEM CELLS. 170 
FIGURE 46: CONTROL INDUCIBLE AND HEMEOXYGENASE -1 INDUCIBLE EMBRYONIC STEM CELL - 
DERIVED MACROPHAGES EXHIBIT A MACROPHAGE -LIKE MORPHOLOGY 172 
19 
FIGURE 47: REPRESENTATIVE SSC AND FSC FLOW ANALYSIS HISTOGRAMS OF CTRL1NDAND HO -1'ND 
EMBRYONIC STEM CELL -DERIVED MACROPHAGES. 173 
FIGURE 48: HEMEOXYGENASE -1 INDUCIBLE EMBRYONIC STEM CELL -DERIVED MACROPHAGES EXPRESS 
CELL SURFACE MARKERS F4/80 AND CD11B. 175 
FIGURE 49: INDUCIBLE EMBRYONIC STEM CELL -DERIVED MACROPHAGES ARE F4 /80 "'" CD 11 BWGH 
CD 11 CMED MHC CLASS IILOW. 176 
FIGURE 50: HEMEOXYGENASE -1 INDUCIBLE EMBRYONIC STEM CELL -DERIVED MACROPHAGES DO NOT 
INDUCE HEMEOXYGENASE -1 OVEREXPRESSION FOLLOWING DOXYCYCLINE TREATMENT. 177 
FIGURE 51: INCREASING THE DOSE OF DOXYCYCLINE DOES NOT RESTORE INDUCIBLE 
HEMEOXYGENASE -1 EXPRESSION IN GENETICALLY MODIFIED EMBRYONIC STEM CELL -DERIVED 
MACROPHAGES. 179 
FIGURE 52: INDUCIBLE HEMEOXYGENASE -1 EXPRESSION DECREASES FROM DAY 4 OF EMBRYOID BODY 
FORMATION AND DISAPPEARS BY DAY 10. 181 
FIGURE 53: THE PERCENTAGE OF EGFP POSITIVE EGFP1ND CELLS DECREASES AS EMBRYONIC STEM 
CELLS UNDERGO DIFFERENTIATION TO MACROPHAGES. 184 
FIGURE 54: THE PERCENTAGE OF EGFP POSITIVE MAML- EGFPIND CELLS FALLS AS EMBRYONIC STEM 
CELLS UNDERGO DIFFERENTIATION TO MACROPHAGES. 185 
FIGURE 55: THE MEAN FLUORESCENCE INTENSITY OF EGFP DECREASES EARLY DURING CELL 
DIFFERENTIATION. 186 
FIGURE 56: EMBRYONIC STEM CELL -DERIVED MACROPHAGES ARE AUTOFLUORESCENT. 187 
FIGURE 57: THE MORPHOLOGY OF RETINOIC ACID TREATED EMBRYONIC STEM CELLS IS DIFFERENT TO 
EMBRYONIC STEM CELLS CULTURED IN LEUKAEMIA INHIBITORY FACTOR 190 
FIGURE 58: RETINOIC ACID TREATED EMBRYONIC STEM CELLS UNDERGO DIFFERENTIATION AND DO 
NOT EXPRESS THE STEM CELL MARKER OCT 4. 191 
FIGURE 59: GENE EXPRESSION OF NANOG GENE IS SILENCED FOLLOWING RETINOIC ACID TREATMENT 
OF GENETICALLY MODIFIED EMBRYONIC STEM CELLS. 192 
FIGURE 60: METHOD FOR THE ASSESSMENT OF INDUCIBLE EXPRESSION OF HO -1 AND EGFP OF OUR 
VARIOUS ESC CLONES FOLLOWING RETINOIC ACID TREATMENT AND DOXYCYCLINE 
STIMULATION 194 
20 
FIGURE 61: RETINOIC ACID DIFFERENTIATED EMBRYONIC STEM CELLS DO NOT EXPRESS INDUCIBLE 
HEMEOXYGENASE- I FOLLOWING DOXYCYCLINE STIMULATION 195 
FIGURE 62: THE PERCENTAGE OF EGFP POSITIVE CELLS DECREASES FOLLOWING RETINOIC ACID 
DIFFERENTIATION OF EGFP1ND ESC AND MAML- EGFP'ND ESC. 197 
FIGURE 63: MEAN FLUORESCENCE INTENSITY OF EGFP DECREASES FOLLOWING RETINOIC ACID 
DIFFERENTIATION 198 
FIGURE 64: HEME ARGINATE MODULATES THE POTENTIAL OF EMBRYONIC STEM CELL TO SELF -RENEW. 
202 
FIGURE 65: HEME ARGINATE INCREASES EXPRESSION OF HEMEOXYGENASE -1 BY EMBRYONIC STEM 
CELL -DERIVED MACROPHAGE 204 
FIGURE 66: HEME ARGINATE TREATMENT PROTOCOLS 206 
FIGURE 67: EXPERIMENTAL DESIGN FOR THE STUDY OF THE EFFECT OF SHORT OR PROLONGED HEME 
ARGINATE TREATMENT UPON THE PHENOTYPE AND FUNCTION OF EMBRYONIC STEM CELL - 
DERIVED MACROPHAGES 207 
FIGURE 68: SHORT OR PROLONGED EXPOSURE TO HEME ARGINATE SIGNIFICANTLY UPREGULATES 
HEMEOXYGENASE -1 EXPRESSION 209 
FIGURE 69: SHORT OR PROLONGED EXPOSURE TO HEME ARGINATE DOES NOT INFLUENCE THE YIELD OF 
EMBRYONIC STEM CELL -DERIVED MACROPHAGES. 211 
FIGURE 70: HEME ARGINATE TREATED EMBRYONIC STEM CELL- DERIVED MACROPHAGES EXHIBIT A 
MACROPHAGE -LIKE MORPHOLOGY 213 
FIGURE 71: FSC AND SSC ANALYSIS BY FLOW CYTOMETRY: HEME ARGINATE DOES NOT INFLUENCE 
EMBRYONIC STEM CELL -DERIVED MACROPHAGE SIZE OR GRANULARITY. 214 
FIGURE 72: EXPOSURE TO HEME ARGINATE DURING EMBRYONIC STEM CELL -DERIVED MACROPHAGE 
DIFFERENTIATION MODULATES EXPRESSION OF CD11B AND CD11C. 216 
FIGURE 73: ASSESSMENT OF MACROPHAGE PHAGOCYTOSIS OF APOPTOTIC THYMOCYTES BY 
FLUORESCENT MICROSCOPY. 218 
FIGURE 74: CONTROL AND HEME ARGINATE TREATED EMBRYONIC STEM CELL -DERIVED MACROPHAGES 
PHAGOCYTOSE APOPTOTIC THYMOCYTES. 220 
21 
FIGURE 75: HEME ARGINATE TREATED EMBRYONIC STEM CELL -DERIVED MACROPHAGES EXHIBIT 
INCREASED PHAGOCYTOSIS OF APOPTOTIC THYMOCYTES 221 
FIGURE 76: EXPOSURE TO HEME ARGINATE DURING EMBRYONIC STEM CELL -DERIVED MACROPHAGE 
DIFFERENTIATION INCREASES THE PHAGOCYTIC INDEX FOR APOPTOTIC THYMOCYTES. 223 
FIGURE 77: HEME ARGINATE TREATED EMBRYONIC STEM CELL -DERIVED MACROPHAGES PRODUCE 
SIGNIFICANTLY LESS NITRIC OXIDE FOLLOWING LPS AND IFNy ACTIVATION 226 
FIGURE 78: PROLONGED HEME ARGINATE EXPOSURE OF EMBRYONIC STEM CELL -DERIVED 
MACROPHAGES SIGNIFICANTLY DOWNREGULATES INOS GENE EXPRESSION FOLLOWING LPS AND 
IFNy STIMULATION. 227 
FIGURE 79: PROLONGED HEME ARGINATE EXPOSURE OF EMBRYONIC STEM CELL -DERIVED 
MACROPHAGES SIGNIFICANTLY DOWNREGULATES TNFa PRODUCTION FOLLOWING LPS AND 
IFNy STIMULATION. 229 
FIGURE 80: HEME ARGINATE TREATMENT OF EMBRYONIC STEM CELL -DERIVED MACROPHAGES HAS NO 
SIGNIFICANT IMPACT ON TNFa GENE EXPRESSION FOLLOWING LPS AND IFNy STIMULATION. 230 
FIGURE 81: EMBRYONIC STEM CELL -DERIVED MACROPHAGES TREATED WITH HEME ARGINATE FOR 24H 
PRODUCE SIGNIFICANTLY MORE IL -10 FOLLOWING LPS AND IFNy STIMULATION 232 
FIGURE 82: PROLONGED HEME ARGINATE EXPOSURE OF EMBRYONIC STEM CELL -DERIVED 
MACROPHAGES SIGNIFICANTLY DOWNREGULATES IL -10 GENE EXPRESSION FOLLOWING LPS AND 
IFNy STIMULATION. 233 
FIGURE 83: HEME ARGINATE EXPOSURE DOWNREGULATES IL -6 AND IL-1I3 GENE EXPRESSION 
FOLLOWING LPS +IFNy STIMULATION BUT HAS NO EFFECT ON IL -12 235 
FIGURE 84: THE ISCHAEMIA /REPERFUSION INJURY MODEL IN THE 129/P2 STRAIN: DETERMINING THE 
EFFECTS OF GENDER AND THE DURATION OF ISCHAEMIA 239 
FIGURE 85: REPRESENTATIVE RENAL HISTOLOGY OF NORMAL KIDNEYS AND KIDNEYS 24 HOURS 
FOLLOWING RENAL ISCHAEMIA REPERFUSION INJURY. 241 
FIGURE 86: THE SEVERITY OF KIDNEY INJURY FOLLOWING 20 MINUTES OF RENAL ISCHAEMIA 
REPERFUSION INJURY IS DEPENDENT ON GENDER. 242 
FIGURE 87: ACUTE TUBULAR NECROSIS INCREASES WITH THE DURATION OF RENAL ISCHAEMIA 
REPERFUSION INJURY 243 
22 
FIGURE 88: 129/P2 FEMALES EXHIBIT HIGHER BASELINE SERUM CREATININE LEVELS THAN MALE MICE. 
246 
FIGURE 89: SEVERITY OF RENAL FUNCTION IMPAIRMENT IS DEPENDENT ON THE DURATION OF THE 
ISCHAEMIC INSULT. 247 
FIGURE 90: IMMUNOHISTOCHEMISTRY STAINING OF F4/80 POSITIVE RESIDENT MACROPHAGES IN THE 
NON -INJURED MEDULLA OF 129/P2 MICE 249 
FIGURE 91: MEDULLAS OF 129/P2 MALE MICE EXHIBIT SIGNIFICANTLY HIGHER NUMBERS OF F4/80 
POSITIVE INTERSTITIAL MACROPHAGES THAN FEMALE MICE. 250 
FIGURE 92: EMBRYONIC STEM CELL DERIVED MACROPHAGES LOCALISE TO SOLID ORGANS 1H POST 
ISCHAEMIA / REPERFUSION INJURY 252 
FIGURE 93: CONTROL AND HEMEOXYGENASE -1 OVEREXPRESSING EMBRYONIC STEM CELL -DERIVED 




TABLE 1: SUMMARY OF THE VARIOUS FUNCTIONS, TISSUE EXPRESSION AND REGULATION OF 
HEMEOXYGENASEISOFORMS. 50 
TABLE 2: BENEFICIAL EFFECTS OF PHARMACOLOGICALLY INDUCED HEMEOXYGENASE -1 
OVEREXPRESSION IN EXPERIMENTAL MODELS OF RENAL DISEASE 57 
TABLE 3: CELL BASED HO -1 DELIVERY SYSTEMS IN VARIOUS DISEASES MODELS 61 
TABLE 4: MACROPHAGE CELL THERAPY IN EXPERIMENTAL RENAL DISEASE 69 
TABLE 5: ESDM GENERAL PHYSIOLOGY STUDIES 75 
TABLE 6: CONJUGATED PRIMARY ANTIBODIES USED FOR FLOW CYTOMETRIC ANALYSIS OF CELLS 
DERIVED FROM BONE MARROW OR EMBRYONIC STEM CELLS 93 
TABLE 7: ANTIBODIES USED FOR WESTERN BLOTTING 104 
TABLE 8: QPCR PRIMERS 108 
TABLE 9: ANTIBODIES USED FOR IMMUNOHISTOCHEMISTRY 113 
TABLE 10: SUMMARY TABLE OF ESC, MPC, ESDM AND BMDM PROPERTIES 151 
24 
List of Abbreviations 
A 
AAV Adeno- Associated Virus 
Ab Antibody 
Ad Adenovirus 
AKI Acute Kidney Injury 
ANOVA Analysis Of Variance 
Anti -GMB Anti -glomerular basement membrane 
Anti -Thy1 Anti Thymocyte differentiation antigen 1 
APC Allophycocyanin 
APCs Antigen Presenting Cells 
ARF Acute Renal Failure 
ATN Acute Tubular Necrosis 
B 
ß Beta 
BMDC Bone Marrow Derived Dendritic Cell 
BMDM Bone Marrow Derived Macrophage 
BMM Bone Marrow Monocytes 
BSA Bovine Serum Albumin 
C 
°C Degree Celsius 
Ca Calcium 
CD11 b Cluster of Differentiation antigen 11 b 
CD11c Cluster of Differentiation antigen 11c 
cDNA Complementary Deoxyribonucleic Acid 
CI Confidence Interval 
CO Carbon Monoxide 
CO2 Carbon Dioxide 
CoCl2 Cobalt Chloride 
CoPP Cobalt protoporphyrin 
CORMs Carbon monoxide -releasing molecules 
COX Cyclooxygenase 
D 
DAB 3,3- Diaminobenzidine 
DAPI 4',6- diamidino -2- phenylindole 
DC Dendritic Cell 
DMEM /F12 Dulbecco's Modified Eagle Medium: Nutrient Mixture F -12 
DMSO Dimethyl Sulfoxide 
Dox Doxycycline 
DT Diphtheria Toxin 
DTR Diphtheria Toxin Receptor 
E 
EB Embryoid Body 
EDTA Ethylenediaminetetraacetic acid 
eGFP Enhanced green fluorescent protein 
ELISA Enzyme Linked Immunosorbent Assay 
ESC Embryonic Stem Cell 
ESDM Embryonic Stem Cell Derived Macrophage 
EtOH Ethanol 
F 
FACS Fluorescence Activated Cell Sorting 
25 
FCS Fetal Calf Serum 
FIHC Fluorescent lmmunohistochemitry 
FITC Fluorescein isothiocyanate 
FSC Forward Scatter 
G 
G Gauge 
GFR Glomerular filtration rate 
GM -CSF Granulocyte- macrophage colony -stimulating factor 




HA Heme Arginase 
H &E stain Hematoxylin and Eosin stain 
HBSS Hank's Balanced Salt Solution 
HEPES 4-( 2- hydroxyethyl ) -1- piperazineethanesulfonic acid 
HO -1 Hemeoxygenase -1 
HPF High Power Field 
HRP Horseradish Peroxidase 
ICE Inducible Cassette Exchange 
IFNy Interferon Gamma 
IgG Immunoglobulin 
IL -1 RA Interleukin 1 Receptor Antagonist 
IHC Immunohistochemistry 
IL -3 Interleukin 3 
IL -4 Interleukin 4 
IL -10 Interleukin 10 
IM Inner Medulla 
Ind Inducible 
iNOS Inducible Nitric Oxide synthase 
IRES Internal ribosome entry site 
IRI Ischemia Reperfusion Injury 




LC Liposome Clodronate 




MAML Mastermind -like 
M -CSF Macrophage Colony Stimulating Factor 
McOH Methanol 
MFI Mean Fluorescence Intensity 
Mg Magnesium 






MPC Macrophage Progenitor Cell 






N/A Non available 
Na Sodium 
NaCI Sodium Chloride 
NEAA Non Essential Amino Acids 
NK Natural Killer 
nm Nanometer 
NO Nitric Oxide 
ns Non significant 
NTN Nephrotoxic nephritis 
O 
Oct4 Octamer- binding transcription factor 4 
OM Outer Medulla 
OMBF Outer medullary blood flow 
OSOM Outer Stripe of the Outer Medulla 
P 
PBS Phosphate Buffered Saline 
PBS -/- Phosphate Buffered Saline without calcium and magnesium 
PE Phycoerythrin 
PerCP -Cy5.5 Peridinin -Chlorophyll Proteins -Cyanin 5.5 
PLA2 Phospholipase A2 
PMN Polymorphonuclear leukocytes 
P/S Penicillin /Streptomycin 
R 
RNA Ribonucleic Acid 
RNase Ribonuclease 
ROS Reactive Oxygen Species 
RT Room Temperature 
rtTA Reverse tetracycline transactivator 
RTU Ready To Use 
S 
SD Standard Deviation 
SDS Sodium Dodecyl Sulfate 
SDS -PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SEM Standard Error of the Mean 
SSC Side Scatter 
T 
TBS Tris Buffered Saline 
TBS -T Tris Buffered Saline -Tween 
TC Tissue Culture 
TE Trypsin EDTA 
TH T helper cell 
TN F-a Tumor Necrosis Factor Alpha 
THE Tet- Responsive Element 
TVP Trypsin Verene Phosphate 
27 
U 




XD Xanthine dehydrogenase 
XO Xanthine oxidase 
28 
Chapter 1. Introduction 
This thesis will examine the anti -inflammatory properties of hemeoxygenase -1 over - 
expressing embryonic stem cell- derived macrophages (Mcp) and their potential to 
limit damage in renal ischemia / reperfusion injury, a devastating entity for which only 
supportive treatments are currently available. 
1.1 The Kidney 
Excretion is one of the basic life processes of all living organisms. In vertebrates, 
the urinary system consists of the kidneys, ureters, bladder and urethra. The 
kidneys are important organs and perform a number of vital homeostatic tasks such 
as the excretion of water, electrolytes, nitrogenous waste through urine production, 
regulation of blood pressure and blood volume, acid -base control as well as the 
synthesis and secretion of hormones such as renin and erythropoietin. 
1.1.1 Anatomy of the kidney 
The kidney has a complex architecture with many structures and is composed of 
various cell types. The kidney consists of two major regions: 
(i) The outer region termed the renal cortex 
(ii) The inner region termed the renal medulla. 
Since structural differences within the kidney are of high importance in the 
pathophysiology studied in this thesis, i.e. ischaemia /reperfusion injury, a short 
anatomical overview is given below and illustrated in Figure 1. 
Outer (OM) and inner (IM) zones are distinguished within the medulla with the OM 
being further subdivided into the outer stripe of the outer medulla (OSOM) and the 
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inner stripe of the outer medulla (ISOM). The nephron is the basic structural and 
functional unit of the organ and carries out nearly all its functions. Each nephron is 
made up of highly specialised cells with marked structural and functional 
differences. 
Nephrons are composed of an initial filtering component, the renal corpuscule 
composed of a glomerulus and the Bowman's capsule, and a tubule specialised for 
reabsorption and secretion of solutes and water. Depending on the position of their 
glomerulus in the renal parenchyma and the length of their tubules, nephrons are 
classified as either cortical or juxtamedullary. Cortical nephrons give rise to long 
loops of Henle entering the inner medulla. The proximal tubule starts at the 
glomerulus and consists of an initial convoluted part also called the Si and S2 
segments, followed by a straight part termed the S3 segment. The transition from 
the proximal tubule to the thin descending limb of Henle's loop is abrupt. Closely 
after the hairpin turn, the thin limb continues into the thin ascending limb, which 
soon enlarges to become the thick ascending limb. The thick ascending limb 
represents the initial straight part of the distal tubule. It extends upwards through the 
outer medulla and the cortex to the glomerulus. The distal convoluted tubule begins 
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Figure 1: Standard nomenclature for structures of the nephron. 
Anatomy of a cortical nephron with regions annotated. Vasculature is shown with 
capillaries in red and venous system in blue. (Modified from (Bonventre and Yang, 
2011) 
31 
1.1.2 Kidney vasculature 
Kidneys receive blood from the renal arteries, which branch directly from the 
abdominal aorta. Despite the relatively small size of the organ, kidney perfusion 
represents approximately 25% of total cardiac output (Friedewald and Rabb, 2004). 
Intrarenal vascularisation (Figure 2) is relatively complex with each renal artery 
branching into lobar arteries, dividing further into interlobar arteries, which supply 
blood to the arcuate arteries that run through the boundary of the cortex and the 
medulla. Each arcuate artery supplies several interlobular arteries that feed into the 
afferent arterioles. Up to that point, the renal arterial system is similar to that of other 
major organs. However, from the afferent arterioles, the renal vascular system 
becomes unique. In most organs, capillary networks are the main sites of 02 -002 
exchange and run between the artery -arteriole and venule -vein systems. In kidneys 
however, the microvasculature consists of two distinct capillaries networks: 
A highly specialised preliminary capillary network where blood filtration 
occurs, the glomerulus, which receives blood from an afferent arteriole 
A second capillary network arising from an efferent arteriole whose structure 
and role vary depending on its location. 
In most cases, after leaving the glomerulus, efferent arterioles branch into a 
complex network of peritubular capillaries in close contact to the tubules in order to 
facilitate reabsorption of solutes etc. In the specific case of juxtamedullary glomeruli, 
the efferent arterioles are dividing into long thin walled vessels called the vasa recta. 
These vasa recta run vertically in the medulla and play an important role in ion and 
fluid exchanges. 
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The glomerulus filters the blood but does not deliver oxygen to tissues nor removes 
significant amount of CO2. The main gaseous exchange happens in the secondary 
network where oxygen is delivered to the tubular cells of the cortex and medulla, 
which have a high demand due to their important metabolic activity. 
After glomerular filtration and the nourishing of tubular cell have occured, the blood 
moves through a small network of venules that converge into interlobular veins. As 
with the arteriole distribution, veins follow the same pattern. Blood exits the kidney 
via the interlobular veins, the arcuate and the interlobar veins, which join to form the 





















Figure 2: Renal Vasculature 
A: The arterial system of the kidney is composed of a renal artery that branches into 
lobar arteries that further divide into interlobar arteries. These supply blood to the 
arcuate arteries that run through the boundary of the cortex and the medulla. B: 
Renal microcirculation. An afferent arteriole, branching from the interlobar artery, 
enters the glomerulus. The efferent arteriole then divides to form a complex 
peritubular capillary network surrounding the cortical tubules. In the case of 
juxtamedullary glomeruli, efferent arterioles give rise to vertically running vessels 
termed the vasa recta. 
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1.2 Renal failure 
Renal failure is a frequent medical condition still associated with high morbidity and 
mortality. Diseases leading to renal failure can be divided into two categories 
according to whether they result in acute kidney injury (AKI) or chronic kidney 
disease (CKD). AKI, previously called acute renal failure (ARF) (Khalil et al., 2008), 
is characterized by a sudden but potentially reversible loss of renal function. In 
contrast, CKD is the progressive and irreversible loss in renal function. 
Acute or chronic renal failure is the result of the inability of the kidneys to 
appropriately filter and excrete toxins and metabolic waste products from the blood. 
It is mainly described as a decrease in glomerular filtration rate (GFR). However, 
various tubular functions as well as intrarenal hemodynamics are also 
compromised. The concentration of serum creatinine is commonly measured to 
evaluate a decline in renal function as creatinine accumulates during renal failure. In 
this work, we measured serum creatinine as our main readout of kidney excretory 
function. Although the causes of AKI are multiple and varied they are commonly 
categorised into pre -renal, intrinsic and post -renal causes (Figure 3). 
Pre -renal AKI is caused by a sudden and severe decrease or interruption of the 
renal blood flow brought about by varied conditions that result in a reduced blood 
volume or pressure (e.g. dehydration, bleeding), heart failure and renal artery 
stenosis (Blantz and Singh, 2011). Although pre -renal kidney dysfunction typically 
resolves if the underlying problem is dealt with (e.g. fluid administration), it can 
result in established intrinsic AKI if the low flow state is prolonged. 
35 
Intrinsic causes of AKI originate from direct damage to the kidneys by inflammation, 
toxins, drugs, infection and /or a prolonged reduction in the blood supply. 
Glomerulonephritis, acute tubular necrosis and acute interstitial nephritis may all 
cause intrinsic AKI (Choudhury, 2010). 
Post -renal AKI is a consequence of an obstruction of urine flow due to extrinsic 
ureteric compression, an enlarged prostate, bilateral kidney stones or a urothelial or 
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Figure 3: Localisation of acute kidney injury causes. 
Pre -renal: sudden and severe drop in blood pressure or interruption of blood flow to 
the kidneys from severe injury or illness. Intrinsic: Direct damage to the kidneys by 
inflammation, toxins, drugs, infection or a reduced blood supply. Post -renal: 
Obstruction of the urine flow due to enlarged prostate, kidney stones, bladder 
tumour or injury. 
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Today, AKI is still a frequent clinical syndrome associated with high morbidity and 
mortality with overall mortality rates of patients with AKI ranging between 25 and 
80 %. However, although supportive care has improved, we still lack specific 
therapies to limit kidney injury, enhance kidney repair and thereby avoid the need 
for dialysis (Bussolati et al., 2008; Lieberthal and Nigam, 2000; Sheridan and 
Bonventre, 2000). 
1.2.1 Pathophysiology of ischaemic acute kidney injury 
Renal ischaemia /reperfusion injury (IRI) is a major cause of AKI and develops 
following a severe drop in total or regional blood flow to the kidney (Bonventre and 
Weinberg, 2003). The severe reduction in glomerular filtration rate (GFR) associated 
with renal IRI has been attributed to the combined effects of modifications in renal 
haemodynamics and tubular injury (Bonventre and Zuk, 2004; Bussolati et al., 2009; 
Sheridan and Bonventre, 2000) (Figure 4). The effects of IRI initially begin in the 
medulla, the region of the kidney most susceptible to hypoxia (Friedewald and 
Rabb, 2004). As the blood flow to the kidney decreases, the cells become 
increasingly hypoxic and undergo cell injury. This cellular injury triggers an 
inflammatory response resulting in endothelial cell activation and injury, enhanced 
endothelial cell -leukocyte adhesion, leukocyte recruitment and a compromised 
microvascular blood flow (Bonventre and Zuk, 2004; Kinsey et al., 2008; Sutton et 
al., 2002). In the following sections, we will discuss the major features of IRI. 
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Figure 4: Key events associated with Renal Ischemia/Reperfusion injury. 
While tissue injury is sustained during the initial ischaemic event, it is exacerbated 
by the robust inflammatory response that occurs during reperfusion. Inflammatory 
mediators are upregulated resulting in leukocyte recruitment and activation. 
Upregulated adhesion molecule expression increases endothelial- immune cell 
interactions with recruited leukocytes increasing injury by generating reactive 
oxygen species (ROS) and enhancing vascular tone. ROS directly injure many 
cytoskeletal and functional cellular components, causing, among other events, the 
redistribution of Na + /K+ ATPase. This results in the loss of the normal Na + /K+ 
gradients, increased intracellular Na +, and subsequent cell swelling. Direct 
endothelial damage and abnormal vascular tone is a result of increased sensitivity 
to and release of vasoconstrictors such as endothelin -1. Increased nitric oxide (NO) 
is generated by inducible nitric oxide synthetase (iNOS), also exacerbates injury. 
Key regulators of apoptosis, such as caspases, are upregulated by these events, 
resulting in increased cell death. 
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1.2.1.1 Proximal tubule alterations and injury 
IRI is characterised by two successive but distinct phases that lead to tissue injury: 
(i) During the initiation phase, or ischaemic period, a severe drop in renal 
blood flow causes increasing hypoxia and cellular ATP depletion, 
creating diverse metabolic changes as well as morphological, functional 
and molecular alterations. 
(ii) During the reperfusion phase, renal blood flow is restored and the tissue 
is re- oxygenated. This phase is critical as the most severe lesions are 
generated during reperfusion. The severity of the lesion generated from 
tissue hypoxia depends upon the nature of the tubular cells. Proximal 
tubular cells are particularly sensitive to hypoxia whilst glomeruli and 
collecting tubules are more resistant to a deficit in oxygen. 
1.2.1.2 Haemodynamic changes 
Cells undergo anaerobic metabolism during the ischaemic period resulting in 
impairment or total inhibition of the mitochondrial respiratory chain, a fall in ATP 
levels and an energy deficit. Cellular ATP depletion results in alteration of the 
cytoskeleton and the integrity of cellular junctions. Moreover, ATP depletion leads to 
tubular cell Na + /K +- ATPase dysfunction and loss of cellular polarisation with 
localisation from the basolateral surface to the apical membrane. The consequent 
intracellular Na+ and water accumulation results in cell swelling that can cause 
tubular obstruction and backleak of fluid. In addition, the proximal tubular cells may 
undergo cell death by necrosis or apoptosis with cell debris forming casts that block 
the tubular lumen. Increased intratubular pressure alters vectorial transport by 
forcing fluid into the interstitium facilitating the development of interstitial oedema. 
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ATP depletion also disturbs calcium- dependent proteases, increases intracellular 
calcium concentration and reactive oxygen species (ROS) generation. Some 
calcium- dependent proteases can convert xanthine dehydrogenase (XD) to xanthine 
oxidase (XO). In the kidney, the most common form present is the XD that uses 
NAD+ as electron acceptor to convert hypoxanthine (generated by ATP degradation) 
into xanthine and uric acid. However, during ischemia, XD is converted into XO, 
which can, during reperfusion, use oxygen as electron acceptor and generate the 
superoxide anion 02: a biologically toxic ROS. Other well -known ROS include 
hydrogen peroxide (H2O2), hydroxyl radical (OH-) and hypochlorous acid (HCIO). 
Apart from XO, sources of ROS in kidneys include cyclo -oxygenases (COX), the 
mitochondria) electron transport chain and polymorphonuclear leukocytes (PMN). In 
normal physiological conditions, the multiple anti -oxidant systems (superoxide 
dismutase, catalase, glutathione peroxidase etc.) limit the potentially deleterious 
effects of ROS. However, in pathological conditions the oxidant /anti- oxidant 
equilibrium shifts towards exacerbated ROS production creating oxidative stress. 
During IRI, this oxidative stress is coupled to a nitrosative stress characterized by 
excess nitrite oxide (NO) production due to the over -expression of inducible nitric 
oxide synthase (iNOS). NO interacts with O2 to form the highly cytotoxic molecule 
peroxynitrite (ONOO-). ROS generation and the resultant oxidative and nitrosative 
stress participate in the progression of ischaemia- associated tissue injury and 
inflammation and further impair kidney function. 
1.2.1.3 Cellular death 
There are two fundamental pathophysiological mechanisms of cellular death. 
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(i) Necrosis is a form of passive, traumatic cell death that results from acute cellular 
injury. It is characterized by the loss of membrane integrity, swelling and cellular 
fragmentation. 
(ii) Apoptosis is a biologically conserved form of programmed cell death (Kerr et al., 
1972). Biochemical events lead to characteristic cell changes including blebbing, 
cell shrinkage, and nuclear and DNA fragmentation leading to cellular death. 
Apoptosis and necrosis generally co -exist after ischaemic injury and their relative 
importance depends on the severity of damage and cellular resilience. In contrast to 
necrosis, apoptosis requires energy. Thus, it is possible for a cell whose active self - 
destruction pathway has started to shift to necrosis in case of a severe ATP 
depletion (Eguchi et al., 1997). 
1.2.1.4 Microvascular alterations 
Impaired flow 
In physiological conditions, the kidney is able to autoregulate its blood supply and its 
perfusion is naturally heterogeneous featuring a decreasing gradient from the cortex 
to the inner medulla. However, the renal blood flow can drop to 50% or more in the 
outer medulla following ischaemia. In these conditions, the kidney is no longer 
capable of autoregulating its blood supply leading to microvascular and 
hemodynamic alterations. 
Renal vasoconstriction follows the activation of tubuloglomerular feedback. Indeed, 
the loss of proximal tubular cell polarity associated with the abnormal localisation of 
Na + /KtATPases pumps and altered tight junctions result in decreased Na' and CI- 
reabsorption by the proximal tubules. The increased concentration of these ions in 
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the macula densa region activates the tubuloglomerular feedback that reinforces 
vasoconstriction. Also, ischaemia induces the production of vasoconstrictor agents 
such as thromboxane A2 (TXA2), angiotensin II (Ang II) or endothelin -1 (ET -1), 
further exacerbating vasoconstriction. 
Prolonged hypoxia also causes structural and biochemical injury to endothelial cells. 
Although the endothelial cell injury is generically similar to that of induced to tubules, 
there are two consequences that are specifically associated with endothelial cells: 
(i) Increased endothelial permeability and 
(ii) Leukocyte -endothelial cell interactions. 
Permeability 
ATP depletion and exposure to hypoxia leads to structural alteration of endothelial 
cells with destabilisation of intercellular interactions. This causes increased 
endothelial permeability that impairs its role as a physical barrier between plasma 
and the renal interstitium. 
Leukocyte adhesion 
Endothelial injury and activation result in increased expression of adhesion 
molecules such as selectins, integrins and members of the immunoglobulin 
superfamily such as intercellular adhesion molecule -1 (ICAM -1) and vascular cell 
adhesion molecule (VCAM). This increases leukocyte -endothelium adhesion and 
enables diapedesis across the endothelium and also contributes to impaired 
microvascular blood flow. Activated leukocytes are also pro -inflammatory and may 
further impair endothelial function by releasing cytokines, proteases and ROS. 
43 
1.2.1.5 Inflammatory response 
A growing body of evidence indicates that inflammation plays a major role in 
ischaemic AKI. Various mediators produced by the ' maladaptive response' of 
proximal tubule to ischaemia amplify the inflammatory cascade, initiated by 
endothelial dysfunction. These include pro -inflammatory cytokines such as tumour 
necrosis factor a (TNF -a), interleukin -1 (IL -1) and IL -6 as well as chemotactic 
cytokines including macrophage inflammatory protein la (MIP -1a), monocyte 
chemotactic protein -1 (MCP -1), regulated upon activation normal T -cell expressed, 
and secreted (RANTES), and IL -8 (Bonventre and Yang, 2011). Several types of 
leukocyte have been implicated as potentially harmful in ischaemic AKI. 
(i) Neutrophils 
Neutrophils are the earliest leukocytes to infiltrate the post -ischaemic kidney. 
However, neutrophil depletion or blockade of their function provides partial 
functional protection in some but not all animal models (Fukuzawa et al., 2009; de 
Vries et al., 2003). Furthermore, neutrophils are not a prominent feature of 
ischaemic AKI in humans, casting doubts about the clinical significance of neutrophil 
infiltration (Devarajan, 2006). 
(ii) Lymphocytes 
The adaptive immune system also contributes to renal IRI. A role for T cells in the 
pathogenesis of kidney IRI has been established in nu /nu mice (which lack CD4 and 
CD8 T cells) and RAG -1 
-i- 
mice (lacking both B and T cells). Nu /nu mice exhibit 
tolerance to ischemia compared to wild -type controls whereas selective 
reconstitution with CD4+ T cells restored kidney injury after IRI ( Burne et al., 2001). 
Additionally, RAG -1 -/- mice were also protected from IRI and adoptive transfer of 
CD4+ T cells from wild -type mice restored injury (Day et al., 2006). Interestingly, 
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transfer of CD4+ T cells from IFN -y -/- mice did not reconstitute injury suggesting a 
critical role for IFN -y. 
Other studies have focused on the role of regulatory T cells (Tregs) in ischaemic 
AKI. Tregs are a subtype of lymphocytes with strong immunosuppressive and anti - 
inflammatory properties and are identified by their expression of CD4 and CD25 and 
upregulation of FoxP3 (Akcay et al., 2009). Depletion of Tregs with an anti -CD25 
monoclonal antibody resulted in greater accumulation of leukocytes and worsened 
kidney damage while Treg repletion significantly attenuated renal injury and 
leukocyte accumulation. However, transfer of IL -10 deficient Tregs did not prevent 
ischaemic injury suggesting an important role for IL -10 in their action (Kinsey et al., 
2009). 
B cell deficient mice are also protected from IRI (Burne -Taney et al., 2003). Unlike T 
cells, the adoptive transfer of purified B cells to these mice did not restore kidney 
injury after ischemia. Interestingly, susceptibility to ischemia could be re- established 
by serum transfer from wild -type animals. The authors suggest that lack of a 
circulating factor, possibly an immunoglobulin, may be responsible for the protection 
observed in B cell- deficient mice. 
(iii) Mononuclear phagocytes 
'Resident' mononuclear phagocytes (macrophages [Mcp] and dendritic cells) are 
present in all normal tissues with replacement via circulating monocytes derived 
from a bone marrow precursor. In the setting of acute or chronic kidney injury, the 
resident mononuclear phagocytes are supplemented by an influx of monocytes from 
the circulation, which themselves undergo activation and are capable of 
differentiating into functionally heterogeneous inflammatory Mcp and dendritic cells 
(Griffin, 2012). Different groups have shown that these cells play a somewhat 
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controversial role in AKI with experimental data suggesting both deleterious and 
protective functions (Ferenbach et al., 2012) and involvement in both the initiation 
and resolution phases of AKI (Kluth et al., 2004; Vinuesa et al., 2008). Today, two 
main systems have been developed for the purpose of selective in vivo depletion of 
Mcp in the hope to distinguish harmful from beneficial effects of these cells during 
AKI: 
(i) The administration of liposomal clodronate (LC), which results in 
widespread death of phagocytic cells within 24 -48 h and 
(ii) Transgenic expression of the diphtheria toxin receptor (DTR) under the 
control of the CD11b or CD11c promoter has generated mice in which 
the administration of diphtheria toxin (DT) results in rapid death of 
CD11b+ monocytes /macrophages or CD11c+ macrophages /dendritic 
cells. 
Although these depletion systems have allowed the role of CD11b+ or CD11c+ to be 
explored in various models of renal inflammation, the results have generated some 
interesting controversies. For instance, studies using LC administration to induce 
monocyte /Mcp apoptosis before IRI have demonstrated a protected phenotype, 
supporting the hypothesis that Mcp are deleterious in the initiation /propagation phase 
of renal IRI (Ferenbach et al., 2012). However, DT administration to CD11b -DTR 
mice had no effect upon the severity of AKI (Ferenbach et al., 2012). Depletion of 
CD11c+ cells by administration of DT to CD11c -DTR mice prior to cisplatin- induced 
AKI (Tadagavadi and Reeves, 2010) was associated with exacerbated injury 
suggesting a protective effect of CD11c+ cells. In contrast, depletion of CD11c+ cells 
prior to ischaemic AKI (Li and Okusa, 2010) was associated with reduced injury 
suggesting a deleterious effect of CD11c+ cells. 
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Concerning the recovery phase of renal IRI, My appear essential for appropriate 
resolution and repair of tissue integrity with depletion of macrophages by LC or DT 
being retarding recovery (Day et al., 2006; Jo et al., 2006; Lin et al., 2010). 
These contrasting results suggest the existence of injurious and reparative Mcp 
phenotypes (see later) and highlight the complexity of interpreting data from 
depletion studies (Griffin, 2012). 
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1.3 The hemeoxygenase system 
Heme (iron protoporphyrin IX) is the chelate complex of an iron atom (Fe2 +) and four 
porphyrin ligand groups (Berl and Chandra, 1993). Despite the vital importance of 
heme molecules in biological processes, an excess of free heme can cause cell 
damage and tissue injury since heme induces ROS formation and oxidative stress 
(Wagener et al., 2003). Cellular homeostasis therefore depends on tight control of 
the amount of free heme in the microenvironment. 
Hemeoxygenase (HO) was originally characterized in 1968 (Tenhunen et al., 1969). 
HO is an ubiquitous inducible stress -response protein and serves a major metabolic 
function in heme turnover. HO is the rate limiting enzyme in the catabolism of the 
heme containing porphyrin ring to equimolar amounts of biliverdin (rapidly converted 
to bilirubin by biliverdin reductase), carbon monoxide (CO) and free iron (Fe2 
which leads to the induction of the iron -binding protein ferritin (Abraham and 
Kappas, 2008; Otterbein et al., 2003; Wagener et al., 2003) (Figure 5). 
To date, three HO isoforms have been identified: Hemeoxygenase -1 (also called 
heat shock protein 32 [HSP32]), HO -2 and HO -3, ( Maines et al., 1986; Tenhunen et 
al., 1969; William et al., 1997). All HO isoforms are highly conserved among species 
in evolution and their various functions, tissue distribution and inducers of 





















Figure 5: Interaction of Hemoxygenase -1 with the substrate heme results in 
three end products: carbon monoxide (CO), bilirubin and Fee+ that stimulates 
the upregulation of ferritin. 
Hemeoxygenase -1 catalyses the breakdown of heme into equimolar amounts of 
CO, free iron (Fe2 +) and biliverdin. Biliverdin is subsequently converted to bilirubin 
through the action of the enzyme biliverdin reductase (BR). Free iron induces ferritin 












































































































































































































































































































Hemoxygenase -1 is the isoform that responds promptly and vigorously to diverse 
stimuli and has been shown to have cytoprotective effects in various inflammatory 
models (Inguaggiato et al., 2001; Lin et al., 2007). Interestingly, the only two human 
cases reported to lack HO -1 enzymatic activity died of an inflammatory syndrome at 
a young age (Kawashima et al., 2002; Radhakrishnan et al., 2011) whilst HO -1- 
deficient mice develop a chronic inflammatory state that progresses with age (Poss 
and Tonegawa, 1997). It is suggested that the clearance of pro- oxidant heme and 
the anti -oxidant and anti -inflammatory properties of its catabolic products account 
for the crucial cytoprotective properties of HO -1 (Nath, 2006). 
Once regarded as a metabolic waste product, CO is now recognised to exert anti - 
inflammatory, anti -apoptotic and anti -proliferative properties at low concentration. 
CO influences a number of signalling pathways, targets NADPH oxidases, which 
regulate intracellular ROS production and influences the mitogen- activated protein 
kinases (MAPK) as well as transcription factors such as NF kappa -B (NF -KB). CO is 
also involved in vasoregulation via its influence on the soluble guanylate cyclase 
(sGC) pathways and calcium- dependent potassium channels (KCa) (Otterbein et al., 
2003; Ryter and Choi, 2009). 
Biliverdin and bilirubin are potent anti -oxidants as they can directly scavenge ROS 
and reduce ROS production, thus reduce cellular damage. These bile pigments are 
associated with the anti -oxidative function of HO -1 (Pae et al., 2008; Ryter and 
Choi, 2009). 
Free iron, another heme catabolite, is known to generate ROS and may act as a 
catalyst of deleterious pro- oxidant reactions if it accumulates in the cell. 
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Interestingly, Fee+ released by the HO -1 reaction can stimulate ferritin synthesis 
which sequesters reactive iron, and thus contributes indirectly to cytoprotection 
(Ryter and Tyrrell, 2000). Suttner and Dennery acknowledged a beneficial threshold 
of HO -1 overexpression related to the accumulation of reactive iron released by 
heme catabolism (Suttner and Dennery, 1999). Low HO -1 expression, low cellular 
heme and low iron may allow for decreased oxidative injury, whereas excessive 
accumulation of reactive iron at high HO -1 expression results in increased oxidative 
stress, cytotoxicity and abnormal cellular proliferation (Suttner and Dennery, 1999). 
More recently, Kinderlerer and colleagues identified an additional cytoprotective 
action of HO -1, showing that HO -1 expression enhances vascular endothelial 
resistance to complement- mediated injury through the induction of the complement 
inhibitory protein decay -accelerating factor (DAF) ( Kinderlerer et al., 2009). 
1.3.1 Hemeoxygenase -1 and the kidney 
HO -1 basal expression is relatively low throughout the kidney with HO -1 localising 
predominantly in the cortical proximal and distal tubules and medullary collecting 
tubules and loops of Henle (Da Silva et al., 2001). However, being an inducible 
enzyme, HO -1 is clearly upregulated in case of stress. The protective effects of HO- 
1 upregulation have proved to be beneficial in different models of IRI including brain 
(Nimura et al., 1996), gut (Attuwaybi et al., 2003), liver (Xue et al., 2007), heart 
(Akamatsu et al., 2004) and kidney (Salom et al., 2007). HO -1 induction also 
improved long term graft outcome in rat renal allografts (Tullius et al., 2001) and 
protected cardiac grafts from transplant associated IRI (Akamatsu et al., 2004). The 
reported cases of HO -1 human deficiency, who both died in childhood, were 
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characterised by systemic inflammation, anemia, thrombocytosis, coagulation 
abnormality, elevated serum levels of ferritin and heme and low serum bilirubin 
concentration in addition to a mesangial proliferative glomerulonephritis and an 
irregular distribution of foamy macrophages with iron pigments (Kawashima et al., 
2002; Radhakrishnan et al., 2011). 
1.3.1.1 Hemeoxygenase -1 in ischaemic acute kidney injury 
As previously discussed, ischaemic AKI is due to a period of significantly reduced 
renal perfusion. Renal dysfunction has been attributed in part to the generation of 
ROS and rapid release of heme by injured cells. As the rate -limiting enzyme in the 
degradation of heme, HO -1 is induced following an ischaemic insult to the kidney. 
Indeed, HO -1 mRNA levels and enzyme activity increase significantly in rodent 
models of IRI. Interestingly, the inhibition of HO -1 activity by tin protoporphyrin 
resulted in worse renal function and increased intracellular heme content in these 
animals (Shimizu et al., 2000). Studies of AKI on HO -1 -I- mice showed significant 
renovascular hypertension and worsen renal function following IRI compared to HO- 
1 +1- mice (Wiesel et al., 2001). 
Although these studied suggest that endogenous HO -1 is protective, the enzyme 
does not provide complete renoprotection and prevention from progression to renal 
failure. Thus, strategies to upregulate HO -1 expression are being studied in an 
attempt to improve the renoprotective capabilities of this cytoprotective enzyme 
(Chung and Perrella, 2004). 
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1.3.2 Strategies of hemeoxygenase -1 up- regulation as therapy in models of 
renal inflammation 
Several strategies are currently being developed to harness HO -1 in inflammatory 
disease. To date, many groups have studied the beneficial efficacy of HO -1 
induction on various models of renal diseases such as AKI, glomerulonephritis (GN), 
drug induced nephrotoxicity and autoimmune renal diseases. Various approaches 
are being studied and whilst pharmacological induction of HO -1 by heme 
derivatives, dietary antioxidants, or currently available drugs is a promising near - 
term approach, HO -1 gene delivery is a long -term therapeutic goal. The various 
available methods of HO -1 overexpression will be discussed in the following 
sections. 
1.3.2.1 Pharmacological induction of hemeoxygenase -1 
Overexpression of HO -1 has been primarily studied with the use of numerous 
pharmacological agents. Amongst these compounds, metalloporphyrins are widely 
recognised as potent HO -1 inducers. These molecules result in the complexing of 
metals such as Fee +, Co2 +, Zn2+ and Sn2+ by the natural precursor of heme, 
protoporphyrin IX (Ryter et al., 2006). Hemin (trade name Panhematin®) is the iron 
(Fe2 +) containing metalloporphyrin approved by the FDA' and widely used in the 
USA as treatment for acute porphyria. However, in its current commercial form, 
hemin is sold as a lyophilised powder that needs to be reconstituted with albumin 
immediately prior to intravenous administration to avoid formation of degradation 
And List of Orphan Products Designation and Approvals. Source: 
http: / /www.fda. gov /ohrms/ dockets /da ilys/00/mar00/030100/Ist0094. pdf 
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products that could potentially be injurious to patients (Anderson et al., 2006). 
Paradoxically, some metalloporphyrins, such as tin protoporphyrin IX (SnPPIX) and 
zinc protoporphyrin IX (ZnPPIX), are used as effective competitive inhibitors of HO -1 
activity (Sardana and Kappas, 1987). HO -1 activity inhibition by SnPPIX and 
ZnPPIX often results in the loss of the protected phenotype and increased damage 
to the tissues (Shimizu et al., 2000). 
Chemical agents such as heme arginate (HA, trade name Normosang®) are also 
potent HO -1 inducers. HA is a stable heme and L- arginine compound (Tenhunen R 
et al., 1987), approved by the FDA2. The addition of L- arginine to the heme 
molecule prevents its rapid degradation in solution and so HA is currently given 
intravenously in the treatment acute porphyria and related neuropathies (Diot et al., 
2007). 
Statins, a widely used class of drugs to reduce cholesterol levels, are capable of 
inducing HO -1 expression. However, the use of statins as HO -1 inducers is at the 
centre of a controversy since the induction is not universally observed and it 
remains unclear whether HO -1 upregulation by the compounds is actually protective 
for humans (Durante, 2010; Golomb and Evans, 2008). 
In the race to discover the best HO -1 inducer, scientists also turned to natural 
compounds such as curcumin, the active ingredient in the spice turmeric (Curcuma 
longa). In vitro and in vivo animal studies have shown that curcumin induces HO -1 
2 And List of Orphan Products Designation and Approvals. Source: 
http: / /www.fda. qov /ohrms/ dockets / dailys /00 /mar00 /030100 /Ist0094.pdf 
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and also possess anti -tumour (Ströfer et al., 2011), anti -oxidant, anti -ischaemic 
(Yang et al., 2009) and anti -inflammatory properties (Zhong et al., 2011) while 
clinical trials in humans are underway (Hatcher et al., 2008). 
Various groups have shown that the pharmacological induction of HO -1 exerted 
renoprotection against ischaemic renal injury, cisplatin induced nephrotoxicity, acute 
glomerulonephritis and renal transplant rejection (Table 2). However, there are 
some challenges associated with the use of pharmacological HO -1 inducers. 
Firstly, as pharmacological HO -1 induction results in a general HO -1 upregulation, it 
might engender non -specific effects that could potentially counteract the therapeutic 
effects associated with HO -1 upregulation. Secondly, as sustained high level of HO- 
1 expression might increase oxygen cytotoxicity and cellular injury, the induction 
and duration of HO -1 expression must be carefully titrated (Suttner and Dennery, 
1999). Furthermore, HO -1 inducibility is largely modulated by polymorphisms in the 
promoter region that may limit the efficacy of pharmacological HO -1 inducers in 
certain patient populations (Durante, 2010). 
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Table 2: Beneficial effects of pharmacologically induced hemeoxygenase -1 
overexpression in experimental models of renal disease 
Model 
(Species) HO -1 
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1.3.2.2 HO -1 gene therapy 
HO -1 gene therapy is a rapidly evolving field in medical research. Various 
experimental techniques using viral, non -viral and cellular vectors have been 
described and employed on different models. However, successful and functional 
HO -1 gene transfer always requires that: 
(i) The gene is delivered into a safe vector and 
(ii) The delivery is site and organ specific (Abraham, 2003). 
In the following section, we will describe available gene delivery techniques, their 
beneficial effects on models of inflammation and possible routes of administration in 
renal disease. 
Viral Vectors 
Viruses such as adenoviruses, retroviruses, lentiviruses and adeno- associated 
viruses (AAV) are commonly used as viral vectors for gene therapy. Indeed, these 
viruses have evolved specialised molecular mechanisms to efficiently transport their 
genomes inside infected cells. Gene therapy trials have used that characteristic to 
deliver the gene of interest to host cells. However, problems of viral gene therapy 
include innate and immune barriers to vector delivery, vector toxicity and the lack of 
sustained therapeutic gene expression. Immune response to viruses impedes gene 
delivery to target cells and can cause severe complications. In one of the early gene 
therapy trials in 1999 this led to the death of a patient who was treated with an 
adenoviral vector (Marshall, 1999). In the case of retroviruses and lentiviruses, 
random integration of the gene of interest into the host's genome can disturb the 
function of cellular genes and eventually lead to cancer (Hacein- Bey -Abina S., 
2003). AAV are known to have site -specific integration that could eliminate the 
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concern for random insertional mutagenesis but are still at risk of an immune 
response. 
While immune responses and insertional mutagenesis pose obstacles, various 
groups are now making progress by modifying existing protocols to overcome these 
hurdles (Herzog et al., 2010). For example, AAV vector capsids are being 
engineered to be more resistant to neutralising antibodies, to transduce target cells 
more efficiently and to show enhanced tropism for specific tissues (Zhong et al., 
2008). Other protocols include transient immune suppression or modulation to 
prevent adaptive responses against capsid or transgene derived antigen (Sack and 
Herzog, 2009). 
Non -Viral Vectors 
Non -viral gene delivery vectors typically consist of DNA or RNA, which may be 
delivered to the target cell usually with the aid of a vehicle. Simple large -scale 
production and low host immunogenicity are their main advantages over viral 
methods. There are several methods for non -viral gene therapy, including the 
injection of naked DNA, the use of oligonucleotides, lipoplexes (micelles and 
liposomes are lipids which can fuse with the cell membrane releasing the nucleic 
acid into the cytoplasm of the cell) and polyplexes, which use a polymer to 
condense the nucleic acid and a lipid coat to aid entry to the cell. Practically, lipids, 
polymers and other naturally occurring compounds have proven to be extremely 
effective for in vitro gene delivery. However, all of the systems have failed or been 
unimpressive in clinical trials because of low delivery efficiency and toxicity. The low 
in vivo transfection efficiency appears to be related to the cationic nature of the gene 
carrier. While effective in protecting DNA from DNA degradation, the polycations in 
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either lipoplexes or polyplexes have the intrinsic property of causing significant 
aggregation in biological matrices full of negatively charged molecules, and of 
preventing effective release of DNA once inside the cells (Gao et al., 2007). 
Cell based delivery systems 
The success of gene therapy relies largely on an effective targeted gene delivery 
system and as described so far, various issues have limited the clinical applications 
of both viral and non -viral delivery systems. Cell -based delivery systems, where 
genetic manipulation is performed ex vivo on cells such as leukocytes, are emerging 
as an alternative for the targeted delivery system. Various groups have shown 
successful HO -1 cell based delivery in various disease models as summarised in 
Table 3. 
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Table 3: Cell based HO -1 delivery systems in various diseases models. 
Model 
(Species) 
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9.3.3 Kidney gene therapy 
Delivering genes to the kidney may offer new strategies to treat diseases of both 
native and transplanted kidneys. The choice of vector for the delivery as well as the 
administration route determines the site of transduction. The challenge with the 
kidney is that the organ is well differentiated with a variety of specialised 
compartments (i.e. glomerular, tubular, interstitial and vascular compartments) 
physically separated by membranes and associated cells. This 
compartmentalisation, as well as factors such as cell turnover rate, blood and urine 
flow may affect the delivery, specificity and efficacy of gene therapy in the kidney 
because the vectors may not pass easily through the anatomical and physiological 
barriers (Imai et al., 2004). On the other hand, the kidney has a major advantage 
over other solid organs since it is accessible by many routes including the renal 
parenchyma, the renal artery, the renal vein and the urinary tract as well as via the 
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Figure 6: Potential routes of gene delivery to the kidney. 
The kidney is accessible by many routes including the renal parenchyma (intra- 
parenchymal), the renal artery (intra- arterial), the renal vein (retrograde venous) and 
the urinary tract (retro -ureteral) as well as via the systemic circulation. 
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1.3.4 Alternatives to direct targeting of HO -1 
The beneficial effects of HO -1 induction are mediated, in large part, through one or 
more products of the heme degradation pathway including CO and bile pigments. 
The last decade has seen an increase in studies using these products as an 
alternative to direct targeting of HO -1. CO can now be inhaled as a gas or delivered 
through CO- releasing molecules (CORMS). CORMs are mostly transition metal - 
containing carbonyls capable of carrying and delivering CO to biological systems 
(Hill -Kapturczak and Agarwal, 2006) and exert functional effects including blood 
vessel relaxation, lowering of blood pressure, protection against cardiac and renal 
IRI, and suppression of endotoxin- induced inflammatory responses (Foresti et al., 
2005; Guo et al., 2004; Sawle et al., 2005; Vera et al., 2005). 
Delivery of biliverdin alone also conferred protection against vascular disease. 
Interestingly, combination of biliverdin and CO resulted in increased protection 
compared to either agent alone in models of heart and kidney transplant associated 
IRI (Nakao et al., 2005). 
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1.4 Macrophages 
Macrophages (My) are key sentinel cells of the innate immune system. Mcp are 
versatile and play a crucial role in the initiation, progression and resolution of 
inflammation (Jaguin et al., 2013). As host primary defence cells, Mcp are present in 
all normal tissues but can also be derived from circulating monocytes that are 
recruited to inflamed tissues. Mcp have various roles including phagocytosis, antigen 
presentation as well as cytokine and pro -inflammatory mediator production (Siamon, 
2007). The Mcp capacity to acquire diverse cellular phenotypes and effector 
functions according to their microenvironment has been revealed by in vitro studies. 
The various Mcp phenotypes described below (Figure 7) have been classified based 
on their fundamental functions that are involved in maintaining homeostasis, i.e.: 
host defence, wound -healing and immune regulation. However it should be noted 
that in vivo, macrophages can evolve to exhibit characteristics that are shared by 
more than one macrophage population described below. 
Classical macrophage activation (Ml phenotype) 
Mcp adopt a classically activated phenotype following stimulation with IFN -y and 
microbial products such as LPS that engage Toll like receptors (TLR). This classical 
or 'M1' phenotype is also induced by innate cells such as natural killer cells (NK) or 
adaptive immune cells such as T helper cells 1(TH1) and results in a Mcp population 
with high microbicidal activity. Indeed, M1 polarised Mcp show enhanced pro - 
inflammatory cytokine production (TNF -a) as well as iNOS expression and ROS 
production (Martinez, 2011; Mosser and Edwards, 2008). 
Wound -healing or alternative macrophage activation (M2 phenotype) 
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The alternative activation of Mcp (M2 phenotype) is also a response to the innate and 
adaptive immune systems. Granulocytes are early sources of innate IL -4 and TH2 
cells also produce IL -4 and IL -13. IL -4 and IL -13 stimulated Mq fail to present 
antigen to T cells, produce limited amounts of pro -inflammatory mediators and are 
considered to play a role in tissue repair by producing increased levels of collagen 
precursors (Hesse et al., 2001; Mosser and Edwards, 2008; Stein et al., 1992). 
Regulatory Macrophage or Deactivation 
The regulatory Mcp phenotype is attained by the presence of IL -10, TGF -(3 and 
glucocorticoids in the milieu and by the ingestion of apoptotic cells. These Mcp 
develop anti -inflammatory properties through the production of IL -10, TGF -p and 
PGE2 as well as a reduced expression of MHC Class II molecules. Their generation 
towards the latter stage of the adaptive immune response suggests an important 
role for Mq in the resolution of inflammation (Mosser, 2008; Gordon, 2005; Erwig, 
2007; Siamon, 2007). 
Taking into account that Mcp will adapt to the local environment by developing 
properties that may either cause further injury or alternatively evolve into cells that 
promote resolution of inflammation and promote tissue repair, different groups have 
focused on the modulation of Mcp phenotype and function and taken an interest in 
harnessing their anti -inflammatory and wound -healing properties for therapeutic 
gain in inflammatory disease. 
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Figure 7: Cytokines produced by immune cells can give rise to distinct murine 
Mcp populations. 
Classically activated M1 Mcp arise in response to IFNy and TNFa produced by TH1, 
natural killer (NK) cells and antigen presenting cells (APC) during immune 
responses. They have a potent microbicidal activity. Regulatory My are generated in 
response to various stimuli including prostaglandins, apoptotic cells, glucocorticoids, 
immune complexes and IL -10. They have an anti -inflammatory activity. Wound - 
healing M2 Mcp arise in response to IL -4 produced by TH2 cells and granulocytes 
and are involved in tissue repair. 
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1.4.1 Macrophages cell therapy in renal inflammation and ischaemic acute 
kidney injury 
Although it is generally recognised that Mcp contribute to the initiation of ischaemic 
AKI (Jo et al., 2006), it has recently been shown that they are also strongly involved 
in renal regeneration after various insults including renal IRI (Vinuesa et al., 2008). 
The 'trapping' of genetically modified Mq in the inflamed kidneys is an elegant 
method for site -specific gene delivery. Experimental models such as 
glomerulonephritis (Kluth et al., 2001b; Wilson et al., 2002a) and tubulointerstitial 
fibrosis (Yamagishi et al., 2001a) have been used to test the effect of 'Mcp cell 
therapy' with Mcp modified to adopt an 'anti- inflammatory phenotype' by 
overexpressing IL -10, IL -4 or IL -1 receptor antagonist respectively. David Harris' 
group extensively investigated the role of ex vivo programmed splenic Mcp for cell 
therapy in a model of proteinuric kidney disease. Data indicates that the adoptively 



























































































































































































































































































































































































































































































































































1.4.2 Macrophages as vector for HO -1 therapy in renal inflammation and 
ischaemic acute kidney injury 
Recent work shows that HO -1 influences Mcp to adopt their regulatory (i.e. anti - 
inflammatory) phenotype (Weis et al., 2009). Bone marrow- derived macrophages 
(BMDM) induced to overexpress HO -1 by adenoviral transduction exhibited an anti - 
inflammatory phenotype with increased IL -10 production, and reduced TNF -a and 
NO production following LPS stimulation. In addition, they exhibited increased 
phagocytosis of apoptotic cells in vitro. Furthermore, administration of these HO -1 
overexpressing BMDM ameliorates AKI in a model of renal IRI (Ferenbach et al., 
2010). 
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1.5 Embryonic Stem Cells 
Embryonic stem cells (ESC) are derived from blastocysts that are structures formed 
in the early development of vertebrates and consist of two primary cell types: 
(i) The inner cell mass (ICM) which is the source of ESC and 
(ii) The trophoblast, which will give rise to the placenta. 
ESC possess two distinctive properties that make them interesting candidates for 
regenerative medicine: 
(I) They are pluripotent and are thus able to give rise to cell types of all 
three germ layers (i.e. mesoderm, ectoderm and endoderm) and thus 
eventually to all of an animal's tissues and organs. 
(ii) They are able to self -renew indefinitely thus dividing and perpetuating the 
stem cell pool whilst maintaining an undifferentiated state (He et al., 
2009). 
Today, mouse and human ESC can be expanded indefinitely in culture and 
differentiated in vitro into mature cells including blood cells, cardiac muscle and 
























Figure 8: Embryonic stem cells originate as inner mass cells within a 
blastocyst. 
ESC can be differentiated in vitro into mature cell types of all three germ layers (i.e. 
endoderm, mesoderm and ectoderm) such as blood cells, cardiac muscle and 
neural cells. 
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1.5.1 Embryonic stem cell derived macrophages 
To a certain extent, our current knowledge of Mcp biology has been generated from 
in vitro examination of isolated macrophages and their precursors. The two main 
approaches used to study Mcp include: 
(i) The isolation of primary Mcp or their precursors followed by culture or 
(ii) The culture of Mq cell lines. 
Each of these approaches has obvious advantages and disadvantages. Acquisition 
of primary cells requires access to living organisms, invasive isolation procedures 
and engenders issues over purity of cell populations and limitation in cell number. In 
addition, primary cells are inherently difficult to manipulate genetically which limits 
their use for studying the molecular mechanisms associated with their function. By 
contrast M4 cell lines provide supplies of limitless numbers of pure cell populations 
that can readily be manipulated but as they are transformed cells they are far 
removed from the normal state. They do however retain certain features of normal 
Mcp and their precursors are consequently widely used in Mq research. 
Today, a new source of Mcp is available as it has been showed that both mouse and 
human ESC can be differentiated in vitro into mature Mcp (Karlsson et al., 2008; 
Odegaard et al., 2007; Zhuang et al., 2012) as well as dendritic cells (Fairchild et al., 
2000) and monocytes (Karlsson et al., 2008). Derivation of Mcp from ESC combines 
both the advantages of tumour cell lines by avoiding in vivo access and isolation 
problems and primary Mq by essentially studying normal cells. ESC can be 
expanded in large numbers in vitro and are highly amenable to sophisticated genetic 
manipulations (Evans and Kaufman, 1981; Thomson et al., 1998) so they have the 
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potential to provide highly pure populations of wild -type or genetically manipulated 
Mcp. This ability to genetically manipulate ESC prior to differentiation makes ESDM 
an attractive source of therapeutic cell types. My cell therapy has great potential to 
improve human disease, such as AKI. Various groups have already reported 
investigating the general physiology of ESDM and their implication in various 
disease models (Table 5). 
For example, murine ESC -derived macrophages (ESDM) have been applied to the 
investigation of macrophage activities in atherosclerotic lesions (Moore et al., 1998) 
and microglial cells (Napoli et al., 2009) as well as general macrophage physiology 
(Odegaard et al., 2007). Similarly, human ESC have been used as productive 

















































































































































































































































































































































































This thesis will examine the hypothesis that anti -inflammatory HO -1 
overexpressing macrophages can be generated from embryonic stem cells in 
vitro and that the administration of these embryonic stem cell -derived 
macrophages overexpressing HO -1 will protect mice from renal lRl in vivo. 
1.7 Aims 
Our aim is to undertake 'proof of principle' studies to determine whether HO -1 
overexpressing ESDM are anti -inflammatory in vitro and renoprotective in vivo 
following renal IRI. For this purpose, we will address the following issues: 
1. ESDM will be phenotyped using a panel of cell surface markers and compared 
to BMDM. 
2. ESC will be genetically manipulated to overexpress HO -1. The effect of genetic 
manipulations undertaken pre- differentiation will be examined to determine any 
deleterious effect upon the ESDM differentiation process. 
3. The phenotype of control and manipulated ESDM in response to inflammatory 
stimuli will be assessed. 
4. A model of murine IRI will be established in the 129/P2 mouse strain to provide 
clinically significant renal injury and dysfunction 
5. Control and ESDM overexpressing HO -1 will be administered to mice with renal 
IRI. 
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Chapter 2. Material and Methods 
2.1 Materials and reagents 
Tissue culture reagents were ordered from Life Technologies (Paisley, UK). Unless 
stated, all other reagents were obtained from Sigma -Aldrich (Poole, UK). Tissue 
culture plates, dishes and tubes were purchased from Costar (Loughborough, UK) 
and Falcon (Runcorn, UK). Antibodies employed for flow cytometry, monocyte 
purification, Western blotting and immunohistochemistry were purchased from 
various suppliers and are summarised in Tables 6 to 9. 
2.2 Embryonic stem cells 
Depending on the genetic manipulation required for a given experiment, the 
murine male embryonic stem cell (ESC) lines were used. 
2.2.1 E14 IV cell line 
E14 IV cells are embryonic stem cells generated from male 129/P2 mice (formerly 
designated 129 /OlaHsd) at the Institute for Stem Cell Research, University of 
Edinburgh. 
2.2.2. A2lox.cre cell line 
The A2lox.cre ESC line was kindly donated by Dr M. Kyba (University of 
Minnesota). A2lox.cre cells constitutively express a reverse tetracycline 
transactivator (rtTA) from the Rosa26 locus located on chromosome 6. Upstream 
from the HPRT locus on the X chromosome, this cell line harbours an Inducible 
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Cassette Exchange (ICE) driven by a tetracycline responsive element (TRE) to 
which the gene of interest can be targeted and stably integrated via loxP, loxM and 
Cre- mediated recombination. In the presence of tetracycline, the rtTA is able to bind 
the TRE and activate expression of the integrated gene of interest. Figure 9 is a 
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Figure 9: The A2lox.cre embryonic stem cell line. 
A: An inducible cassette exchange (ICE) has been targeted to the HPRT locus on the 
X chromosome. The cDNA for cre recombinase has been inserted behind a 
tetracycline response element (TRE) and between IoxP and IoxM sites. In the 
presence of rtTA protein produced by the ROSA26 locus on chromosome 6 and 
doxycycline, the cells express cre and the ICE is self excised and exchanged for an 
incoming plasmid containing the gene of interest cDNA. B: stable new inducible cell 
line expressing the gene of interest protein upon the addition of doxycycline. 
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2.2.3 Embryonic stem cell self -renewal -alkaline phosphatase activity assay 
Embryonic stem cells are able to divide and renew themselves while remaining in an 
undifferentiated state. It is possible to assess their potential to self renew by 
monitoring the expression and activity of the enzyme alkaline phosphatase, an 
enzyme responsible for dephosphorylating molecules such as nucleotides and 
proteins under alkaline conditions. Cells were taken out of the -140 °C freezer and 
quickly thawed in a 37 °C water -bath. Using a plugged Pasteur pipette, the cells 
were resuspended in a final volume of 10m1 warmed ESC medium (500m1 GMEM, 
50m1 FCS, 5ml NEAA, 5ml sodium pyruvate, 500p1 2- mercaptoethanol, 5ml 
glutamine) and transferred to a gelatinised flask (25 cm2). In order to inhibit 
spontaneous differentiation, 10p1 of Leukaemia Inhibitory Factor (LIF) (100 U /ml) 
was added to the cells. After 2 days, confluent cells were trypsinised and passaged 
at 1.5x106 cells per gelatinised 25cm2 flask in 10m1 warmed ESC medium 
supplemented with LIF. After another 2 days, confluent cells were trypsinised again 
and counted prior to commencing alkaline phosphatase activity assay. 1x103 cells 
were plated per well in 6 -well plates and cultured for 6 days in ESC medium in 
triplicate. The propagation of ESC in an undifferentiated pluripotent state is 
dependent on the presence of LIF. Consequently, cells were either grown in the 
presence or absence of LIF (100 U /ml). On day 6, colonies were stained for alkaline 
phosphatase (AP) activity using the Leukocyte AP staining kit (Sigma Diagnostics). 
AP Staining Kits are histochemical assays that use a solution containing a substrate 
and colour dye as the colorimetric read -out for the enzymatic activity. The entire 
experiment was performed at room temperature and the staining was carried 
according as directed by the manufacturer. Demonstration of AP activity can be 
done by simultaneous capture using substituted naphtols and diazonium salts as 
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substrate. To prepare the substrate (made up and stored in the dark), 1m1 of sodium 
nitrite solution was added to 1m1 of Fast Red Violet- Alkaline solution and allowed to 
stand for 2min (i.e. coloured diazonium salt). This mixture was then added to 45ml 
of de- ionised water followed by addition of 1 ml Naphthol AS -BI Alkaline solution. 
Media was removed from the wells and colonies were fixed by addition of citrate - 
formaldehyde- acetone fixative (25ml citrate solution, 65ml acetone and 8ml 
formaldehyde) for 30 seconds then washed off carefully with water (1 ml /well) for 45 
seconds. Colonies were then incubated with 1m1 substrate per well for 15 minutes in 
the dark. Wells were carefully rinsed with water, counterstained with hematoxylin 
solution for 2min and air -dried. Active AP expressed by ESC can be visualised by 
the generation of a pink colour following incubation with the substrate. Differentiated 
cells that do not express the enzyme remain unstained and appear white. 
Subsequently, the number of colonies of stem cells (pink), unstained differentiated 
cells (white) and mixed stem cell and differentiated cells were scored by microscopic 
examination. Figure 10 depicts representative examples of the 3 different types of 
colonies discernible during microscopic analysis of cell cultures following staining for 
active alkaline phosphatase. 
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A 
Figure 10: Microscopic examination of alkaline phosphatase activity 
assay. 
1x103 cells were plated per well in 6 -well plates and cultured for 6 days in ESC 
medium. On day 6, colonies were stained for alkaline phosphatase activity using the 
Leukocyte AP staining kit. A: A stem cell colony stains pink indicating expression of 
alkaline phosphatase. B: A mixed colony of stem cells (pink) and differentiated cells 
(white). C: A fully differentiated colony does not express alkaline phosphatase and 
appears white with no pink staining evident. 
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2.2.4 Retinoic acid - embryonic stem cell differentiation assay 
Stem cells were induced to differentiate using retinoic acid (RA) treatment as 
previously described (Forrester et al., 1996). 1.5x105 cells were plated on 
gelatinised TC dishes and incubated at 37 °C in 10 ml GMEM medium supplemented 
by 5% FCS for 24h. The medium was then complemented with RA at a final 
concentration of 10-6M for a further 48h. 
2.2.5 Embryonic stem cell cryopreservation 
Embryonic stem cells were resuspended in a 1 in 10 dilution of DMSO in GMEM 
medium and stored in 1m1 cryovials (2 cryovials per 25 cm2 flask). They were kept 
overnight at -80 °C then stored in a -140 °C freezer until next use. 
2.3 Preparation of macrophages, dendritic cells and monocytes 
2.3.1 Preparation of L929- Conditioned Medium 
L929 conditioned medium, a source of murine macrophage colony -stimulating factor 
(M -CSF), was prepared by maintaining L929 cells in 50m1 DMEM F/12 medium 
supplemented with 10% FCS and 1% P /S, in a T -162 filter cap flask. After a week, 
the supernatant, further referred to as "L929- conditioned medium ", was removed 
from the T -162 flask, collected in 0.22pm filter units, aliquoted in 50m1 Falcon tubes 
then frozen at -20 °C until further use. 
L929 cells still plated in the T -162 flask were gently washed with 50m1 of warmed 
PBS -/- to remove all trace of FCS. The PBS was removed and the cells trypsinised 
with 10m1 of Trypsin EDTA (TE) for 3 -5mins at 37 °C until detached from the flask, 
then rinsed with 20m1 of fresh DMEM F/12 medium to deactivate the TE and 
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transferred to 50m1 Falcon tubes. Cells were pelleted by centrifugation at 300g for 
5 min and excess medium discarded. The cells were then thoroughly resuspended 
in 50m1 fresh DMEM F /12 medium supplemented with 10% FCS and 1% P /S. The 
single cell suspension was transferred to a new T -162 filter cap flask and cultured 
for another week. 
2.3.2 Preparation of embryonic stem cell- derived macrophages 
Stem cells were taken out of the -140 °C freezer and quickly thawed out in a 37 °C 
water -bath. Using a plugged Pasteur pipette, the cells were resuspended in a final 
volume of 10m1 warmed ESC medium and transferred to a gelatinised flask (25 
cm2). In order to inhibit spontaneous differentiation, 10p1 of LIF (100 U /ml) was 
added to the cells. After 2 days, confluent cells were trypsinised and passaged at 
1.5x106 cells per gelatinised 25cm2 flask in 10m1 warmed ES medium supplemented 
with LIF. After another 2 days, confluent cells were trypsinised again and counted 
prior to commencing the preparation of embryoid bodies (EB) and the generation of 
embryonic stem cell- derived macrophages (ESDM). A drop of 6x105 ESC in 
suspension was added to each bacteriological dish in the presence of 17ml ESC 
medium, 3ml L929 conditioned medium (15% final concentration) and 2p1 IL -3 (1 
ng /ml final concentration). The medium was refreshed on day 4 and day 6 and after 
8 days, the cells spontaneously formed mature EB that were plated down onto 
gelatinised TC dishes with 17ml ESC medium, 3ml L929 conditioned medium, 2pl 
IL -3 and 200p1 of 100 U /ml penicillin and 100 pg /ml streptomycin (P /S). Every 
second day from day 10 to day 30, non -adherent cells in the supernatant were 
collected and subsequently re- plated onto bacteriological dishes (100x15mm) in the 
presence of 17ml ES medium, 3m1 L929 and 200p1 P/S to produce ESDM (Figure 
11). Medium was replaced in the gelatinised dishes to enable further cell production. 
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This whole protocol was based on work done in the CIR by Dr Lihui Zhuang 
(Zhuang et al., 2012). Figure 12 depicts representative pictures of EB in suspension, 
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Figure 11: Method for the differentiation of embryonic stem cells into 
macrophages. 
On day 0, a drop of 6x105 ESC in suspension is added per bacteriological dish 
(100x15mm) and cultured for 8 days. During these 8 days, ESC spontaneously form 
embryoid bodies (EB) in suspension. On day 8, EB are plated down onto a 
gelatinised TC dish. While plated, EB start releasing non -adherent cells into their 
culture supernatant. We call these cells macrophage progenitor cells (MPC). On day 
10, the first harvest of MPC is plated onto a bacteriological dish and after 7 days of 
maturation, adherent cells are produced. The media in the plated EB dish is 





Figure 12: Representative pictures of cells generated during the 
embryonic stem cell- derived macrophage differentiation. 
A: Embryoid bodies (EB) in suspension B: EB plated down onto a gelatinised TC 
dish. C: Adherent cells produced from plated macrophage progenitor cells (MPC) 
generated by plated EB (x100 magnification). 
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2.3.3 Preparation of bone marrow derived macrophages 
Bone marrow derived macrophages (BMDM) were derived from femurs and tibias of 
129/P2 mice aged 6 -8 weeks old obtained commercially or from in -house colonies. 
The mouse was killed by cervical dislocation and its coat was washed with 70% 
ethanol (EtOH) to limit contamination by fur. Autoclaved instruments were used to 
incise the skin laterally about midway down the abdomen and the skin was removed 
from the lower abdomen and the legs. The legs were detached and tissue debrided. 
The intact femurs and tibias were then harvested, rinsed with 70% EtOH and placed 
directly on ice in DMEM /F12 containing 100 U /ml penicillin and 100pg /ml 
streptomycin (P /S) and transported to a sterile pre -cleaned tissue culture hood. In 
the hood, the residual muscle and tissue was removed with a sterile scalpel and 
bones cleaned in 70% EtOH. Bone extremities were severed and the bone marrow 
of 1 femur and tibia was flushed into a universal container with 10m1 of macrophage 
(Mcp) medium that consisted of DMEM /F12 supplemented with 20% L929 
conditioned medium (a source of murine macrophage colony -stimulating factor [M- 
CSF]), 10% FCS and 1% P /S). Cells were resuspended and counted with a 
haemocytometer. Bone marrow cells from 1 femur and tibia were then plated down 
onto three 55cm2 petri dishes in a total volume of 20m1 Mcp medium. Cells were 
matured for seven days with medium being entirely renewed every second day. 
2.3.4 Preparation of bone marrow derived dendritic cells 
Femurs and tibias of 129/P2 mice aged 6 -8 weeks old were obtained as described 
for the preparation of BMDM. However, bone marrow cells were cultured for 7 days 
in dendritic cell medium that comprised RPM] 1640 supplemented with 10% FCS, 
88 
1% P/S and 20 ng /ml of granulocyte macrophage colony -stimulating factor (GM- 
CSF). Fresh GM -CSF was added every third day. 
2.3.5 Purification of bone marrow monocytes 
Femurs and tibias of 129/P2 mice aged 6 -8 weeks old were obtained as described 
for the preparation of BMDM. The extremities of the bones were severed to allow 
flushing of the bone marrow into a 50m1 Falcon tube with sterile HBSS -Prep 
(Ca2 + /Mg2+ free HBSS supplemented with 20mM Na -HEPES [pH 7.4] and 0.5% 
FCS) using a 25G needle and a 20m1 syringe. Bone marrow from different bones 
was pooled into the same tube and disaggregated through a 19G needle prior to 
centrifugation at 400g for 5 min. The pellet was resuspended in 5ml 0.2% NaCI for 
45 seconds to lyse red blood cells and osmolarity was restored by adding an equal 
volume of ice cold 1.6% NaCI. The suspension was filtered through a 100pm cell 
strainer in order to remove residual blood clot and bone remnants. Cells were 
pelleted again by centrifugation at 400g for 5 min. A 90% Percoll solution (3ml 10x 
PBS in 27m1 Percoll Stock) and a 62% Percoll solution (3.2ml of 90% Percoll 
solution in 1.8 ml HBSS -Prep) in a 15m1 Falcon tube were prepared. The bone 
marrow was then resuspended in 5ml HBSS -Prep and carefully layered on top of 
the 62% Percoll gradient prior to a 30 min centrifugation at 1000g on acceleration 5 
with no brake. At the end of the gradient centrifugation, a sharp interface formed on 
top of the 62% Percoll containing immature cells of the non -granulocyte lineages. In 
contrast, the cloudy pellet at the bottom contains granulocytes. The interface 
containing the non -granulocyte cells was carefully harvested into another 15m1 
Falcon tube (approximately 3ml) and washed twice at 400g for 5 min with HBSS- 
Prep made up to 15m1. The cells were counted and resuspended in 2001LI FACS 
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buffer (PBS -/- with 10% mouse serum) for 5 min. In order to deplete the T cells, B 
cells and NK cells, 21AI of biotinylated anti -CD3E, anti -B220 and anti -NK1.1 
antibodies were added and left for 30 min on ice. After a PBS wash, cells were 
resuspended in 2001.1I MACS buffer (PBS, 2mM EDTA, 0.5% BSA) and 1511I 
magnetic beads and left in the fridge for 15 min. In order to remove any unbound 
beads, cells were washed in 5ml MACS buffer then resuspended in a volume of 
5004 Magnetic selection columns were rinsed with MACS buffer prior to running 
the sample. Cells that run through the column are negatively selected monocytes. 
2.4 Characterisation of macrophages 
2.4.1 Cytospin followed by Diff -quick staining 
The morphology of BMDM and ESDM was assessed by the cytospin and Diff -quick 
staining method. 200p1 of a suspension of BMDM or ESDM was added to the well of 
a ` cytospin holder' and the cells were cytocentrifuged at 300g for 3 min in a 
Shandon Cytospin II (Shandon, UK). The cells were then fixed with 100% methanol 
(MeOH) for 2 min, followed by staining in the Diff -quick Red solution for 1 min 
followed by staining in the Diff -quick Blue solution for 1 min (Gaminor Ltd, UK). All 
steps were performed at room temperature (RT). The slides were rinsed with 
distilled water, left to air dry and finally coverslipped and mounted. 
2.4.2 lmmunohistochemistry analysis of cells 
An indirect 3,3'- Diaminobenzidine (DAB) based detection system was used to detect 
the stem cell marker Oct4 and the mononuclear phagocyte markers F4/80 and 
CD11 b. Cytospin preparations of ESDM and supernatant cells were fixed with 3% 
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paraformaldehyde for 20 minutes and stored in PBS at 4 °C. BMDM and ES cells 
were also fixed as positive and negative controls for F4/80/CD11 b and Oct4 
respectively. The slides were transferred to a sequenza rack (Shandon, Inc.) and 
washed with PBS. Non -specific avidin, biotin and protein interactions were then 
blocked for 10 min each using an Avidin /Biotin Blocking Kit (Vector Labs SP -2001) 
and a Protein Block (DAKO Cat X0909) respectively. Slides were incubated at 4 °C 
overnight with 125p1 primary antibody or 125p1 ISO -rat IgG2a isotype antibody. To 
stain for the intracellular transcription factor Oct4, cells were further permeabilised 
with 0.2% triton x100 in PBS (10 minutes). After washing 3 times with PBS, cells 
were incubated with a biotinylated secondary antibody at room temperature (RT) for 
30 minutes, washed 3 times with PBS. Three drops of Vectastain RTU elite solution 
(Vector labs) were then added per slides for 30 minutes. Cells were washed 3 times 
with PBS prior to addition of 12511 DAB solution (Dako, North America Inc) and 
incubation for 5 min (1 drop of stock DAB solution per ml buffer). The slides were 
then placed in a PBS bath prior to being counterstained with haematoxylin for 20 
seconds, rinsed with running tap water and dehydrated through baths of increasing 
ethanol concentration (70 %, 80 %, 90 %, 100 %) for 1 min each prior to immersion in 
xylene for 5 min followed by mounting and coverslipping. Cells that were positive for 
Oct 4, F4/80 or CD11 b were identified by the presence of brown staining under a 
Leica Zeiss Axiovert light microscope. 
2.4.3 Flow cytometry 
Mature BMDM and ESDM were also characterised by flow cytometric analysis of 
surface expression of several Mcp and dendritic cell markers including F4/80, 
CD11b, CD11c and MHC class Il (Table 6). 
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My) were harvested from Petri dishes using detachment buffer (HBSS, 5mM EDTA, 
0.2% BSA) and gently scrapped off with a cell lifter prior to being transferred to 
chilled polystyrene FACS tubes (2.5x105 cells /tube) and centrifuged at 300g for 
5min at 4 °C. The supernatant was carefully discarded and the cells were washed by 
adding 2ml of cold PBS, followed by centrifugation at 300g for 5 min at 4 °C. After 
discarding the supernatant, cells were resuspended in 100p1 blocking solution (PBS 
-/- containing 10% mouse serum) and incubated for 5 min on ice. Fluorochrome 
conjugated antibodies of interest or their respective isotype control diluted 1/100 in 
blocking solution were then added. The cells were mixed gently and incubated on 
ice for 30 min in the dark. Before undergoing flow cytometric analysis, 1m1 PBS -/- 
was added and the tubes centrifuged once more at 300g for 5 min at 4 °C. The 
supernatant was discarded and the reaction was completely stopped by adding 
100p1 of 10% formalin. Analyses were performed using a FACScalibur instrument 
and the results were analysed with FlowJo software (Treestar, USA). 
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Table 6: Conjugated primary antibodies used for flow cytometric 
analysis of cells derived from bone marrow or embryonic stem cells 
Antigen Target Cell Fluorochrome Supplier Reference Isotype 







F4/80 Macrophage & 
dendritic cell 






































B220 B lymphocytes Biotin BD 
Biosciences 
553085 N/A 
NK1.1 NK cells Biotin BD 
Biosciences 
553163 N/A 





2.4.4 Phagocytosis assay 
2.4.4.1 Flow cytometry analysis of phagocytosis of fluorescent latex beads 
BMDM and ESDM were seeded into 12 -well plates (5x105 cells /well) and left to 
adhere for 3h in 0.5ml of Mcp media at 37 °C. After washing non -adherent Mcp away 
with media, 3µm fluorescent green latex beads (Polysciences Inc, Germany) were 
added to each Mcp well at a ratio of 10 beads per Mcp and the plates gently agitated 
manually to ensure an even `carpet' of beads (i.e the availability of beads for 
ingestion was not limiting). Plates were then placed in a dark incubator for 1h at 
37 °C. One experimental plate was kept on ice in order to prevent phagocytosis and 
was used as a control to assess non -specific binding of beads to Mcp. Wells 
containing My alone were used to assess the intrinsic autofluorescence of Mcp 
alone. On completion of the incubation period, and the 
wells washed vigorously 3 times with ice -cold PBS to remove any non -ingested or 
unbound beads. Mcp were lifted off the plastic using detachment buffer (HBSS, 5mM 
EDTA, 0.2% BSA) and gently scrapped off with a cell lifter. The cells were then 
transferred into chilled polystyrene FACS tubes and stained for F4/80 as outlined 
previously. Analyses were performed using a FACScalibur instrument and the 
results were analysed with FlowJo software (Treestar, USA). 
94 
2.4.4.2 Preparation of apoptotic thymocytes 
Thymi from 4 -8 week old female mice were stored in ice -cold RPMI 1640 media 
containing 1% P /S. In a sterile hood, the thymus was dissociated to single cells by 
grinding and washing with media. 10p1 CM green fluorescent dye was added and 
the tubes were incubated at 37 °C for 30 min. 1m1 of 1% FCS was then added to 
quench any free CM green dye and the suspension was transferred to a 75cm2 
tissue culture flask. The volume was made up to 100m1 and dexamethasone was 
added at a final concentration of 1pM to facilitate the induction of apoptosis. The 
flask was incubated in an upright position to increase cell density for 20 hours. Cells 
were then resuspended and transferred to falcon tubes. After centrifuging at 300g 
for 5 min, the cells were pooled and centrifuged again at 300g for 5 min before 
counting with a haemocytometer. 
2.4.4.3 Fluorescent microscopy analysis of phagocytosis of apoptotic thymocytes 
Mcp were seeded onto glass coverslips in 12 -well plates (5x105 cells /well) and left to 
adhere for 3h in 0.5ml of Mcp media at 37 °C. After washing non -adherent Mcp away 
with media, apoptotic thymocytes were added to each Mcp well at a ratio of 10 
particles per Mcp and the plates gently agitated to ensure that an even 'carpet' of 
apoptotic cells overlay the Mcp. Plates were then placed in a dark incubator for 1h at 
37 °C. One experimental plate was kept on ice in order to prevent phagocytosis and 
was used to assess non -specific binding. On completion of the incubation period, all 
plates were placed on ice and the wells washed vigorously 3 times with ice -cold 
PBS to remove excess non -ingested or unbound apoptotic thymocytes. Mcp were 
then stained with Cell Tracker Orange (Life Technologies Invitrogen, UK) in serum 
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free medium and the plates were incubated for 30min. Wells were washed with 10% 
FCS containing media to quench any remaining dye and cells fixed with 10% 
formalin. Images of the phagocytic macrophages were taken with a fluorescent 
microscope (Fluorescent Axiovert 200, Zeiss). When assessing phagocytosis of 
particles by Mcp, the main issue is distinguishing actual ingestion from cell surface 
binding. We visually defined phagocytosis on a case -by -case analysis of the Mq. 
Cell tracker orange labelling of the cytoplasm helped define the contour of the Mcp 
and once ingested, green apoptotic cells would appear yellow. In contrast, non - 
ingested apoptotic cells bound to the Mq cell surface remained green (Figure 13). 
We visually quantified two phagocytosis parameters: 
(i) The percentage phagocytosis: the number of Mq that have ingested 
particles divided by the total number of Mq multiplied by a hundred. 
(ii) The phagocytic index: the mean number of particles ingested by Mcp 
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Figure 13: Visual assessment of macrophage phagocytosis of apoptotic 
thymocytes under fluorescent microscope. 
Representative fields of bone marrow derived macrophages (BMDM) cultured on 
glass coverslips that were exposed to fluorescent green apoptotic cells for 1h. 
BMDM were then labelled with cell tracker orange and fixed with 10% formalin prior 
to fluorescent microscopy. A: fluorescent green apoptotic cells bound to the surface 
of a BMDM remain green whilst B: ingested fluorescent green apoptotic cells 
appear yellow following phagocytosis by a cell tracker orange labelled macrophage. 
C: Cell tracker orange labelling of the cytoplasm of a non -phagocytic BMDM (x320 
magnification). 
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2.4.5 Macrophage activation: LPS and IFNy stimulation 
1x106 cells were plated in 6 -well plates and left to adhere for 3h. Unbound cells 
were washed off with PBS and adherent cells were activated by incubation with LPS 
(1pg /ml) and IFNy (1000 /m1). Control non -activated cells were exposed to culture 
medium alone. Every condition was prepared in triplicate and the plates were 
incubated for 24h at 37 °C. 
2.4.5.1 Nitric oxide measurement 
Nitric oxide (NO) released from cells is rapidly oxidised to nitrite (NO2) in culture 
medium so that nitrite concentrations were used as an indirect measurement of NO 
production. The Griess method of measuring nitrite concentration consists of a two - 
step reaction where nitrite molecules react with sulfanilamide to generate a transient 
diazonium derivative. This intermediate further interacts with N- (1- naphthyl)ethylene 
diamine to yield a coloured diazo end product that strongly absorbs at 540nm as 
showed on Figure 14. Briefly, 50p1 of cell culture supernatants derived from control 
or LPS /IFNy activated Mcp were mixed with 50p1 of Griess reagent (1% 
sulphanilamide, 0.1% N- (1- naphthyl) ethylene diamine) in triplicate in 96 -well plates. 
After 15 min incubation at RT, absorbance was read at 540 nm and the level of NO 
was calculated using a standard curve generated by known sodium nitrite 
concentrations. 
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Coloured diazo product 
strong absorbance at 540nm 
Figure 14: Griess reaction assay following LPS and IFN-y activation of 
macrophages. 
Nitric oxide (NO) released in the supernatant of LPS /IFN -y activated macrophages 
was assessed by the Griess assay. NO is rapidly oxidized to nitrite (NO2) that 
subsequently reacts with sulfanilamide to generate a transient diazonium derivative. 
This intermediate product further interacts with N- (1- naphthyl)ethylene diamine to 
yield a coloured diazo end product that absorbs strongly at 540nm. The level of NO 
was then calculated using a standard curve generated by known sodium nitrite 
concentrations. 
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2.4.5.2 Enzyme Linked Immunosorbent Assay 
An Enzyme Linked Immunosorbent Assay (ELISA) was used to determine the 
concentration of murine TNFa and IL -10 in supernatants from control and LPS /IFNy 
activated My according to the manufacturer's instructions (R &D Systems, Abingdon, 
Oxfordshire, UK). Briefly, the goat anti -mouse TNFa or IL -10 capture antibody was 
diluted in PBS and used to coat a 96 well plate (50pl /well). The plates were sealed 
and incubated overnight at RT. The capture antibody was removed and the wells 
were washed 3 times using PBS containing 0.05 %Tween -20 (pH 7.4). 300pI of 
blocking buffer (1% BSA in PBS) was applied to each well for 1h at RT. Blocking 
buffer was removed and the wells washed 3 times as previously described. 50p1 of 
either standard or experimental sample diluted in reagent diluent was applied to 
each well. Both standards and experimental samples were run in duplicate. The 
plates were sealed and incubated at RT for 2h. Wells were washed 3 times as 
described and 50p1 of biotinylated goat anti -mouse TNFa or IL -10 detection antibody 
diluted in reagent diluent was added to each well. Following 2h incubation, the 
detection antibody was removed and the wells washed 3 times again. 50p1 of 
streptavidin- horseradish peroxidase (HRP) was applied to each well. The plate was 
covered and incubated for 20 min at RT. Further washing was followed by the 
addition of 50p1 of substrate solution to each well and the plates were incubated for 
a further 20 min with protection from light. The reaction was then stopped by the 
addition of 50p1 of stop solution (2N H2SO4) to each well. The optical density of each 
well was evaluated using a microplate reader (Dynatech Laboratories, USA) set to a 
wavelength of 450nm with the wavelength correction set to 570nm. 
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2.5 Induction of hemeoxygenase -1 expression 
2.5.1 Pharmacological induction of hemeoxygenase -1 expression 
The pharmacological induction of hemeoxygenase -1 (HO -1) expression was 
achieved by incubation of cells with heme arginate (HA) (Orphan Europe, Paris, 
France). Cells were plated in 12 -well plates (5x105 cells /well) and exposed to 10pM 
HA (dissolved in MT medium) for 24h. 
2.5.2 Genetically engineered induction of hemeoxygenase -1 expression 
Generation of HO -1 overexpressing ESC was performed by Dr Richard Axton from 
the MRC Centre for Regenerative Medicine at the University of Edinburgh. Genetic 
engineering was employed to generate ESC cell lines with either: 
(i) Constitutive overexpression of HO -1 or, 
(ii) Inducible overexpression of HO -1. 
In both cases, amplified murine HO -1 cDNA (Reverse: 5'- 
GCGGCCGCTTACATGGCATAAATTCCCACTGCCACTGTT-3'; Forward: 
5' CTCGAGAATTCGGTACCACCATGGAGCGTCCACAGCCCGACAGCATGC -3') 
was subcloned into a TA Cloning® vector using a TOPO® cloning kit (Invitrogen, 
Paisley, UK). 
2.5.2.9 Constitutive overexpression of hemeoxygenase -1 under the pCAG promoter 
The HO -1 /TA cloning® vector was subsequently cloned into a mammalian 
expression vector pCAG containing an internal ribosome entry site (IRES) and 
puromycin. Integration of the expression vector into the cell genome via 
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electroporation then produced stable HO -1 expressing ESC lines selected by their 
puromycin resistance. 
2.5.2.2 Tetracycline inducible system: using the A2lox.cre embryonic stem cell line 
The HO -1 /TA cloning® vector was subsequently cloned into a p2Lox targeting 
vector. Cre /Lox recombination was used to insert p2Lox into the inducible cassette 
exchange (ICE) behind a tetracycline responsive element as previously described 
(lacovino et al., 2011). In the tetracycline inducible system, doxycycline (Dox - a 
broad -spectrum antibiotic of the tetracycline family) is required in conjunction with 
rtTA to drive the Cre /Lox recombination as well as THE and HO -1 expression 
(Figure 9). Inducible cells were exposed to 5pg /ml Dox and incubated at 37 °C for 
24h. 
2.6 Detection of Hemeoxygenase -1 Protein 
2.6.1 Western blotting 
The protein content of My) was assessed with a Bio -Rad Protein Assay Kit, based 
on the Bradford method prior to performing Western blotting. 20pg of protein 
samples were subjected to 10% SDS- polyacrylamide gel electrophoresis (SDS- 
PAGE) in 1mm slab gels according to the procedure of Laemmli (Laemmli, 1970) 
and the separated polypeptides were then transferred electrophoretically from the 
gel to a pure nitrocellulose membrane using transfer buffer (0.25M Tris base, 1.92M 
glycine, and 1% SDS). Following electroblotting, the nitrocellulose membrane was 
stained with Ponceau Red for protein detection. Destaining was performed with 
distilled water and the membrane blocked with skimmed milk powder (5% in Tris 
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Buffered Saline [TBS]) for 30min at RT. The nitrocellulose blot was then incubated 
overnight on a shaker at 4 °C with a rabbit anti -mouse HO -1 antibody (diluted 1/5000 
in 1% BSA made up in TBS -0.05% Tween 20). The membrane was then washed 3x 
with TBS -Tween and exposed to a secondary goat anti -rabbit IgG -HRP antibody for 
35 min on a shaker at RT. The membrane was washed repeatedly with TBS -Tween 
with the final wash being with TBS without Tween as this can interfere with the 
developing agent. The blots were developed using the chemiluminescence reagent 
SuperSignal West Femto Trial Kit (Thermo Scientific) and visualised in a VersaDoc 
Molecular Imager (VersaDoc MP 4000 Imaging System, PC /Mac from Bio -Rad). 
Other antibodies used for Western blotting can be found in Table 7. 
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2.6.2 Flow cytometry analysis of intracellular hemeoxygenase-1 expression 
As previously described, My were stained for the cell surface marker F4/80 with an 
APC- conjugated anti -mouse F4/80 antibody prior to intracellular staining of HO -1, 
performed using a monoclonal PE- conjugated HO -1 antibody. Cells were 
permeabilised using the Fixation /Permeabilisation Concentrate and Diluent kit and 
10x Permeabilisation Buffer (eBioscience, UK) according to the manufacturer's 
instructions. Analyses were performed using a FACScalibur instrument and the 
results were analysed with FlowJo software (Treestar, USA). 
2.7 Detection of Hemeoxygenase -1 gene expression 
2.7.1 RNA extraction 
RNA was extracted from cells using the Trizol method (Chomczynski and Sacchi, 
1987). Briefly, cells grown in Petri dishes were lysed directly by adding 1m1 of Trizol 
Reagent and homogenised by passing the cell lysate several times through a 
pipette. The homogenised samples were transferred to autoclaved eppendorf tubes 
and were either frozen at -80 °C until further use, or incubated for 5 min at room 
temperature (RT) to permit the complete dissociation of nucleoprotein complexes. 
200p1 of chloroform was then added to the samples. The eppendorf tubes were 
vigorously shaken and incubated for 3 min at RT prior to 15 min centrifugation at 
12,000g at 4 °C. Following centrifugation, the RNA remains in the colourless upper 
aqueous phase and was transferred to fresh eppendorf tubes. The RNA was 
precipitated by adding 500p1 isopropyl alcohol and samples incubated for 10 min at 
RT prior to 10 min centrifugation at 12,000g at 4 °C. The supernatant was carefully 
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removed and the RNA pellet washed once with 75% ethanol (in RNase -free water) 
by vortexing then centrifuging the samples for 5 min at 7500g at 4 °C. The RNA 
pellet was air -dried for 10 min and then dissolved in 30p1 RNase -free water and 
incubated for 10min at 55 °C. 
2.7.2 DNase treatment 
To exclude genomic DNA contamination, RNA samples were treated with DNase I 
using a TURBO DNA- freeTM kit (Applied Biosystems /Ambion, Ref. AM1907). Briefly, 
RNA samples were incubated with DNase I at 37 °C for 30 min. Controls samples 
were incubated with TURBO Buffer instead. The reaction was stopped using DNase 
inactivation reagent for 5 min. Samples were centrifuged at 10,000g for 1.5 min and 
RNA transferred to fresh eppendorfs. 
2.7.3 Reverse transcriptase PCR 
The RNA concentration of the samples was determined using a NanoDrop 
spectrophotometer (Thermo Fisher Scientific Inc.). For the Reverse Transcriptase 
assay, 1 pg RNA was mixed with 3.5p1 RNase -free water, 2p1 10x MMuLV Reverse 
Transcriptase Buffer (Stratagene, Ref. 600083 -52), 2pl of 40mM dNTP Mix 
(Stratagene, Ref. 200415 -51), 0.5p1 RNasin® RNase Inhibitor (Promega, Ref. 
N211A), 1pl MMuLV Reverse Transcriptase (Stratagene, Ref. 600084 -51) and 1p1 
Oligo (dT) 15 Primer (Promega, Ref. C110A). In order to allow the reverse 
transcription of RNA into cDNA to take place, samples were incubated for 10 min at 
20 °C followed by 60 min at 37 °C and 5 min at 95 °C in a Bio -Rad iCycler. At the end 
of the cycle, samples were kept at 4 °C then kept at -20 °C until further use. 
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2.7.4 Quantitative real time PCR 
Quantitative real time PCR (qPCR) was used to detect the expression levels of 
various genes (Table 8). Samples were dispensed in triplicates in MicroAmp® 
Optical 96 -well reaction plates (Applied Biosystems®, Life Technologies Ltd, 
Paisley, UK) and analysed using an Applied Biosystems 7500 Fast -Real PCR 
System with the following thermal cycle conditions: 
(i) 20 seconds at 95 °C followed by 
(ii) 40 repetitions of 3 seconds at 95 °C and 30 seconds at 60 °C 
Relative quantitation was calculated using the deltaCT method in ABI SDS1.4 
software using 18s or GAPDH as the endogenous control. Data are presented as 
the fold change in gene expression relative to an internal calibrator. 
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Table 8: qPCR primers 
All primers with SYBR® green detection were designed by Dr A. Czopek, the 
University of Edinburgh. Professor L. Forrester's team designed the HPRT primers 
(Gordon -Keylock et al., 2010). Ready -made primers were purchased from Applied 
Biosystems®, LifeTechnologies Ltd (Paisley, UK). 






























Applied Biosystems®, LifeTechnologies Ltd primers 
Gene Assay ID Cat# Detection 
18s Mm03928990_g1 4331182 
NANOG Mm02019550_s1 4331182 TaqMan® 
ROSA26 Mn03456292 m1 4426961 
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2.8 Murine Model of Renal lschaemia/Reperfusion Injury 
Female and male 129 -P2 mice aged 6 -8 weeks old were obtained commercially or 
from in -house colonies. Anaesthesia was induced by injection of 250p1 of ketamine 
and metatomidine mix (4.14m1 normal saline, 0.36m1 ketamine, 0.5ml metatomidine) 
via the intraperitoneal route. Via a midline laparotomy a right nephrectomy was 
performed and the kidney fixed in methyl -Carnoy's solution (60% methanol, 30% 
chloroform and 10% acetic acid) for histological analysis as baseline normal tissue. 
The left renal pedicle was then clamped using an atraumatic clamp (Teleflex 
Medical, UK) for 20, 25 or 30 minutes and the kidney was observed to ensure that it 
became pale. During the ischaemic period the body temperature was maintained at 
37 °C using a heating blanket with a homeostatic control via a rectal temperature 
probe (Harvard Apparatus, Boston MA). The clamp was then removed and the 
kidney was observed to ensure a complete restoration of blood flow. The 
peritoneum was closed with 5/0 silk suture and the skin was closed with metal clips. 
Anaesthesia was reversed using 200p1 atipamezole diluted 1:10 in normal saline 
and 50p1 buprenorphine (0.04m1 made up to 1ml with normal saline) injected 
subcutaneously to provide post- operative analgesia. To ensure adequate hydration, 
1m1 of sterile saline was administered subcutaneously both prior to and following 
surgery. The animals were maintained in a 28 °C incubator overnight. Mice were 
culled 24 hrs following ischaemia /reperfusion injury (IRI) and the left kidney was 
removed, cut longitudinally and either snap frozen in liquid nitrogen or fixed in 
methyl -Carnoy's solution prior to embedding in paraffin. Blood samples were 
collected at 24h post surgery under terminal anaesthesia. Procedures were 
performed under Home Office licences 60/3317 (Project license - Renal 
Inflammation and Repair Licence held by Dr David Kluth) and 60/12064 (Personal 
Licence held by Miss Noémie Nkejabega). 
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2.8.1 Characterisation of ischaemic injury 
2.8.1.1 Assessment of renal histology 
Paraffin embedded kidneys sections were cut into 4pm tissue slices and stained 
with haematoxylin and eosin by members of the QMRI Histology Laboratory 
(University of Edinburgh). All sections were then assessed using a Leica light 
microscope. Acute tubular necrosis (ATN) scores were obtained by taking 5 non - 
overlapping pictures (x100 magnification) of the outer stripe of the outer medulla 
(OSOM) region of the kidney (Figure 15) and tubules counted as either viable or 
necrotic based on nuclear morphology and integrity of the epithelial cell layer using 
ImageJ software (NIH). The percentage of necrotic tubules was calculated using the 
formula: 
Percentage Necrosis = Number of necrotic tubules x 100 
Number of total tubules 




I S OM 
Inne Medulla 
Figure 15: The outer stripe of the outer medulla (OSOM) is one of four 
kidney regions. 
Representative 4pm slice of paraffin embedded kidney section stained with 
haematoxylin and eosin. The outer stripe of the outer medulla (OSOM) is the region 
of the renal medulla adjacent to the cortex. It is mainly constituted of the S3 
segments of the proximal tubules and distal nephron tubules. Acute tubular necrosis 
scores were determined following analysis of the OSOM as this area is the most 
severely injured kidney region following renal ischaemia- reperfusion injury. 
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2.8.1.2 Immunohistochemistry of tissue sections 
An indirect 3,3'- diaminobenzidine (DAB) based detection system was used to detect 
expression of HO -1 and the My and dendritic cell marker F4/80 in renal cells. 
Paraffin embedded kidneys were cut into 4pm tissue sections and mounted on glass 
slides then dewaxed in xylene for 10 min and rehydrated through decreasing 
ethanol concentration baths (100 %, 90 %, 80 %, 70 %) for 1 min each prior to being 
immersed in PBS. The slides were transferred to a sequenza rack (Shandon, Inc.) 
and then washed with PBS. Potential non -specific interaction of the tissue with 
avidin, biotin and protein were blocked for 10 min each using an Avidin /Biotin 
Blocking Kit (Vectro Labs SP -2001) and a Protein Block (DAKO Cat X0909) 
respectively. Tissue sections were incubated at 4 °C overnight with 125p1 primary 
antibody or the corresponding isotype (Table 9). After 3 PBS washes, the tissue 
sections were incubated with a biotinylated secondary antibody at room temperature 
(RT) for 30 min and then washed 3 times with PBS and incubated in Vectastain 
RTU elite (Vector labs) for 30 min. Tissue sections were then washed 3 times with 
PBS prior to the addition of 125p1 DAB solution (5 min, 1 drop of DAB stock per ml 
buffer) (Dako, North America Inc). The slides were counterstained with 
haematoxylin for 20 seconds, rinsed then dehydrated through baths of increasing 
ethanol concentration (70 %, 80 %, 90 %, 100 %) for 1 min each prior to being 
immersed in xylene. The slides were coverslipped to avoid degradation. Positive 
immunoreactive cells were identified by the presence of brown staining under a light 
microscope. Cell counts were expressed as mean cell number per microscope field 
(x400 magnification) with 5 fields being assessed per tissue section. 
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Table 9: Antibodies used for immunohistochemistry 
This table summarises the various antibodies (Ab) used to analyse both cytospins of 


























































2.8.1.3 Assessment of renal function 
Blood collected pre- and post -injury was centrifuged at 1000g for 5 min. Serum was 
aliquoted and subsequently analysed for creatinine and urea concentration. Dr 
Forbes Howie of the Department of Clinical Chemistry, the University of Edinburgh 
performed the creatinase assay (enzymatic colorimetric Trinder kit, Sentinel CH., 
Italy) and the InfinityTM Urea Liquid Stable Reagent (Thermo Electron, USA) on a 
Cobas Fara Centrifugal Analyser (Roche Diagnostics Ltd., Welwyn Garden City, 
UK) according to the manufacturer's instructions. 
2.9 In vivo localisation of embryonic stem cell- derived macrophages 
2.9.1 PKH26 dye labelling of macrophages 
In order to track ESDM in vivo, they were labelled prior to injection using the PKH26 
red fluorescent cell linker kit for phagocytic cells (PKH26PCL) according to 
manufacturer's instructions. The labelling occurs through the formation of dye 
aggregates, which significantly limits the uptake of dye by non -phagocytic cells, but 
facilitates ingestion by phagocytic cells. Figure 16 shows PKH26- labelled 
macrophages. Following staining, ESDM were counted and kept on ice until being 
intravenously administered to mice via the tail vein after the induction of renal IRI. 
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Figure 16: PKH26 labelled embryonic stem cell- derived macrophages. 
Cytospin preparations of PKH26 positive embryonic stem cell- derived macrophages. 
A: photomicrograph (50x magnification) showing that the majority of cells are 
strongly labelled. B: photomicrograph (320x magnification) showing the nature of 
the labelling, which localises to the phagolysosomes within the macrophage. 
115 
2.9.2 Localisation of macrophages following renal ischaemia /reperfusion 
injury 
The model of IRI was adapted to facilitate a direct comparison of the localisation of 
ESDM to either injured or normal kidney tissue. The right kidney was left in situ 
while the left kidney pedicle was clamped for 25 min as described previously. After 
restoration of the renal blood supply, 5x106 PKH26- labelled ESDM were injected via 
the tail vein. The left and right kidneys, liver, spleen and lungs were harvested 1h 
post cell injection under terminal anaesthesia and snap frozen in liquid nitrogen. The 
localisation of PKH26- labelled ESDM to the normal or injured kidney was 
determined by counting PKH26- labelled cells by fluorescence microscopy on 5pm 
frozen sections mounted on glass slides with DAPI mounting medium. The results 
were expressed as mean cell number per high power field (x400 magnification) with 
5 fields being counted per organ. 
2.10 Statistical analysis 
All statistical analysis was performed using GraphPad Prism version 4.0c for 
Macintosh (GraphPad Software, USA). All data, unless otherwise stated, are 
expressed as mean ± standard deviation (SD). The Student's Unpaired t -test was 
employed to compare two groups whereas multiple conditions were compared using 
one -way ANOVA coupled with Tukey's post hoc test for multiple comparisons. Two - 
way ANOVA was used to compare the effects of 2 or more factors on different 
groups. When populations were not normally distributed, samples were compared 
using the non -parametric Mann -Whitney U test. P values of less than 0.05 (p <0.05) 
were deemed to be statistically significant. N values stand for experiment repeats 
(i.e. when cells are involved, n values are for number of cell preparations). 
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Chapter 3. Deriving and phenotyping embryonic stem 
cell- derived macrophages 
3.1 Introduction 
In recent years, data from various groups has shown that macrophage 'cell therapy' 
has significant potential to improve human disease. In nephrology more specifically, 
experimental models of renal inflammation such as ischaemic acute kidney injury 
(Ferenbach 2010), immune -mediated glomerulonephritis (Kluth 2001, Wilson 2002) 
and progressive tubulointerstitial fibrosis (Yamagishi 2001) have been used to test 
the effect of cell therapy with bone marrow derived macrophages (BMDM) modified 
to adopt an 'anti- inflammatory phenotype' by overexpression of HO -1, IL -10, IL -4 or 
IL -1 RA respectively. These studies indicate that adoptively transferred modified 
BMDM can localise to the inflamed kidney and ameliorate disease. However, the 
relative complexity of genetically manipulating primary macrophage cultures 
represents a considerable problem. To overcome this difficulty, scientists have 
turned to embryonic stem cells (ESC) that are highly amenable to genetic 
manipulation. Recent work has shown that both mouse and human ESC can be 
differentiated in vitro into mature macrophages, monocytes (Odegaard 2007, 
Karlsson 2008, Zhuang, 2012) as well as dendritic cells (Fairchild 2000). Embryonic 
stem cell- derived macrophages (ESDM) are an attractive source of potentially 
therapeutic cells to use to ameliorate the progression of disease because of their 
ability to be genetically manipulated prior to being differentiated into macrophages. 
This chapter outlines the derivation, phenotyping and functional characterisation of 
ESDM in comparison to primary BMDM. 
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3.2 Phenotyping embryonic stem cell- derived macrophages 
Macrophages are key sentinel cells of the innate immune system and exhibit various 
key functions including phagocytosis as well as cytokine and pro -inflammatory 
mediator production. To assess whether ESDM possess these crucial properties, 
we studied their morphology, the expression of cell surface markers, phagocytic 
capacity and the response to Toll -like receptor stimulation. 
3.2.1 Embryonic stem cell -derived macrophages exhibit a macrophage -like 
morphology 
Macrophages possess morphological features that distinguish them from other 
leukocytes and reflect their scavenger function. They are the largest of the white 
blood cells, have a small round nucleus with abundant cytoplasm and are 
vacuolated. Macrophage morphology was primarily assessed by examining Diff 
Quick stained cytospin preparations of both ESDM and BMDM. Microscopic 













Figure 17: Embryonic stem cell- derived macrophages exhibit a 
macrophage -like morphology. 
Cytospin preparations of macrophages were prepared and stained using the Diff 
Quick Method. Cells were photographed using a Leica Zeiss Axiovert light 
microscope. Representative photomicrographs demonstrating similar morphology 
between mature A: ESDM and B: BMDM (x100 magnification). 
119 
Flow cytometry was also used to compare the Forward Scatter (FSC) and Side 
Scatter (SSC) profiles of ESDM and BMDM. As the macrophages are aspirated into 
the flow cytometer, they pass through a laser beam and refract or scatter light at 
different angles. FSC is the amount of light that is scattered in the forward direction 
and the magnitude of FSC is roughly proportional to the size of the cell. In contrast, 
SSC is the amount of light that is scattered at wide angles and reflects the 
granularity and structural complexity of the cell. FSC /SSC profiles of the 
macrophages were analysed and the mean fluorescence intensity (MFI) was 
calculated for each parameter (Figure 18). Our FSC results indicate that ESDM are 
of comparable size to BMDM (483 ±32 vs. 536 ±38 FSC MFI; ESDM vs. BMDM; 
p =0.32, n =4). However, SSC data analysis reveals that ESDM are significantly more 
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Figure 18; Embryonic stem cell- derived macrophages exhibit similar 
size but higher granularity than bone marrow derived macrophages. 
Flow cytometry analysis of the SSC /FSC parameters of macrophages. A: 
Representative SSC /FSC contour plots of ESDM and BMDM. B: ESDM and BMDM 
FSC parameter analysis revealed both cell types have the same size. C: Study of 
ESDM and BMDM SSC parameter revealed that ESDM are more granular than 
BMDM (p= 0.006, n=4). ** p <0.01 
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3.2.2 Embryonic stem cell- derived macrophages express macrophage cell 
surface markers 
Any given cell type possesses specific cell surface markers that may be useful in 
distinguishing it from other cell types. Murine macrophages can be recognised by 
their dual expression of F4/80 and CD11b. ESDM and BMDM expression of these 
`macrophage markers' was assessed by flow cytometry. Our results demonstrate 
that the expression of both F4/80 and CD11b by ESDM is comparable to that of 
BMDM (91 ±4 vs. 87 ±6% of cells co- expressing F4/80 and CD11b; ESDM vs. 
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Figure 19: Day 7 embryonic stem cell- derived and bone marrow derived 
macrophages exhibit comparable expression of F4/80 and CD11 b by 
flow cytometry. 
ESDM and BMDM were dual labelled with antibodies for F4/80 and CD11 b and 
analysed by flow cytometry. A: Representative dot plot showing an ESDM 
population with 91% cells being F4/80+ and CD11b +. B: Representative BMDM dot 
plot showing 88% of cells being F4/80+ and CD11 b +. C: Percentage of double 
positive cells for F4/80 and CD11 b (n =3). 
123 
As macrophages are very versatile and plastic cells, we also assessed the 
expression of CD11c, an integrin associated with dendritic cells, and MHC (major 
histocompatibility complex) Class II that is found on professional antigen -presenting 
cells (APCs) such as dendritic cells, activated macrophages and B cells. We 
therefore compared the expression of F4/80, CD11b, CD11c and MHC Class Il by 
ESDM and BMDM to that of BMDC (Figure 20). Our results indicate that ESDM and 
BMDM are F4 /80h'9hCD11bh'9hCD11ch'9hMHC Class 1110w whereas BMDC are 
F4 /801°WCD11bh'9hCD11ch'9h MHC Class Ilh'9h To quantify the various levels of 
expression, we measured the mean fluorescent intensity (MFI) of each cell surface 
marker for the different cell types (Figure 21). Statistical analysis of the results 
generated by flow cytometry indicates that the level of expression of F4/80, CD11 b, 
CD11c and MHC Class II by ESDM is comparable to BMDM. ESDM and BMDM 
differ significantly from BMDC by exhibiting high levels of F4/80 and low levels of 
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Figure 20: Flow cytometric analysis of F4/80, CD11b, CD11c and MHC class Il 
expression of day 7 ESDM, BMDM and BMDC. 
Representative histograms of F4/80, CD11b, CD11c and MHC class II expression of 
ESDM (A), BMDM (B) and BMDC (C). The green and blue lines represent 
unstained cells and staining with an isotype control antibody respectively whilst the 
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Figure 21: Embryonic stem cell- derived macrophages and bone marrow 
derived macrophages exhibit comparable cell surface expression of 
F4 /80, CD11b, CD11c and MHC II. 
Comparison of ESDM, BMDM and BMDC cell surface marker expression by flow 
cytometry. ESDM are comparable to BMDM and are F4 /80h'gh CD11bh'gh CD11ch'gh 
MHC Class II'°W whereas BMDC are F4 /80'°W CD11bb°W CD11ch'gh MHC Class Ilh'gh. 
* p <0.05, ** p <0.01 and * ** p <0.001 vs BMDC; n =3. 
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3.2.3 Embryonic stem cell -derived macrophages phagocytose latex beads 
A phagocytosis assay was performed to assess the ability of ESDM to engulf 
particulate material in vitro and compare them to BMDM. Cells were cultured on 
plastic and then incubated with fluorescent latex beads for 1 hour prior to washing 
and transfer to FACS tubes for flow cytometry analysis (Figure 22). Alternatively, 
cells were cultured on glass coverslips prior to incubation with fluorescent latex 
beads and mounting on glass slides for microscopic analysis (Figure 24). In the 
microscopy experiments, the macrophages were labelled with Cell Tracker Orange 
after the incubation with fluorescent latex beads. In the flow cytometry experiments, 
macrophages were immunostained for the macrophage marker F4/80 prior to 
analysis. 
We analysed the phagocytic capacity of cells by determining the percentage of cells 
that ingested fluorescent latex beads (% phagocytosis). Flow cytometric analysis 
was used to determine the percentage of F4/80 positive cells that were also positive 
for fluorescent green latex beads. These data indicated that both ESDM and BMDM 
were phagocytic with no significant difference evident between the cell types (32 ±2 
vs. 28 ±2 % phagocytosis; ESDM vs. BMDM; p =0.11, n =3, Figure 23). Similarly, no 
significant difference in the phagocytic capacity of ESDM and BMDM was evident 
when phagocytosis was analysed by fluorescent microscopy (67 ±6 vs. 79 ±5 % 
macrophages exhibiting phagocytosis of beads; ESDM vs. BMDM; p =0.20, n =4). In 
addition, we calculated the macrophage phagocytic index, which is the mean 
number of beads ingested by each macrophage that exhibits phagocytosis. The 
macrophage phagocytic index of ESDM was also comparable to that of BMDM 
(3.0 ±0.44 vs. 3.3 ±0.35 beads per macrophage; ESDM vs. BMDM; p =0.60, n =4) 
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(Figure 25). Additional control experiments included the incubation of beads with 
macrophages at 4 °C prior to flow cytometry or microscopy. Macrophages would be 
metabolically inactive and unable to actively ingest particles at this low temperature 
and this 4 °C interaction could be used to assess any non -specific binding between 
the beads and the macrophages. Analysis indicated very limited interaction between 
beads and the macrophages at this low temperature. 
Flow cytometry and microscopy analysis are qualitatively similar in that there is no 
difference in phagocytosis between ESDM and BMDM. However, the different 
methodologies did generate markedly different levels of phagocytosis with flow 
cytometry demonstrating -30% phagocytosis compared with -70% phagocytosis for 
the microscopy analysis. In other words, the microscopy assay appeared to 
overestimate the phagocytic signal. This may reflect several aspects that differed 
between the assays. First, although all macrophages were washed extensively, flow 
cytometric analysis required macrophages to be physically removed from the plate 
for processing and this manoeuvre might act to remove any adherent beads to the 
macrophage cell surface. Also, the very strong brightness of the green fluorescent 
latex beads and the comparatively weak cytoplasmic staining of macrophages with 
Cell Tracker Orange made it difficult to discern actual phagocytosis of beads from 
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Figure 22: Flow cytometric analysis of the phagocytosis of fluorescent 
green latex beads by F4/80 positive macrophages. 
ESDM and BMDM were cultured on plastic, incubated with fluorescent green latex 
beads, transferred to FACS tubes and labelled with F4/80 for flow cytometry 
analysis. SSC /FSC profile of A (i): ESDM and B (i): BMDM populations were 
subsequently analysed for the expression of F4/80 and uptake of fluorescent green 
latex beads. A (ii): Flow cytometric analysis of the ESDM population showing that 
34.9% of ESDM ingested beads at 37 °C. A (iii): 4.3% of ESDM ingested beads at 
4 °C. B (ii): 30.4% of BMDM phagocytosed beads at 37 °C. B (iii): 3.5% BMDM 
ingested beads at 4 °C. 
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Figure 23: Embryonic stem cell- derived macrophages and bone - 
marrow- derived macrophages exhibit comparable phagocytosis of 
fluorescent latex beads. 
ESDM and BMDM were cultured on plastic, incubated with fluorescent green latex 
beads at 37 °C (or 4 °C as a control for non -specific binding), transferred to FACS 
tubes and labelled with F4/80 for flow cytometry analysis. The percentage of ESDM 
and BMDM double positive for F4/80 and fluorescent green latex beads was 
assessed by flow cytometry. The phagocytosis of latex beads by ESDM was 




Figure 24: Microscopic analysis of fluorescent green latex bead 
phagocytosis by Cell Tracker Orange labelled embryonic stem cell - 
derived and bone marrow derived macrophages. 
Macrophages were cultured on glass coverslips, incubated with fluorescent green 
latex beads then labelled with Cell Tracker Orange and mounted on glass slides for 
microscopic analysis. Representative fields of ESDM and BMDM phagocytosis of 
latex beads at 37 °C (Left panels) and 4 °C (Right panels). The brightness of the 
green fluorescent latex beads and relatively weak cytoplasmic stain of macrophages 




















Figure 25: Percentage phagocytosis and phagocytic index of 
embryonic stem cell- derived and bone marrow derived macrophages 
following incubation with fluorescent latex beads. 
ESDM and BMDM were cultured on glass coverslips, incubated with fluorescent 
latex beads then labelled with Cell Tracker Orange and mounted on glass slides for 
microscopic analysis. The percentage of cells exhibiting phagocytosis and the 
macrophage phagocytic index (expressed as the mean number of beads 
phagocytosed per macrophage) were visually assessed. No significant differences 
were evident between ESDM and BMDM in either A: the percentage of cells 
exhibiting phagocytosis (Mann -Whitney U non -parametric test; p =0.3; n =4) or B: the 
macrophage phagocytic index (p =0.6; n =4). 
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3.2.4 Embryonic stem cell -derived macrophages respond to a pro- 
inflammatory stimulus 
Macrophages may acquire diverse cellular phenotypes and effector functions 
according to their microenvironment. Depending on cytokines produced by other 
immune or parenchymal cells, we can distinguish different macrophages 
populations. These include (i) 'classically activated' macrophages that exhibit 
microbicidal activity, (ii) 'wound healing' macrophages that help tissue repair and (iii) 
'regulatory' macrophages that are anti -inflammatory. 
We induced macrophages to adopt the 'classically' activated phenotype by 
stimulating them for 24h with LPS (a microbial product that engages Toll like 
receptors) and IFNy (a cytokine involved in combating viral and bacterial infections). 
A Griess assay was used to determine macrophage production of the pro - 
inflammatory mediator nitric oxide (NO). Our results show that both ESDM and 
BMDM respond to LPS and IFNy stimulation that leads to a significant increase in 
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Figure 26: Embryonic stem cell- derived macrophages are activated by 
LPS /IFNy stimulation and release nitric oxide. 
ESDM and BMDM were activated for 24h by incubation with LPS (1 pg /ml) and IFNy 
(100 U /ml). Control cells were exposed to medium alone. ESDM and BMDM 
responded to the LPS and IFNy stimulation and increased production of NO 
measured as nitrite. However, there was no difference between the levels of NO 
released by ESDM compared to BMDM (p =0.44; n =4). 
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3.3 Analysis of embryonic stem cell- derived macrophage differentiation 
Monocytes are key inflammatory cells that patrol the body in the bloodstream and 
represent both a source of cells to replenish resident tissue macrophage 
populations and to rapidly respond to tissue inflammation and injury. Previous work 
from our group has demonstrated that BMDM genetically modified to overexpress 
HO -1 adopt an anti -inflammatory phenotype and result in reduced functional injury 
when administered to mice following renal ischaemia /reperfusion injury (IRI). 
However, the macrophages do not circulate in the blood and also localise to a range 
of non -inflamed tissues including spleen, liver and lungs (Ferenbach, Ramdas et al. 
2010). 
Our method for generating ESDM involved the 'harvesting' of non -adherent cells in 
the supernatant of embryoid body cultures. These cells are then plated and cultured 
for a further 7 days to produce ESDM. Since macrophages differentiate from 
monocytes in vivo, we hypothesised that the supernatant cells (termed 'Macrophage 
progenitor cells' or MPC) may be monocytes. If this was the case, MPC may 
actually represent a more useful reagent for cell therapy as monocytes circulate in 
the blood until recruited to inflamed sites. 
3.3.1 Phenotyping the embryonic stem cell- derived macrophage progenitor 
cells isolated from embryoid body culture supernatants. 
MPC were isolated from the supernatant of EB tissue culture plates. To phenotype 
these MPC, we studied their morphology, expression of monocyte /macrophage cell 
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surface markers and their phagocytic capacity. MPC were compared to ESC, 
ESDM, BMDM and bone marrow monocytes (BMM). 
3.3.1.1 Embryonic stem cell -derived macrophage progenitor cells acquire a 
macrophage -like morphology with maturity 
Morphology was assessed by light microscopy analysis of cytospin preparations of 
the different cell types following Diff Quick staining. As previously described, both 
ESDM and BMDM form a homogenous population and exhibit standard 
macrophage morphology. They are mononuclear cells, vacuolated with a small 
nucleus to cytoplasm ratio and do not resemble ESC, which form a heterogeneous 
population of small cells with the nucleus filling almost the entire cytoplasm (Figure 
27). As stem cells have the capacity to give rise to all embryonal tissues, it was 
important for further experiments to confirm that the MPC population was 
homogeneous. We examined the morphology of MPC at different time points 
following setting up the EB cultures (d10, d12, d14, d16, d18 MPC harvests and 
ESDM) (Figure 28). Early MPC (d10) formed a highly heterogeneous population. 
However, as the EB culture matures the MPC were noted to increase in size and 
their nucleus to cytoplasm ratio increased. By day 14, the ESC formed a more 
homogeneous population of large, vacuolated, mononuclear cells that were similar 
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Figure 27: Qualitative assessment of cell morphology by light 
microscopy. 
Representative pictures of Diff Quick stained cytospin preparations of A: 










Figure 28: Maturation of embryonic stem cell- derived macrophage 
progenitor cells. 
Cytospin cell preparations were stained by Diff- quick. Representative pictures 
illustrating the macrophage progenitor cells (MPC) morphological changes as the 
embryoid body cultures mature. At d10, the MPC exhibit variable morphology with 
cellular debris and ghosts present. However, as the maturity of the EB culture 
increases, the MPC develop an increasing similarity to ESDM (x100 magnification). 
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3.3.1.2 Embryonic stem cell -derived macrophage progenitor cells do not express the 
stem cell marker Oct4 
Oct4 is a stem cell marker and involved in the self -renewal of undifferentiated ESC. 
We assessed the expression of Oct4 protein in different MPC populations (d12, d14 
and d18 MPC harvests) as well as ESC and ESDM (Figure 29). The results suggest 
that the harvested MPC are no longer stem cells as they have lost Oct4 expression 
by d12. 
3.3.1.3 Embryonic stem cell -derived macrophage progenitor cells express the 
macrophage cell surface markers F4/80 and CD1lb 
The expression of the macrophage cell surface markers F4/80 and CD11 b was 
evaluated by immunohistochemistry. Our results show that, as for ESDM and 
BMDM, the MPC are positive for both F4/80 (Figure 30) and CD11b (Figure 31). 
The number of positively stained cells appears to increase as the maturity of the EB 




















Figure 29: Embryonic stem cell- derived macrophage progenitor cells 
and embryonic stem cell- derived macrophages do not express the stem 
cell marker Oct4. 
Oct4 immunohistochemistry was undertaken on cytospin cell preparations of 
embryonic stem cells (ESC), macrophage progenitor cells (MPC) and ESDM. The 
complete absence of staining for the transcription factor Oct4 in the MPC and ESDM 
confirms the cellular differentiation of these cells from the Oct4 positive ESC 
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Figure 30: Embryonic stem cell- derived macrophage progenitor cells 
express F4/80. 
F4/80 immunohistochemistry was undertaken on macrophage progenitor cells 
(MPC) cytospin preparations. Representative photomicrographs illustrating that 
MPC are positive for the macrophage marker F4/80. At d10, the MPC exhibit limited 
F4/80 immunostaining. However, as the maturity of the embryoid body culture 
increases, MPC show generalised high F4/80 expression comparable to ESDM. No 
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31: Embryonic stem cell- derived macrophage progenitor cells 
(EPC) express CD11b. 
CD11b immunohistochemistry was undertaken on macrophage progenitor cells 
(MPC) cytospin preparations. Representative photomicrographs illustrating that 
MPC are positive for the macrophage marker CD11b. At d10, the MPC exhibit 
limited immunostaining for CD11b with occasional cells being CD11b positive. 
However, as the maturity of the embryoid body culture increases, MPC show 
generalised high CD11 b expression comparable to ESDM. No significant staining is 
evident on ESDM with the control isotype antibody (x100 magnification). 
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We also used flow cytometry analysis to examine the expression of F4/80 and 
CD11 b by MPC. Since flow cytometry analysis requires a minimum of 1.5x106 cells 
per sample, MPC yields were recorded throughout the various harvests to 
determine if sufficient cells were available for flow cytometry. From the original 
6x105 ESC cultured, the optimum yields of MPC were obtained from day 14 and day 
16 supernatants with a mean of 3.2x106 and 3x106 cells being produced 
respectively (Figure 32). Subsequently, day 14 and day 16 MPC were used for flow 
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Figure 32: Day 14 and Day 16 embryonic stem cell- derived macrophage 
progenitor cells harvests produce the highest cell yields. 
Embryoid bodies cultures were established and the number of macrophage 
progenitor cells (MPC) quantified at time points between day 10 and day 18. The 
highest yield of MPC was obtained at days 14 and 16 (n =3, except d12 n =1). 
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The dual expression of the cell surface markers F4/80 and CD11 b was then 
assessed in a quantitative manner using flow cytometry. The ESC population was 
again found to be negative for both F4/80 and CD11b while the MPC and ESDM 
were predominantly positive for both markers (Figure 33). In addition, these 
population graphs along with the histograms suggest that the expression level of 
macrophage markers in MPC increases with time and maturity of the EB cultures as 
only 79% cells were double positive for F4/80 and CD11b on d14 rising to 88% on 
d16 and reaching 90% as ESDM (n =1). We also studied expression of the integrin 
CD11c and it increased in a similar fashion to F4/80 and CD11b. This is illustrated 
by both the shift in cell populations towards the double positive F4/80 and CD11c 
quadrant in the flow cytometry dot plot diagrams and by the right shift in the 
histograms representing the level of marker expression (Figure 34). 
The expression of F4/80, CD11b, CD11c and MHC class II by d14 and d16 MPC 
was also compared to bone marrow monocytes (BMM), expected to be F4/801°W and 
CD11 bb0W, and ESDM. BMM were obtained from femur and tibia bone marrow of 
129/P2 mice aged 6 -8 weeks old and isolated as described in Material and 
Methods. As predicted, BMM were F4/801°w CD11bb°w CD11cb°w MHC Class II". In 
contrast, ESDM were F4 /80h'9h CD11bh19h CD11ch'9h MHC class ll1 °w. Interestingly, 
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Figure 33: Embryonic stem cell- derived macrophage progenitor cells 
exhibit dual expression of the macrophage cell surface markers F4/80 
and CD11 b that increases with cell maturity. 
Flow cytometry of macrophage progenitor cells (MPC) harvested at d14 and d16 for 
macrophage markers F4/80 and CD11b. MPC expression of F4/80 and CD11b 
increases as the embryoid body cultures mature though it is more evident for 
CD11 b. A: Flow cytometry dot plots show a double negative ESC population for 
F4/80 and CD11b while d14 and d16 MPC populations and the ESDM population 
are positive for both F4/80 and CD11 b. B: Histograms representing the increase in 
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Figure 34: Embryonic stem cell- derived macrophage progenitor cells 
exhibit expression of the cell surface marker CD11c that increases with 
cell maturity. 
Flow cytometry of macrophage progenitor cells (MPC) harvested at d14 and d16 for 
F4/80 and CD11c. MPC expression of CD11c increases as the embryoid body 
cultures mature. A: Flow cytometry dot plots show the ES cell population is negative 
for F4/80 and CD11c while day 14 and day 16 MPC and the ESDM population are 
predominantly within the double positive quadrant. B: Histogram representing the 
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Figure 35: Comparison of the cell surface expression of F4/80, CD11b, 
CD11c and MHC class Il by bone marrow monocytes, d14 and d16 
embryonic stem cell- derived macrophage progenitor cells and 
embryonic stem cell- derived macrophages. 
Comparison of BMM, d14 and d16 MPC and ESDM F4/80, CD11b, CD11c and 
MHC class II expression by flow cytometry. Our results indicate that BMM are 
F4/80" CD11b10 CD11cb°W MHC Class IIb°". In contrast, ESDM are F4 /80hgh 
CD11bh'9h CD11chigh MHC Class 1110w Day 14 and d16 MPC exhibit a somewhat 
intermediate phenotype. Although MPC are F4/80 positive, the expression of 
CD11b, CD11c and MHC Class Il increases as the embryoid body cultures mature 
though this is only significant for CD11c (n =3, * p <0.05, ** p <0.01 and * ** p <0.001). 
148 
3.3.1.4 Embryonic stem cell -derived macrophage progenitor cells are phagocytic 
The immunostaining and flow cytometry data suggested that the expression of cell 
surface markers by MPC depends on the maturity of the EB cultures and that the 
cells exhibit a phenotype that is intermediate between ESDM and BMM. We 
therefore determined whether they were phagocytic as this is a key feature of 
macrophages and incubated MPC with green fluorescent beads at 37 °C. Although 
the percentage phagocytosis was not formally quantified, microscopy indicated that 
d14 MPC were phagocytic as were ESDM and BMDM (Figure 36) with minimal 
phagocytosis in control plates kept on ice (4 °C). 
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Figure 36: Embryonic stem cell- derived macrophage progenitor cells 
are able to phagocytose green fluorescent beads. 
Cells were incubated with green fluorescent beads for 30 minutes in the dark at 
37 °C or on ice (4 °C). Microscopic assessment of the cells reveals that d14 MPC are 
able to phagocytose green fluorescent beads at 37 °C like ESDM and BMDM whilst 
little or no phagocytosis was evident at 4 °C (n =1). 
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Table 10: Summary table of ESC, MPC, ESDM and BMDM properties 
ESC MPC ESDM BMDM 
Morphology 
Heterogeneou 
s population of 






cells with small 
nucleus over 















Oct4 Yes No No No 
F4/80 No Yes - increases 
over time 
Yes Yes 
CD11b No Yes - increases 
over time 
Yes Yes 
CD11c No Yes - increases 
over time 
Yes Yes 
MHC II N/A Yes - increases 
over time 
Yes Yes 




N/A N/A Yes Yes 
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3.4 Summary 
In this chapter, we demonstrated that ESDM are highly comparable to BMDM using 
various cell surface markers and multiple functional assays. We report that ESDM: 
Exhibit a large mononuclear cell morphology, 
Are F4 /80h'9hCD11bhighCD11ch'9hMHC class III' by flow cytometry, 
Actively phagocytose beads, 
Produce significant levels of NO when classically activated by LPS and IFNy. 
Further analysis of ESDM differentiation showed that ESC can be used to produce a 
substantial number of MPC. Our data suggests that MPC: 
Develop into a homogeneous population of large, vacuolated cells that 
resemble ESDM as EB cultures mature, 
Do not express the stem cell marker Oct4 and express high levels of the 
macrophage cell surface marker F4/80, 
Phagocytose beads, 
Express increasing levels of CD11b and CD11c as the EB cultures mature and, 
depending upon the EB culture maturation stage, have a phenotype that is 
somewhat intermediary between BMM (F4 /80b°W CD11bb°W CD11c1°W MHC 
Class III') and ESDM (F4 /80h'9h CD11bh'9h CD11chigh MHC Class 111') 
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Chapter 4. Constitutive and inducible overexpression 
of hemeoxygenase -1 in embryonic stem cells and 
embryonic stem cell- derived macrophages 
4.1 Introduction 
As previously outlined, macrophages (MT) have the ability to exhibit considerable 
anti -inflammatory and pro- reparative properties and there is growing interest in 
harnessing these properties for therapeutic gain in inflammatory disease. A body of 
work indicates that 'cell therapy' with MT modified to adopt an anti -inflammatory 
phenotype results in amelioration of disease in various experimental models of 
kidney inflammation including renal ischaemia reperfusion injury, immune -mediated 
glomerulonephritis, ureteric obstruction, adriamycin induced nepropathy and 
streptozotocin- induced diabetic nephropathy (Ferenbach et al., 2010; Kluth et al., 
2001; Wang et al., 2007; Wilson et al., 2002; Yamagishi et al., 2001; Zheng et al., 
2011). However, these previous studies were either using modified bone marrow 
derived or splenic MT. 
In Chapter 3, we demonstrated our capacity to generate functional embryonic stem 
cell derived My) (ESDM). We now plan to extend work done in the field of 'MT cell 
therapy' by developing and using genetically manipulated ESDM to ameliorate 
disease. Our aims include: (i) the production of a genetically modified HO -1 
expressing embryonic stem cell line and (ii) the subsequent derivation of functional 
HO -1 expressing ESDM for in vivo studies. We hypothesise that HO -1 expressing 
ESDM will exhibit an anti -inflammatory phenotype in vitro and be renoprotective in 
experimental ischaemic AKI in vivo. Genetic engineering was employed to generate 
ESC cell lines with either constitutive or inducible overexpression of HO -1. 
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4.2 Constitutive over expression of hemeoxygenase -1: the pCAG 
system 
4.2.1 Embryonic stem cells constitutively overexpress hemeoxygenase -1 
under the exogenous pCAG promoter 
Dr Richard Axton at the University of Edinburgh generated stable ESC lines that 
constitutively overexpressed HO -1 under the exogenous pCAG promoter. The HO -1 
cDNA was cloned into a pCAG vector containing an internal ribosome entry site 
(IRES) and the puromycin resistance gene. The pCAG -HO -1 plasmid was then 
randomly integrated into the ESC genome via electroporation and stable HO -1 
expressing ESC lines were selected by their puromycin resistance. 
The HO -1 expression level of seven different ESC lines was determined by Western 
blot analysis (Figure 37) and this suggested that the generated clones exhibited 
various levels of HO -1 overexpression. In order to determine any potential 
deleterious effects that the genetic manipulation might have upon the stem cells, 
four HO -1 over -expressing ESC clones were selected for further analysis: 
(i) HO -1/2 and HO -1/3 represented "low HO -1 expressing ESC" 
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Figure 37: Stable embryonic stem cell lines overexpressing 
hemeoxygenase -1 under the constitutive pCAG promoter. 
Representative HO -1 Western blot of seven stable HO -1 overexpressing ESC lines 
(1 to 7). Variable expression of HO -1 is evident. Low HO -1 expressing ESC line 2 
(HO -1/2) and 3 (HO -1/3) and high HO -1 expressing ESC line 5 (HO -1/5), and 6 
(HO -1/6) were selected in order to assess whether the genetic manipulation had any 
deleterious effects upon the stem cells. 
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4.2.2 Random integration of pCAG -HO -1 adversely affects the ability of 
embryonic stem cells to self -renew 
When ESC are thawed from their cryopreservation state, they are generally 
passaged twice at a concentration of 1.5x106 cells /25cm2 flask in 10m1 ESC medium 
supplemented with 10p1 of LIF in order to assess their general condition and 
increase cell number. Previous work with the E14 IV line suggested that a flask of 
healthy ESC should yield a minimum of 5.5x105 cells /ml /flask after 2 passages. 
Subsequently, we assessed the general condition of the genetically modified HO -1 
overexpressing ESC clones by quantifying cell number. Cell yields of the genetically 
modified clones were compared to that of unmodified parental E14 IV cells (Figure 
38). The cell number data indicated a significant reduction in the cell yields of ESC 
lines HO -1/3 (p <0.001), HO -1/5 (p <0.01) and HO -1/6 (p <0.001) whereas clone HO- 
1/2 yielded similar amounts of cells compared to the unmodified parental E14 IV line 
(p >0.05). 
We then explored these findings further by analysing the ability of the pCAG -HO -1 
ESC clones to engage in cell division while remaining in a pluripotent, 
undifferentiated state using a self -renewal assay. For this experiment, the 
expression and activity of the enzyme alkaline phosphatase, an ESC marker, was 
determined after the cells have been cultured for 6 days. Usually, three different 
types of colonies are then discernible: (i) alkaline phosphatase positive ESC 
colonies that self renew and are pluripotent, (ii) mixed colonies containing both ESC 
and differentiated cells and (iii) fully differentiated alkaline phosphatase negative 
colonies that have lost their pluripotency. The colonies of the various pCAG -HO 
-1 
clones were compared to the control unmodified parental E14 IV ESC 
line (Figure 
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39). The percentage of mixed colonies containing both stem cells and differentiated 
cells as well as totally differentiated colonies is significantly higher in all of the 
pCAG -HO -1 clones. This suggests an impairment of pCAG -HO -1 clone self -renewal 
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Figure 38: General stem cell condition is impaired following insertion of 
a pCAG -HO -1 vector into the genome of the cells. 
The different stem cell lines were taken out of the -140 °C freezer and quickly 
thawed out in a 37 °C water -bath. The cells were cultured in a gelatinised 25cm2 
flask in a total volume of 10m1 ESC medium supplemented with 10p1 of LIF. After 2 
days, cells were trypsinised and passaged at 1.5x106 cells per gelatinised 25cm2 
flask in 10m1 of warm ES medium supplemented with LIF. After another 2 days, cells 
were trypsinised again and counted with a haemocytometer. Our results indicate 
significantly reduced cell number of genetically modified ESC lines HO -1/3, HO -1/5 
and HO -1/6 whereas clone HO -1/2 yielded a comparable cell number to the control 
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Figure 39: The random integration of pCAG -HO -1 reduces embryonic 
stem cell self -renewal ability and promotes cell differentiation. 
ESC were plated in 6 -well plates (1x103 cells per well) and cultured for 6 days in 
ESC medium. On day 6, colonies were stained for alkaline phosphatase activity - 
an ESC marker. Expression of the enzyme by the pCAG -HO -1 clones was 
compared to the control E14 IV ESC line. Depending on the pCAG clone observed, 
the percentage of either mixed stem cell and differentiated colonies and totally 
differentiated colonies is significantly higher than the E14 IV control, suggesting 
impaired ESC self -renewal and a potentially detrimental effect of the genetic 
modification (n =3). 
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4.2.3 Random integration of the pCAG -HO -1 plasmid can affect the differentiation of 
embryonic stem cell -derived macrophages 
In order to investigate the impact of the genetic manipulation upon the differentiation 
of embryonic stem cells to Mcp, the modified pCAG -HO -1 ESC clones were cultured 
to form My) as previously described in Chapter 2. Since the ESC clones HO -1/3 and 
HO -1/6 had a markedly impaired self -renewal capacity, and generated particularly 
low cell yields, we were not able to undertake the ESDM differentiation studies with 
them. Subsequently, the following experiments only describe clones HO -1/2 (low 
HO -1 expresser) and HO -1/5 (high HO -1 expresser). 
Following ESDM differentiation, the number of adherent cells was counted and this 
provided the first insight of the potential deleterious effect of the genetic modification 
on the MT differentiation process (Figure 40). The differentiation of ESDM from the 
low HO -1 expressing clone HO -1/2 generated a comparable yield of adherent cells 
to the control E14 IV line (2.9 ±0.17 vs. 3.2 ±0.23x106 cells; E14 IV vs. HO -1/2; 
p =0.28, n =3). In contrast, the high expressing clone HO -1/5 failed to produce 
respectable cell numbers and generated 20 -fold less cells (2.9 ±0.17 vs. 
0.14 ±0.03x106 cells; E14 IV vs. HO -1/5; p <0.001, n =3). 
Diff Quick stained cytospin preparations of adherent cells generated by the ESDM 
differentiation protocol reinforced the cell count findings. Cells derived from E14 IV 
cells and the low HO -1 expressing clone HO -1/2 exhibited a comparable phenotype 
with similar Mcp -like features. In contrast, the cells derived from the 
high HO -1 
expressing clone HO -1/5 were few in number and highly abnormal with 
variable cell 
size (Figure 41). Since the high HO -1 expresser HO -1/5 clone did 
not generate 
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sufficient My for flow cytometry experiments, it was not included in further 
experiments. 
In order to confirm the generation of My from the modified pCAG- HO -1/2 clone, we 
assessed the expression of My cell surface markers by flow cytometry. Results 
indicate that low HO -1 expresser HO -1/2 ESC were able to differentiate into My as 
the cells generated are F4 /80h'9h CD11bh'9h CD11cb°w MHC class Ill' (Figure 42). 
Rather than studying gene expression to confirm that the pCAG- HO -1/2 clone still 
overexpressed HO -1, and trying to dissect the mechanisms responsible for the 
clonal variability outlined in this chapter, we attempted to overcome this problem by 
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Figure 40: A variable number of adherent cells are generated by the 
embryonic stem cell- derived macrophage protocol following genetic 
modification of embryonic stem cells. 
6.5x105 embryonic stem cells were plated per dish and the cells were induced to 
differentiate into macrophages. At the end of 17 days in culture, the number of 
adherent cells produced per dish was counted with a haemocytometer. The high 
HO -1 expresser clone HO -1/5 generates significantly less cells than the control E14 
IV cell line and the low HO -1 expresser clone HO -1/2 (p <0.001 vs. control E14 IV 














Figure 41: Cell morphology of day 7 E14IV, HO -1/2 and HO -1/5 
embryonic stem cell- derived macrophages. 
Diff Quick staining of cytospin preparations indicating the morphology of cells 
derived from A: E14IV, B: HO -1/2 and C: HO -1/5 stem cells (x100 magnification) 
following the ESDM differentiation protocol. Cells generated from E14IV cells and 
HO -1/2 clones exhibit macrophage -like features with abundant cytoplasm. In 
contrast, the limited number of cells derived from clone HO -1/5 were heterogeneous 
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Figure 42: Flow cytometric analysis of cell surface marker expression 
of day 7 embryonic stem cell- derived macrophages derived from E14 IV 
and HO -1/2 cell lines. 
Representative flow cytometry histograms showing F4/80, CD11b, CD11c and MHC 
Class II expression of day 7 ESDM derived from A: E14 ESC and B: HO -1/2 
ESC. The green and blue lines represent unstained cells and isotype control 
antibody respectively and the red line corresponds to the expression of the indicated 
cell surface marker. 
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4.3 Summary 1 
We generated genetically manipulated ESC that constitutively overexpressed HO -1 
and examined the effects of these manipulations upon the behaviour of ESC 
including their capacity to undergo differentiation to ESDM. Our results differ 
according to the clone analysed indicating that the genetic modification does not 
result in uniform alteration of cell behaviour. In some clones, the constitutive 
overexpression of HO -1 in ESC with the pCAG system adversely impacts upon the 
yield of ESC following routine ESC culture (HO -1/3 and HO -1/6 clones). All HO -1 
clones exhibited reduced self -renewal associated with increased cell differentiation. 
Lastly, HO -1/2 ESC (low HO -1 expresser) generated comparable Mcp to control E14 
IV ESC following ESDM differentiation both in cell number and cell surface marker 
expression whilst the HO -1/5 ESC (high HO -1 expresser) generated a minimal 
number of Mcp. 
The HO -1 cDNA is cloned into a pCAG vector that is then randomly integrated into 
the genome of ES cells. This random insertion increases the risk of inadvertently 
disrupting key genes such as those involved in ESC self -renewal and /or Mcp 
differentiation. Rather than trying to dissect the mechanisms responsible for the 
clonal variability outlined in this chapter, we attempted to overcome this problem by 
developing and testing a more precise, targeted tetracycline inducible system. There 
are numerous potential advantages of this approach. First, we will target a specific 
site in the genome of the ESC in order to avoid silencing of any other genes. 
Secondly, the use of an inducible system will provide tight control over the cellular 
expression of HO -1. This will allow us to study the effect of HO -1 overexpression 
upon either ESC biology or Mcp differentiation by inducing HO -1 expression at 
different time points. 
165 
4.4 Tetracycline inducible over -expression of hemeoxygenase -1: the 
A2lox.cre cell line inducible system. 
The genetically modified A2lox.cre embryonic stem cell line ( Ctrlind ESC) used by Dr 
Richard Axton from the University of Edinburgh to generate HO -1 inducible ESC 
(HO- 1'ndESC) was kindly donated by Dr Michael Kyba from the University of 
Minnesota (lacovino et al., 2011) (Figure 43). 
4.4.1 Hemeoxygenase -1 inducible embryonic stem cells overexpress 
hemeoxygenase-1 following doxycycline treatment 
Ctrlind and HO -1'nd ESC were subjected to either 5pg /m1 Dox for 24h or cultured in 
Dox -free medium. The inducibility of HO -1 overexpression in HO -1'nd ESC following 
exposure to Dox was then verified by Western blot analysis. Our results illustrate 
that HO -lind ESC exhibit increased HO -1 expression when treated with Dox 
compared to cells cultured in normal medium with Ctrlind ESC not expressing HO -1 
at all (Figure 44). These findings indicated the successful generation of a genetically 
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Figure 43: Use of the A2lox.cre embryonic stem cell line to generate 
HO -11nd embryonic stem cells. 
In order to overcome any adverse effects of the random insertion of genes into the 
genome, we developed an inducible HO -1 expression system. A: An inducible 
cassette exchange (ICE) has been targeted to the HPRT locus on the X chromosome. 
The cDNA for cre has been inserted behind a tetracycline response element (TRE) 
and between IoxP and loxM sites. Only in the presence of both the rtTA protein 
produced by the ROSA26 locus on chromosome 6 and doxycycline, can the cells 
express cre and the ICE is self excised and exchanged for an incoming plasmid 
containing HO -1 cDNA. B: stable new inducible cell line expressing HO -1 protein 









Figure 44: Doxycycline induces hemeoxygenase -1 overexpression in 
the inducible embryonic stem cells. 
Representative Western blot of CtrlInd and HO -1ind ESC treated with 5pg /ml Dox for 
24h ( +) or cultured in Dox -free medium ( -). The HO -1 positive control is a HO -1 
expressing COS -7 clone. Ctrlind ESC do not express HO -1 in the absence or 
presence of Dox stimulation. In contrast, HO -lied ESC do not express HO -1 under 
basal conditions but do upregulate HO -1 expression following treatment with Dox. 
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4.4.2 Inducible Hemeoxygenase -1 expression has no effect on the self- 
renewal properties of the inducible embryonic stem cells 
Self- renewal assays were performed on the HO -lino ESC and the colonies were 
stained for alkaline phosphatase activity (ESC marker). This experiment was key in 
order to identify any possible adverse effects of the doxycycline treatment and HO -1 
upregulation in the inducible ESC upon the self -renewal and differentiation 
properties of the stem cells. After staining for alkaline phosphatase activity, the 
number of ESC, mixed and differentiated colonies was counted by light microscopy. 
Our results confirm that doxycycline and thus HO -1 overexpression, has no effect 
on the self -renewal properties of ESC (Figure 45). 
4.4.3 The generation of hemeoxygenase -1 inducible embryonic stem cell- 
derived macrophages from the genetically modified stem cell line 
The genetically engineered HO -1'nd ESC were cultured to form ESDM as previously 
described in Chapter 3. However, 24h before their final harvest, the cells were 
exposed to 5pg /ml Dox to induce expression of HO -1 or treated with control 
medium. In this section we investigated (i) the impact of the genetic manipulation 
upon ESDM differentiation, (ii) the effect of Dox treatment upon ESDM morphology 
and cell surface marker expression and more importantly, (iii) the 'inducibility' of the 






























Figure 45: Inducible Hemeoxygenase -1 expression has no effect on the 
self -renewal properties of the inducible embryonic stem cells. 
ESC were plated in 6 -well plates (1x103 ESC per well) and cultured for 6 days in 
ESC medium. 5pg /ml Dox was added on day 5 for 24h and on day 6, colonies were 
stained for alkaline phosphatase activity. A: Ctrlind ESC and HO -1'nd ESC colonies, 
B: Percentage of mixed colonies and C: Percentage of differentiated colonies are 
not affected by inducible HO -1 expression following Dox treatment (n =3). 
170 
4.4.3.1 Hemeoxygenase -1 inducible embryonic stem cell- derived macrophages 
exhibit a large mononuclear cell morphology 
MT morphology was primarily assessed by the cytospin method followed by Diff 
Quick staining and light microscopy. Analysis demonstrates the Mcp -like and similar 
features of Ctrlind and HO -1ind ESDM exposed to control ( -Dox) or Dox- containing 
medium ( +Dox) (Figure 46). We also examined the FSC and SSC parameters 
(reflecting the size and the complexity of the inducible ESDM respectively) by flow 
cytometry (Figure 47). Similar to the microscopic analysis, the FSC and SSC 
histograms did not reveal any notable differences between control or Dox- treated 
Ctrl'nd and HO -1'nd ESDM. Thus, both the microscopic and flow cytometric 
approaches suggested that neither the genetic modification nor exposure to Dox 
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Figure 46: Control inducible and hemeoxygenase -1 inducible embryonic 
stem cell- derived macrophages exhibit a macrophage -like morphology. 
HO -1" embryonic stem cell- derived macrophages (ESDM) were generated as 
described in the text. 24h before harvest, the cells were exposed to 5µg /ml Dox. Cell 
cytospins were stained using the Diff Quick Method. Light microscopy analysis 
indicates a comparable large mononuclear cellular morphology of all ESDM 
preparations with no discernible difference between Ctrl" and HO -1" ESDM in the 
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Figure 47: Representative SSC and FSC flow analysis histograms of 
Ctrlind and HO -1'nd embryonic stem cell- derived macrophages. 
Ctrlind and HO -lino embryonic stem cell- derived macrophages (ESDM) were cultured 
in control medium or exposed to 5µg /ml Dox for 24h. Representative histograms of 
A: Side scatter (SSC -H) and B: forward scatter (FSC -H) of untreated Ctrlind (green), 
Dox treated Ctrlind (red), untreated HO -1 ind (orange) and Dox treated HO -1 Ind (blue) 
cells. The overlapping histogram lines signify that neither the HO -1 cDNA insert nor 
the Dox treatment have an impact on the side scatter or forward scatter of ESDM. 
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4.4.3.2 Hemeoxygenase -1 inducible embryonic stem cell- derived macrophages 
express macrophage cell surface markers 
To confirm that the cells generated from the modified inducible ESC line were MT, 
we assessed the expression of various cell surface markers by fluorescent 
immunohistochemistry (FIHC) and flow cytometry. FIHC pictures demonstrate that 
HO-1 Ind ESDM express both of the MT cell surface markers F4/80 and CD11b 
(Figure 48). These results are confirmed by flow cytometry (Figure 49) where it is 
clear that both Ctrlind and HO -1ind ESDM are F4 /80hi9h CD11bhi h CDllcmed MHC 
class IIl°W. 
4.4.3.3 Inducible hemeoxygenase -1 embryonic stem cell -derived macrophages do 
not overexpress hemeoxygenase -1 following doxycycline treatment 
As demonstrated earlier in this chapter, the HO -1 ind ESC express high levels of HO- 
1 protein when treated with 5pg /ml Dox for 24h. Furthermore, ESDM can be 
successfully derived from HO -1 ind ESC and exhibit a comparable morphology and 
cell surface marker profile to Ctrlind ESC. However, it was important to determine 
that the ability of Dox to induce the expression of HO -1 was not impaired following 
the My) differentiation process such that the genetically modified ESDM are still able 
to induce HO -1 upon the addition of doxycycline. Therefore, the lysates of Ctrlind and 
HO -1 ind ESDM treated with 51.1g /ml Dox or control medium were analysed by 
Western blot (Figure 50). Surprisingly, the results indicated that Dox treated HO -1 
ind 
ESDM do not significantly upregulate HO -1 as there was no significant difference 
between the level of HO -1 expression of Ctrlind and HO -1 ind irrespective of whether 
the cells were exposed to Dox. 
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isotype 
Figure 48: Hemeoxygenase -1 inducible embryonic stem cell- derived 
macrophages express cell surface markers F4/80 and CD11 b. 
Cytospin preparations of embryonic stem cell- derived macrophages (ESDM) derived 
from HO -1 ind ESC were fixed in acetone and exposed to rat anti -mouse F4/80 or 
CD11b primary antibodies followed by biotinylated goat anti -rat secondary 
antibodies. Positive staining was revealed by Alexa Fluor -488 streptavidin dye and 
fluorescence microscopy. A: Diff Quick staining indicating that the mononuclear cell 
morphology of HO-1 Ind ESDM. B: Isotype antibody treatment revealed no significant 
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Figure 49: Inducible embryonic stem cell -derived macrophages are 
F4 /80h'9h CD11 bh'gh CD11cmea MHC class IIIOw. 
Embryonic stem cell- derived macrophages (ESDM) derived from Ctrli" and HO -11° 
ESC underwent antibody staining for F4/80, CD11b, CD11c and MHC class Il 
followed by flow cytometry. Representative flow cytometry histograms and mean 
fluorescence intensity graphs representing A: F4/80, B: CD11b, C: CD11c and D: 
MHC Class Il expression. Ctrllnd and HO -11ná ESDM express similar levels of 
markers irrespective of Dox treatment as confirmed by the MFI graphs (green: 
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Figure 50: Hemeoxygenase -1 inducible embryonic stem cell- derived 
macrophages do not induce hemeoxygenase -1 overexpression 
following Doxycycline treatment. 
Ctrl'nd and HO -lind embryonic stem cell- derived macrophages (ESDM) lysates were 
analysed by Western blot following 24h treatment with Dox ( +) or control medium 
without Dox ( -). A: Western blot illustrating a low level of HO -1 expression with no 
upregulation of HO -1 expression by HO -1'"d ESDM following Dox treatment (HO -1 
positive control is an HO -1 pCAG ESC clone). B: Densitometry analysis of the 
Western blot band analysis where HO -1 relative intensity represents the HO -1 band 
intensity corrected by the intensity of the (3 -actin band (n =3). 
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4.5 Investigating the loss of hemeoxygenase -1 inducibility in 
genetically modified hemeoxygenase -1 inducible embryonic stem cell - 
derived macrophages. 
The complete loss of HO -1 inducibility by Dox following the differentiation of HO-1 ¡rid 
ESC to ESDM was an unexpected finding and required further investigation. In the 
following sections we set out to investigate a number of factors that might influence 
the performance of the inducible system. These included (i) the dosage of 
tetracycline used to treat the ESDM, (ii) whether the loss of HO -1 inducible 
expression is a feature of ESDM differentiation per se or whether it occurs following 
differentiation to non -MT cells and (iii) underlying molecular biology issues. 
4.5.1 Increasing the dose of Doxycycline does not restore inducible 
hemeoxygenase -1 expression in embryonic stem cell derived macrophages 
We first wondered whether the recommended dose of 5pg /ml doxycycline was 
sufficient to induce HO -1 in the genetically modified ESDM. Therefore, ESDM 
derived from HO-1'd ESC were treated with increasing doses of tetracycline for 24h 
(Opg /ml, 5pg /ml, 10pg /ml and 20pg /ml Dox). Western blot analysis shows similar 
levels of HO -1 expression in HO-1 Ind ESDM across the various doses of Dox with no 
evidence of HO -1 overexpression compared to Ctrlind ESDM (Figure 51). These 
results raise the possibility that there is a genuine loss of tetracycline inducible HO -1 
expression that occurs at some stage along the pathway of My) differentiation from 
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Figure 51: Increasing the dose of Doxycycline does not restore 
inducible hemeoxygenase -1 expression in genetically modified 
embryonic stem cell- derived macrophages. 
HO -1ind embryonic stem cell- derived macrophages (ESDM) were treated with 
Opg /ml, 5pg /ml, 10pg /ml and 20pg /ml of Dox for 24h, harvested and ESDM cell 
lysates analysed by Western blot analysis. A: Representative HO -1 Western blot of 
HO -1 expression following treatment with increasing doses of Dox. B: Densitometry 
analysis of HO -1 relative intensity based on the HO -1 band analysis corrected for 
the intensity of the band of the control housekeeping protein f3 -actin (n =3). 
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4.5.2 The ability of Dox to induce hemeoxygenase -1 overexpression is 
diminished during macrophage differentiation 
To determine at which point the loss of HO -1 inducible expression occurred, we 
performed a time course of the entire My) differentiation process. HO -1' "d cells (ESC 
and cells undergoing differentiation to ESDM) were treated with 5pg /ml Dox for 24h, 
harvested and lysed and HO -1 expression determined by Western blot analysis. 
The selected time points spanned the entire ESDM differentiation process and 
included ESC, d4 EB, d6 EB, d8 EB, d10 EB, d14 EB and both d10 and d14 MPC 
supernatant cells. These experiments were both time consuming and expensive and 
were thus undertaken on 2 occasions only thereby preventing any formal statistical 
analysis. However, our results suggest that the inducible HO -1 expression peaks 
when embryoid bodies are 4 days old with expression subsequently decreasing 
below the induction level of HO -11ná ESC by day 6. By day 10, the inducible Dox - 
treated cells express low levels of HO -1 that were comparable to the HO -1 
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Figure 52: Inducible hemeoxygenase -1 expression decreases from day 
4 of embryoid body formation and disappears by day 10. 
HO -1ind ESC, d4 embryoid bodies (EB), d6 EB, d8 EB, d10 EB, d14 EB and both 
d10 and d14 macrophage progenitor supernatant cells (MPC) were treated with 
5pg /ml Dox or control media for 24h before being lysed for Western blot analysis of 
HO -1 expression. A: Western blot of the various cells (no Dox ( -), 5pg /ml Dox ( +)). 
B: Densitometry analysis of HO -1 band with respect to (3 -actin control (n =2). 
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4.5.3 The loss of inducibility is specific to the A2lox.cre cell line and not 
related to the hemeoxygenase -1 cDNA insert. 
A key question was whether the loss of inducible gene expression was specific to 
the HO -1 inducible clones or whether it was simply the result of the many changes 
that undoubtedly occur during the differentiation of ESC to ESDM. In order to 
dissect this further, we replicated the time course experiment with two different ESC 
clones that exhibited inducible expression of enhanced green fluorescent protein 
( eGFPind). The first clone is eGFPind and exhibits eGFP expression following Dox 
treatment. The second clone is MAML -eGFPind and expresses mastermind -like 
(MAML), a transcriptional co- activator for Notch signalling, fused to eGFP (MAML - 
eGFPind) These cells were generated and kindly donated by Ms Caoxin Huang 
(University of Edinburgh). Ms Huang also used the genetically modified A2lox.cre 
embryonic stem cell line but either inserted eGFP or MAML -eGFP cDNA into the 
Inducible Cassette Exchange rather than HO -1 cDNA. An additional advantage of 
working with eGFP expressing cells is that the induced green fluorescence enables 
the tracking of any changes in eGFP expression levels by flow cytometry. As 
previously described, eGFP'nd and MAML -eGFPind cells were treated with 5pg /ml 
Dox for 24h, harvested and transferred to FACS tubes for flow cytometry analysis. 
Selected time points covering the whole period of ESC to ESDM differentiation 
included ESC (d0), d4 EB, d6 EB, d8 EB, d10 and d12 MPC supernatant cells as 
well as d12 ESDM. We examined our results by two different approaches. Firstly, 
we plotted the percentage of eGFP positive (% eGFP +) eGFPind and MAML -eGFPind 
cells (Figure 53 and Figure 54). It is striking for both clones that the percentage of 
eGFP+ cells steadily decreases as soon as the cells start differentiating. 87% 
eGFPind ESC exhibited induce expression of eGFP at baseline but this fell to 71.9% 
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by d4 of the ESDM differentiation process and to below 50% by d6. ESDM 
differentiated from eGFP'nd ESC were predominantly eGFP negative with only 
12.7% being eGFP positive. The results from MAML- eGFP'nd cells were similar with 
86.2% of MAML- eGFP'nd ESC cells being eGFP positive at baseline. eGFP positivity 
gradually fell during the differentiation time course with 26.1% of ESDM being eGFP 
positive. Thus, the majority of ESDM differentiated from 2 different ESC clones that 
exhibited strong baseline induction of eGFP expression with Dox treatment do not 
exhibit induction of eGFPlnd following Dox treatment. 
Secondly, as the percentage of eGFP+ cells does not indicate the intensity of 
fluorescence, we also determined the change in eGFP mean fluorescence intensity 
(MFI) over time (Figure 55). The MFI results for eGFP'nd and MAML- eGFP'nd cells 
during the differentiation time course mirrored the previous data. By day 6 of EB 
formation, the induced eGFP protein expression was drastically reduced compared 
to that expressed by ESC. Day 12 exhibited a slight augmentation of the eGFP MFI 
but this was an artefact due to the auto -fluorescence of the ESDM after a total 19 
days in culture as it was also seen in HO -1' "d cells that do not express eGFP (Figure 
56). 
Overall, although multiple separate time course experiments were not undertaken, 
the combined results confirm that the loss of Dox inducibility over time is linked to 


















































101 16' to: 10' 1d 
eGFP 










d06(ES) d4 d6 d8 d106EPCs d126EPCs d12 ÉSDM 
Figure 53: The percentage of eGFP positive eGFPind cells decreases as 
embryonic stem cells undergo differentiation to macrophages. 
eGFPi" ESC were induced to undergo differentiation to macrophages (ESDM) and 
cells from different time points of the differentiation process were treated with 5pg /ml 
Dox for 24h prior to flow cytometry analysis to determine the percentage of eGFP 
positive cells. A: Representative eGFP histograms indicating that eGFPind cells lose 
eGFP expression during ESDM differentiation as the shift between Dox treated cells 
(red line) and control untreated cells (blue line) is progressively reduced from 
baseline dO eGFPind ESC cells to d10 embryoid body (EB) cells. B: time course 
representation of eGFPind ESDM differentiation shows a gradual fall in the 
percentage of eGFP positive cells during ESDM differentiation (87% ESC at dO 
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Figure 54: The percentage of eGFP positive MAML- eGFP'nd cells falls as 
embryonic stem cells undergo differentiation to macrophages. 
MAML- eGFPInd ESC were induced to undergo differentiation to macrophages 
(ESDM) and cells from different time points of the differentiation process were 
treated with 5pg /ml Dox for 24h prior to flow cytometry analysis to determine the 
percentage of eGFP positive cells. A: Representative eGFP histograms indicating 
that MAML- eGFP'nd cells lose eGFP expression during ESDM differentiation as the 
shift between Dox treated cells (red line) and control (blue line) is progressively 
reduced from dO to d10. B: time course representation of MAML- eGFP'nd ESDM 
differentiation shows a gradual fall in the percentage of eGFP positive cells (86.2% 
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Figure 55: The mean fluorescence intensity of eGFP decreases early 
during cell differentiation. 
eGFPind ESC or MAML- eGFPind ESC were induced to undergo differentiation to 
macrophages (ESDM) and cells from different time points of the differentiation 
process were treated with 5pg /ml Dox for 24h prior to flow cytometry analysis to 
determine the mean fluorescence intensity of eGFP expression. A: time course of 
eGFPind ESDM differentiation indicates that eGFP MFI falls early during the 
differentiation process and is at a low level by d6. B: time course of MAML -eGFPind 
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Figure 56: Embryonic stem cell- derived macrophages are 
autofluorescent. 
Flow cytometry histograms of d4 embryoid body (EB) (green), d12 macrophage 
progenitor cells (MPC) (blue) and d12 embryonic stem cell- derived macrophages 
(ESDM) (red) following 24 hour treatment with Dox A: HO -1ind d12 ESDM (red) 
exhibit a positive shift in fluorescence but these cells do not express inducible 
eGFP. The shift is therefore secondary to the intrinsic autofluorescence of d12 
ESDM. B & C: eGFP'nd and MAML- eGFP'nd respectively. The eGFP inducible clones 
express green eGFP protein by d4 EB (green) but not by d12 MPC (blue). The slight 
shift to the right by the d12 ESDM (red) is similar to the change seen in the HO -1'nd 
cells and so can be attributed to autofluorescence. 
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4.5.4 The loss of Dox inducibility is not specific to process of cellular 
differentiation to macrophages 
Another crucial issue was whether the loss of the Dox inducibility was specific to Mg) 
differentiation or was an effect of cell differentiation per se. We therefore induced 
HO -1'nd, eGFPind and MAML- eGFP'nd ESC towards a non -My differentiated state by 
treating them with retinoic acid (RA) as previously described (Forrester et al., 1996). 
RA is frequently used to promote neural differentiation of pluripotent cells under a 
wide variety of culture conditions. The effect of RA upon the differentiation of HO -11nd 
ESC was primarily assessed by microscopic analysis of cytospin preparations and 
Western blot and gPCR analysis of the ESC markers Oct 4 and NANOG 
respectively. 
We initially compared the morphology of Ctrlind and HO -1 Ind ESC cultured either in 
LIF or treated with RA. Photomicrographs of Diff Quick stained cell cytospins reveal 
the drastic change in shape and size of the RA treated HO -1 ind cells, indicating cell 
differentiation compared to ESC cultured in LIF (Figure 57). 
We then determined the expression of the stem cell transcription factor Oct4 
following RA treatment by Western blot analysis. Ctrlind ESC and HO -1 
'nd ESC were 
either cultured in LIF or treated with 10 -6M RA for 48h to induce cell differentiation. 
Cells were then lysed and the expression of Oct 4 was determined by Western blot 
analysis. LIF treated Ctrlind ESC and HO -1 Ind ESC exhibited prominent expression of 
the stem cell marker Oct4. In contrast, Ctrlind ESC and HO -1 
ind ESC exposed to RA 
for 48hrs exhibited a dramatic loss of Oct4 expression indicating the effective 
induction of cell differentiation by RA (Figure 58). 
188 
We also studied the profile of NANOG gene expression levels by real -time 
quantitative polymerase chain reaction (qPCR) (Figure 59). NANOG gene encodes 
the NANOG protein that is another transcription factor critically involved with self - 
renewal of undifferentiated embryonic stem cells. Control E14 IV ESC together with 
Ctrl'nd ESC or HO-1 Ind ESC were either cultured in LIF or treated with 10-6M RA for 
48h to induce cell differentiation. NANOG mRNA expression was determined by 
qPCR. NANOG mRNA was expressed by all ESC cultured in LIF but expression 
was completely lost in cells treated with RA. The loss of NANOG expression 
indicates a loss of the ESC phenotype secondary to RA- induced cell differentiation. 
These experiments indicate that RA treated cells adopt a distinct morphology and 
lose the expression of the ESC markers Oct4 and NANOG indicating that the cells 
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Figure 57: The morphology of retinoic acid treated embryonic stem 
cells is different to embryonic stem cells cultured in leukaemia 
inhibitory factor. 
1.5x105 Ctrlind ESC or HO -1ind ESC were plated in 5% FCS medium for 24h and then 
treated with 10 "6M retinoic acid (RA) for 48h. Control cells were cultured in 
leukaemia inhibitory factor (LIF) medium alone. Cell cytospins were stained by the 
Diff Quick method and pictures captured on a Zeiss Axiovert light microscope (200x 
magnification). A change in the shape and size of the RA treated Ctrlind ESC and 
HO -1 ind ESC is evident indicating cell differentiation compared to control ESC 
cultured in LIF. 
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Figure 58: Retinoic acid treated embryonic stem cells undergo 
differentiation and do not express the stem cell marker Oct 4. 
Ctrl'nd ESC and HO -1'nd ESC were either cultured in leukaemia inhibitory factor (LIF) 
or treated with 10-6M retinoic acid (RA) for 48h to induce differentiation. Cells were 
then lysed to determine Oct 4 expression by Western blot analysis. Representative 
Oct4 Western blot reveals prominent expression of the stem cell marker Oct4 by LIF 
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Figure 59: Gene expression of NANOG gene is silenced following 
retinoic acid treatment of genetically modified embryonic stem cells. 
E14 IV ESC, Ctrl "'d ESC or HO -1'"d ESC were either cultured in leukaemia inhibitory 
factor (LIF) or treated with 10-6M retinoic acid (RA) for 48h to induce differentiation. 
The level of NANOG mRNA expression was then determined by qPCR. NANOG 
mRNA is expressed by all ESC cultured in LIF but is completely silenced following 
RA treatment indicating a loss of the ESC phenotype secondary to RA- induced cell 
differentiation (n =1, in triplicate). 
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The previous experiments indicated that RA treated ESC rapidly lose their stem cell 
phenotype. This provided us with an additional approach to study the Dox inducible 
system as we were now able to determine whether the observed loss of the 
inducible system was specific to MT differentiation per se or whether it resulted from 
any cell differentiation process and the resultant loss of the ESC phenotype. We 
therefore investigated the inducible expression of HO -1 and eGFP of our various 
clones following RA treatment and subsequent doxycycline stimulation. ESC 
cultures (HO -lind eGFP'nd or MAML- eGFP'nd ESC) were treated with RA for 48 
hours (days 1 -3) with cells being exposed to Dox either at day 3 or day 5. After 24 
hours of Dox treatment cells were analysed at day 4 or day 6 by flow cytometry 
(eGFP), Western blotting (HO -1) and gPCR (Figure 60). 
Western blot analysis and HO -1 relative intensity graph indicated that HO -1ind 
embryonic stem cells express stable and relatively high levels of inducible HO -1 
when they are maintained in an undifferentiated state by LIF. However, analysis of 
day 4 and day 6 cells following sequential treatment with both RA and Dox indicated 
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Figure 60: Method for the assessment of inducible expression of HO -1 
and eGFP of our various ESC clones following retinoic acid treatment 
and doxycycline stimulation. 
On dO, 1.5x105 ESC were plated on gelatinised tissue culture dishes and incubated 
at 37 °C in 10m1 5% FCS medium for 24h. The medium was then supplemented with 
Retinoic Acid (RA) at a final concentration of 10-6M for a further 48h. Retinoic acid 
supplemented medium was subsequently removed and either A: replaced by 
medium containing 5pg /ml Dox for 24h. Following 24h incubation with Dox the 
medium was removed and the cells harvested at d4; or B: RA medium was replaced 
by Dox -free medium until d5. On d5, medium was supplemented with 5pg /ml Dox 
with cells being harvested 24 hours later on d6. 
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Figure 61: Retinoic acid differentiated embryonic stem cells do not 
express inducible hemeoxygenase -1 following doxycycline stimulation. 
1.5x105 HO -1'nd ESC were left to adhere for 24h, differentiated with 10 -6M retinoic 
acid (RA) for 48h and treated with 5pg /ml Dox for 24h. DO represents untreated, 
undifferentiated ESC. HO -1 Western blot: ESC cultured in LIF and treated with 
5pg /ml Dox for 24h maintain the capacity to induce HO -1 whilst this is lost following 
RA- induced cell differentiation (n =1). 
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Analysis of eGFP expression by flow cytometry was undertaken in a series of 
experiments with the eGFPind and MAML -eGFPind cells. The induction of eGFPind 
and MAML -eGFPind following sequential RA and Dox differentiation, was determined 
by the percentage of eGFP positive cells (Figure 62) as well as the mean 
fluorescent intensity of the eGFP (Figure 63). For both clones, the percentage of 
eGFP+ cells remains stable and relatively high when they are maintained as 
undifferentiated ESC by LIF. Indeed, around 80% of eGFPind ESC and MAML- 
eGFPind ESC express eGFP with expression being maintained between day 4 and 
day 6. However, following RA treatment of eGFPind ESC, the number of eGFP+ cells 
falls from around 80% to 40% by day 4 and to 20% by day 6. Comparable results 
were found following RA treatment of MAML -eGFPind cells with the percentage of 
eGFP+ cells falling from about 90% to 70% on day 4 and 50% on day 6. Similarly, 
the eGFP mean fluorescent intensity of RA treated eGFPind and MAML -eGFPind ESC 
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Figure 62: The percentage of eGFP positive cells decreases following 
retinoic acid differentiation of eGFPina ESC and MAMI- eGFPind ESC. 
Flow cytometry analysis of the percentage of eGFP positive cells. 1.5x105 eGFPind 
ESC and MAMI- eGFPind ESC were left to adhere for 24h, differentiated with 10-°M 
retinoic acid (RA) for 48h and treated with 5pg /ml Dox for 24h. The percentage of 
eGFP+ cells was determined for flow cytometry A: eGFPind ESC B: MAML- eGFPind 
ESC. Red histograms: ESC not exposed to Dox are eGFP negative. Blue 
histograms: Dox treatment of LIF treated ESC induced eGFP expression by the 
majority of cells. Orange histograms: RA treatment of ESC resulted in reduced 
proportion of cells being eGFP positive with this effect being more evident following 
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Figure 63: Mean fluorescence intensity of eGFP decreases following 
retinoic acid differentiation. 
Flow cytometry analysis was used to determine the level of expression of eGFP with 
expression being expressed as mean fluorescence intensity (MFI). Embryonic stem 
cells (ESC) are differentiated in the presence or absence of 10-6M retinoic acid (RA) 
for 48h and treated with 5pg /ml Dox for 24h. dO represents untreated, 
undifferentiated ESC. A: time course of eGFPind RA differentiated ESC indicates a 
marked fall in eGFP MFI with RA treatment. B: time course of MAML- eGFP'nd RA 
differentiated cells show a similar fall in eGFP MFI with RA treatment. (n =1). 
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4.6 Summary 
The work is this section has generated a significant number of findings including the 
following: 
HO -1'nd ESC exhibit significant HO -1 up- regulation following Dox treatment. 
HO -1 induction has no adverse impact on the self -renewal capacity of ESC. 
HO -1'nd ESC can be used to generate F4 /80h'9h CD11bh'9h CD11cint MHC 
ESDM. 
The inducibility of HO -1 with Dox treatment is lost following ESDM 
differentiation. 
In addition, the ability of Dox to induce eGFP expression by eGFP'nd and 
MAML- eGFP'nd cells diminishes following ESDM differentiation. 
The ability of Dox to induce both HO -1 and eGFP decreases following RA 
induced differentiation of ESC. 
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Chapter 5. Pharmacological induction of 
hemeoxygenase -1: heme arginate treatment of ESDM. 
5.1 Introduction 
Heme Arginate (HA) is a stable heme compound (Tenhunen et al., 1987) and 
approved by the FDA3 for use in humans. HA (Normosang® trade name) is currently 
used in the treatment of acute porphyria (Diot et al., 2007). Various studies have 
shown that HA is a potent inducer of HO -1 expression in rats (Kubulus et al., 2008), 
mice (Ferenbach et al., 2011) and humans (Doberer et al., 2010) and may exert an 
anti -inflammatory effect. In this chapter, we examined the effect of HA upon HO -1 
expression of both embryonic stem cells (ESC) and embryonic stem cell- derived 
macrophages (ESDM) and the subsequent modulation of cell phenotype. We 
hypothesise that HA treatment will result in ESDM adopting an anti -inflammatory 
phenotype. 
5.2 Heme arginate modulates the potential of embryonic stem cells to 
undergo self -renewal 
One unique feature of ESC is their ability to self -renew i.e. engage in cell division 
while remaining in a pluripotent, undifferentiated state. In a standard ESC self- 
3 List of Orphan Products Designation and Approvals. Source: 
http://www.fda. qov/ohrms/dockets/da ilys/00/mar00/030100/Ist0094. pdf 
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renewal assay (see Material and Methods for details), three different types of 
colonies are discernible: (i) ESC colonies that self -renew and are pluripotent, (ii) 
mixed colonies comprising of both ESC and differentiated cells and (iii) fully 
differentiated colonies that have lost pluripotency and contain no ESC. To our 
knowledge, there are no previous studies of the impact of HA on ESC self -renewal. 
1x103 ESC were plated in 6 -well plates and cultured for 6 days in ESC medium. On 
day 5, HA (final concentration 10pM) was added for 24h and the colonies were 
stained for alkaline phosphatase activity on day 6. The proportion of each type of 
colony (ESC, mixed or differentiated) was determined (Figure 64). The presence of 
HA resulted in a small but significant increase in the percentage of ESC colonies 
(58 ±2.6 vs. 68 ±2.3 % ESC colonies; ES vs. ES +HA; p= 0.0499, n =3). However, no 
differences were evident in the proportion of either mixed (p =0.14) or differentiated 





















Figure 64: Heme arginate modulates the potential of embryonic stem 
cell to self- renew. 
An embryonic stem cell (ESC) self -renewal assay was performed in the absence or 
presence of 10mM heme arginate (HA). The percentage of alkaline phosphatase 
positive ESC colonies was significantly higher when treated with HA for 24h (58 -x-2.6 
vs. 68 ±2.3 % ESC colonies; ES vs. ES +HA; p= 0.0499, n =3). No effect upon the 
percentage of mixed (p= 0.1356) or differentiated colonies (p= 0.486) was evident 
(n =3). 
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5.3 Heme arginate significantly upregulates the expression of 
hemeoxygenase -1 by embryonic stem cell- derived macrophages 
Although HA is a potent HO -1 inducer in various cell types and tissues, it was 
important to determine whether HA effectively upregulated HO -1 expression in 
ESDM. Western blot analysis was used to determine the duration of HA treatment 
that maximally induced ESDM HO -1 expression and the duration of HA induced HO- 
1 expression following HA exposure. Day 7 ESDM were exposed to 10pM HA for 
either 6h or 24h and cell lysates prepared at the end of the incubation period to 
determine HO -1 expression by Western blotting compared to control untreated cells 
(Oh). The duration of HO -1 induction in ESDM following 24hr HA treatment was then 
determined. Cells were washed after 24h of HA treatment and cell lysates prepared 
after a further 24h or 48h (Figure 65). Densitometry analysis of the Western blots 
indicates that HA strongly increases HO -1 expression with the strongest signal 
evident after 24h HA treatment. Furthermore, HO -1 is still expressed by ESDM 48h 
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Figure 65: Heme arginate increases expression of hemeoxygenase -1 by 
embryonic stem cell -derived macrophage. 
0.5x106 embryonic stem cell- derived macrophages (ESDM) were plated down in E- 
well plates and treated with 10pM HA for either 6h or 24h with control ESDM not 
being exposed to HA (Oh). In a parallel experiment, ESDM were treated with HA for 
24h before washing to remove HA before further culture for 24h and 48h (24 post 
and 48h post). A: HO -1 and (3 -actin Western blot and B: densitometry graph of the 
relative intensity of HO -1 compared to p- actin. HA increases ESDM HO -1 
expression and the ESDM still express HO -1 48h post removal of HA (n =1). 
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5.4 Study of the effect of heme arginate exposure upon the phenotype 
of embryonic stem cell- derived macrophages 
Previous results indicated that 10pM HA for 24h did not adversely affect ESC self - 
renewal and could upregulate HO -1 expression by ESDM. The pharmacological 
manipulation of cells such as ESDM derived from ESC could either include short 
periods of treatments with HA or other drugs or the inclusion of HA/drug for the 
entire differentiation period. Also, the administration of several doses of HA over a 
period of time to experimental mice (or humans) would expose monocytes, mature 
MT and monocytes undergoing maturation to My to HA. We therefore explored the 
effects of short or prolonged exposure of cells to HA to determine whether the 
prolonged upregulation of HO -1 had any deleterious effect on ESDM. We set up 
experiments comprising (i) control ESDM (Ctrl), (ii) ESDM that had been treated 
with 10pM HA for 24h (24h HA) and (iii) ESDM that were differentiated from ESC 
cultures exposed to 10 pM HA for the entire duration of the ESDM differentiation 
process (later referred to as 'HA differentiation')(Figure 66). In this section, we 
investigated the impact of HA treatment on the phenotype of ESDM and their 
inflammatory response following stimulation with LPS and IFNy. The experimental 
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Figure 66: Heme arginate treatment protocols 
Embryonic stem cell- derived macrophages (ESDM) were generated as described in 
the text. A: Cells were not exposed to heme arginate (HA) in the `Control ESDM' 
differentiation, B: '24h HA ESDM' were treated with 10pM HA for 24h on the last 
day of their differentiation process and C: 'HA differentiation ESDM' were cultured in 
medium supplemented with 10pM HA throughout their differentiation. HA medium 
was entirely refreshed every second day. (Note: control medium was also refreshed 
every second day for 'Control' and `24h HA' ESDM). 
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Figure 67: Experimental design for the study of the effect of short or 
prolonged heme arginate treatment upon the phenotype and function of 
embryonic stem cell- derived macrophages 
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5.4.1 The duration of heme arginate exposure has an impact on the level of 
expression of hemeoxygenase -1 by Embryonic Stem Cell- Derived 
Macrophages 
We performed HO -1 Western blots and qPCR of Control ESDM, '24h HA' ESDM 
and 'HA differentiation' ESDM. The Western blot shows that cell lysates from 24h 
HA treated ESDM and HA differentiation ESDM exhibited strong upregulation of 
HO -1 compared to control ESDM (Figure 68 A). Importantly, the control ESDM 
expressed a low baseline level of HO -1 expression thereby indicating that the cell 
culture conditions did lead to HO -1 upregulation via hypoxia or cell stress pathways. 
In contrast, ESDM treated with HA for only 24h exhibit a striking HO -1 upregulation. 
ESDM differentiated in the presence of HA also strongly upregulated HO -1 though 
this is to a lesser extent than that exhibited by 24h HA treated ESDM. 
Densitometry was used to analyse the relative intensity of HO -1 expression of 24h 
HA ESDM and HA differentiation ESDM compared to control ESDM. This analysis 
indicated that both short and prolonged HA treatment significantly upregulated HO -1 
(Control ESDM vs. 24h HA ESDM; p <0.001, n =3 and Control ESDM vs. HA 
differentiation ESDM; p <0.05, n =3) (Figure 68 B). However, these results also 
underline the fact that HO -1 upregulation is significantly higher when ESDM are 
treated for 24h compared to ESDM that have undergone the entire differentiation 
process in the presence of HA (24h HA ESDM vs. HA differentiation ESDM; p <0.01, 
n =3). 
Finally, HO -1 gene expression analysis indicated a low level of HO -1 mRNA 
expression in Control ESDM that was in accordance with the Western blot result. 
Both 24h HA treated ESDM and ESDM differentiated in HA exhibited strong and 
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Figure 68: Short or prolonged exposure to heme arginate significantly 
upregulates hemeoxygenase -1 expression. 
A: HO -1 Western blot of untreated control ESDM (Ctrl), ESDM exposed to 10pM HA 
for 24h (24h HA) and ESDM that were exposed continuously to 10pM HA during 
their differentiation (HA differentiation). B: HO -1 Western blot band intensity 
analysis corrected for p-actin (n =3). C: qPCR results of HO -1 mRNA levels (n =3). 
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5.4.2 The effect of heme arginate treatment upon the phenotype of 
embryonic stem cell -derived macrophages 
Previous work outlined in Chapter 3 indicated that ESDM are phenotypically 
comparable to BMDM. ESDM exhibit a Mcp -like morphology, express the classic Mcp 
cell surface markers F4/80 and CD11 b and phagocytose beads. ESDM also 
produce pro -inflammatory mediators when classically activated by LPS and IFN -y. In 
order to determine whether treatment with HA modulates ESDM differentiation and 
phenotype, we repeated these experiments on (i) control ESDM (Ctrl), (ii) ESDM 
that have been treated with 10pM HA for 24h (24h HA) and (iii) ESDM that were 
differentiated from cultures exposed to 10 pM HA for the entire duration of the 
ESDM differentiation process (HA differentiation). 
5.4.1.1 Heme arginate does not influence the yield of embryonic stem cell- derived 
macrophages 
To determine whether HA had any effect upon the number of ESDM generated, we 
compared the cell yields of control ESDM, 24h HA ESDM and HA differentiation 
ESDM (Figure 69). No difference was evident in the final number of ESDM 
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Figure 69: Short or prolonged exposure to heme arginate does not 
influence the yield of embryonic stem cell -derived macrophages. 
The final number of embryonic stem cell- derived macrophages (ESDM) was 
determined in untreated control ESDM (Ctrl), ESDM exposed to 10pM HA for 24h 
prior to analysis (24h HA) and ESDM that were exposed continuously to 10pM HA 
during their differentiation (HA differentiation). The numbers of ESDM generated 
were comparable under all cell culture conditions. (p= 0.234, n =4). 
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5.4.1.2 Heme arginate treated embryonic stem cell -derived macrophages exhibit a 
macrophage -like morphology 
Cytospin preparations of mature day 7 ESDM were analysed by light microscopy 
following Diff Quick staining (Figure 70). 24h HA treated ESDM and ESDM 
differentiated in the presence of HA display similar morphological characteristics to 
control ESDM. The cell populations are homogeneously composed of large 
mononuclear cells. 
In addition, the FSC and SSC characteristics of the ESDM were determined by flow 
cytometry as these reflect cell size and cell granularity respectively. No difference 
was evident between ESDM preparations neither in FSC nor is SSC analysis 
(p =0.135 and p =0.051 respectively, n =4) (Figure 71). 
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Figure 70: Heme ar inat treated embryonic stem cell-derived 
macrophages exhibit a macrophage-like morphology. 
D# Quick stained c tospin preparations of A: control embryonic stem cell-derived 
macrophages (ESDM), B: ESDM treated with hemeammmefor24h and C ESDM 
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Figure 71: FSC and SSC analysis by flow cytometry: heme arginate 
does not influence embryonic stem cell -derived macrophage size or 
granularity. 
Control embryonic stem cell- derived macrophages (ESDM), ESDM treated with 
heme arginate for 24h and ESDM differentiated in the presence of heme arginate 
underwent flow cytometry analysis. Analysis of the FSC and SSC parameters, which 
respectively reflect cell size and cell granularity, revealed no significant differences 
between the groups (p =0.135 and p= 0.051, n =4). 
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5.4.1.3 Exposure to heme arginate during embryonic stem cell- derived macrophage 
differentiation modulates expression of CD11b and CD11c 
In chapter 3, we established that ESDM are comparable to BMDM by flow cytometry 
and are F4 /80h'9hCD11bh'9hCD11ch'9hMHC class III °". The potential impact of HA on 
ESDM phenotype was also assessed by flow cytometry. Expression of F4/80, 
CD11b, CD11c and MHC class Il for control ESDM, 24h HA ESDM and HA 
differentiation ESDM is illustrated in Figure 72. The intensity of expression is 
indicated by the mean fluorescence intensity with all ESDM expressing My) cell 
surface markers. Interestingly, the exposure to HA during ESDM maturation 
modulates the expression of CD11b and CD11c (both p <0.0001) with no effect upon 
F4/80 and MHC class Il expression (p =0.094 and p =0.094 respectively). The ESDM 
generated when HA is present throughout the differentiation process are 
characterised by increased expression of CD11b (HA differentiation ESDM vs. 
Control ESDM and 24h HA ESDM, both p <0.001) and a significantly reduced 
expression of CD11c (HA differentiation ESDM vs. Control ESDM and 24h HA 
ESDM, both p <0.001). In contrast, the short -term exposure of d7 ESDM to HA for a 
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Figure 72: Exposure to heme arginate during embryonic stem cell - 
derived macrophage differentiation modulates expression of CD11 b 
and CD11c. 
The following cells were analysed by flow cytometry to assess the expression of cell 
surface markers F4/80, CD11 b, CD11 c and MHC class I I: (i) control embryonic stem 
cell- derived macrophages (ESDM), (ii) d7 ESDM treated with 10pM HA for 24h HA 
and (iii) ESDM exposed to 10pM HA for the entire differentiation process (17 days). 
Significant effects are only evident in ESDM exposed to HA during differentiation 
with significantly increased CD11b expression and decreased CD11c expression 
(n =4). 
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5.4.1.4.Heme arginate treated macrophages are significantly more phagocytic 
Phagocytosis of dying cells and debris is a key Mg) function and we therefore 
explored the effect of HA upon apoptotic cell (AC) ingestion. The potential effect of 
HA on ESDM phagocytosis was studied in vitro by incubating ESDM with apoptotic 
thymocytes. The same experimental groups of ESDM were studied as in previous 
experiments i.e. control ESDM, d7 ESDM treated with 10pM HA for 24h and ESDM 
exposed to 10pM HA for the entire differentiation process (17 days). All ESDM were 
grown on glass coverslips and cultured with fluorescent Cell Tracker green labelled 
AC for 1h at a ratio of 10 AC per Mcp in order to ensure that the availability of AC 
was not limiting. ESDM were then labelled with Cell Tracker orange, fixed in situ and 
representative fields captured by a fluorescent microscope. Depending on the colour 
of the cells i.e. non -ingested AC are green, ingested AC are yellow and non - 
phagocytic ESDM are orange (Figure 73). Two parameters of phagocytosis were 
determined: (i) the percentage of ESDM that exhibited phagocytosis and (ii) the 
mean number of AC ingested by each phagocytic My) (the phagocytic index). 
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Figure 73: Assessment of macrophage phagocytosis of apoptotic 
thymocytes by fluorescent microscopy. 
Representative fields of bone marrow -derived macrophages (BMDM) cultured on 
glass coverslips that were exposed to fluorescent green AC for 1h. Macrophages 
were then labelled with cell tracker orange and fixed in situ prior to fluorescent 
microscopy. A: fluorescent green AC bound to the surface of a macrophage remain 
green whilst B: ingested fluorescent green AC appear yellow following phagocytosis 
by a cell tracker orange labelled macrophage. C: Cell tracker orange labelling of the 
cytoplasm of a non -phagocytic macrophage. 
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Microscopic analysis indicated that control and HA treated ESDM are notably 
phagocytic. Control experiments undertaken with metabolically inactive ESDM 
cultured at 4 °C revealed a minimal interaction between AC and ESDM thereby 
suggesting that there was very limited non -specific adhesion between the cells 
(Figure 74). Interestingly, quantification of phagocytosis shows that the proportion of 
ESDM exhibiting active AC phagocytosis was significantly increased by short 24h 
HA exposure or long -term HA exposure during the entire period of ESDM 
differentiation (Control ESDM vs. 24h HA ESDM % phagocytosis; p <0.05 and 
Control ESDM vs. HA differentiation ESDM % phagocytosis; p <0.001, n =4) (Figure 
75). However, there was no significant difference in the percentage of phagocytic 
cells in 24h treated ESDM compared to HA differentiation ESDM cultures (p >0.05). 
These data indicate that exposure of ESDM to HA results in a greater proportion of 
ESDM exhibiting the ability to recognise, bind and ingest AC and is in accord with 
previous data from our group indicating that murine BMDM adenovirally transduced 
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Figure 74: Control and heme arginate treated embryonic stem cell - 
derived macrophages phagocytose apoptotic thymocytes. 
Embryonic stem cell- derived macrophages (ESDM) were cultured on glass 
coverslips and incubated with fluorescent green apoptotic cells for 1h at 37 °C or 
4 °C, labelled with cell tracker orange then fixed in situ for further analysis by 
fluorescent microscopy. A: Control ESDM B: ESDM exposed to HA for 24h C: 
ESDM exposed to HA during the entire differentiation process. All ESDM 
populations ingest AC at 37 °C whilst minimal AC ingestion is evident at 4 °C. 
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Figure 75: Heme arginate treated embryonic stem cell- derived 
macrophages exhibit increased phagocytosis of apoptotic thymocytes. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were incubated with fluorescent green apoptotic cells 
(AC) for 1h at 37 °C and the proportion of ESDM exhibiting AC phagocytosis 
quantified by fluorescent microscopy. Short -term or long -term exposure of ESDM to 
HA significantly increased ESDM phagocytosis compared to control ESDM. 
However, there was no statistical difference in the percentage of phagocytic cells 
between 24h HA exposure and exposure to HA during the ESDM differentiation. 
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The phagocytic index is a measure of the mean number of AC ingested by each 
ESDM that exhibits AC ingestion and is thus a measure of the phagocytic capacity 
of ESDM that are phagocytically competent. Analysis of control ESDM indicated that 
they ingested -2.5 AC per cell (Figure 76). Interestingly, the phagocytic index of 
ESDM was unaltered by 24h exposure to HA but was significantly elevated in ESDM 
that underwent differentiation in the presence of HA for 17 days (HA differentiation 
ESDM vs. Control ESDM; p <0.01 and HA differentiation ESDM vs. 24h HA ESDM; 
p <0.05, n =4). No statistical difference was noted between Control ESDM and 24h 
HA ESDM (p >0.05). Thus, although short -term exposure to HA increases the 
proportion of ESDM able to recognise and ingest AC, the phagocytic index is only 
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Figure 76: Exposure to heme arginate during embryonic stem cell - 
derived macrophage differentiation increases the phagocytic index for 
apoptotic thymocytes. 
Control embryonic stem cell -derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were incubated with fluorescent green apoptotic cells 
(AC) for 1h at 37 °C and the mean number of AC ingested per phagocytic ESDM 
was quantified by fluorescent microscopy. Short -term exposure of ESDM to HA had 
no effect upon the phagocytic index compared to control ESDM. In contrast, 
exposure to HA during the ESDM differentiation process significantly increased the 
phagocytic index of ESDM compared to control ESDM (p <0.01) and 24h HA ESDM 
(p <0.05). 
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5.4.1.5 Heme arginate modulates the response of embryonic stem cell- derived 
macrophages to pro -inflammatory stimuli 
My) may be pro -inflammatory and induce tissue damage in the kidney or other 
organs during disease. We therefore explored the effect of HA treatment upon the 
regulation and expression of key mediators produced by ESDM following stimulation 
with LPS (1 pg /ml) and IFN -7 (1000/m1). The pro- and anti -inflammatory mediators 
assessed included the release of nitric oxide (NO), TNFa and IL -10. We also 
studied the effect of HA upon the gene expression of HO -1, iNOS, IL -10, TNFa, IL- 
6, IL -1¡3 and IL -12 following the treatment with LPS and IFN -y. 
5.4.1.5.1 Heme arginate treated embryonic stem cell- derived macrophages produce less 
nitric oxide following treatment with LPS and IFNy 
Control ESDM (Ctrl), ESDM exposed to HA for 24h (24hr HA) and ESDM exposed 
to HA during the entire differentiation process (HA differentiation) were exposed to 
LPS (1 pg /ml) and IFN? (1000/m1) for 24h and then the cell culture supernatants 
were collected and nitrite quantified by the Griess method. Treatment with LPS and 
IFN? induced significant NO production from control ESDM. However, exposure of 
ESDM to HA for 24h or during the entire differentiation period resulted in a 
significant reduction in NO production (Control ESDM vs. 24h HA ESDM; p <0.05 
and Control ESDM vs. HA differentiation ESDM; p <0.01, n =4) (Figure 77). The 
duration of exposure to HA had no significant effect upon NO production with 
comparable NO production by ESDM exposed to HA for 24 hr or during the 
differentiation period. These results indicate that HA exposure significantly reduces 
ESDM production of NO and exerts an anti -inflammatory effect of HA that may well 
be secondary to the upregulation of HO -1. 
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5.4.1.5.2 Prolonged HA exposure significantly downregulates iNOS gene expression 
following stimulation with LPS and IFNy 
We then explored the effect of HA upon the expression of iNOS mRNA. 
Interestingly, our results reveal differing effects of the HA treatment protocol upon 
the mRNA expression of iNOS. Prolonged exposure of ESDM to HA during the 
differentiation process modulates the iNOS gene expression with significant 
downregulation of iNOS mRNA expression evident following LPS and IFNy 
stimulation (p <0.05, n =4) (Figure 78). In contrast, 24h treatment of ESDM with HA 
had no effect upon iNOS mRNA expression despite the reduction in NO production 
detected by the Griess assay. Thus, the more prolonged exposure of cells to HA 
resulted in downregulation of iNOS gene. Interestingly, despite the differential effect 
of short or long -term HA exposure upon the expression of iNOS mRNA, there was 
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Figure 77: Heme arginate treated embryonic stem cell- derived 
macrophages produce significantly less nitric oxide following LPS and 
IFNy activation. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were exposed to LPS (lpg /ml) and IFNy (1000/m1) for 
24h. Nitric oxide generation was measured by a Griess assay of ESDM cell culture 
supernatants. Non -stimulated ESDM do not generate significant NO. HA treated 
ESDM released significantly less NO than untreated control ESDM. The duration of 
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Figure 78: Prolonged heme arginate exposure of embryonic stem cell - 
derived macrophages significantly downregulates iNOS gene 
expression following LPS and IFNy stimulation. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were exposed to LPS (lpg /ml) and IFNy (1000 /ml) for 
24h at which time the expression of iNOS mRNA was determined. Non -stimulated 
ESDM do not express ¡NOS mRNA. LPS /IFNy markedly increased iNOS mRNA 
expression with 24 hour HA treatment having no inhibitory effect. However, ESDM 
exposed to HA during differentiation exhibit significantly reduced iNOS gene 
expression compared to both Control ESDM and 24h HA ESDM (both p <0.05, n =4). 
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5.4.1.5.3 Prolonged heme arginate exposure significantly downregulates TNFa production 
by embryonic stem cell- derived macrophages following LPS and IFNy stimulation 
Tumour necrosis factor -a (TNFa) is a pro -inflammatory cytokine produced by 
activated Mcp. Following LPS /IFNy stimulation, TNFa production was determined by 
performing a TNFa ELISA on the ESDM supernatants. Our results indicate that 
control non -activated cells do not produce TNFa whilst LPS /IFNy stimulation results 
in striking TNFa production. Although HA treatment for 24 hours reduces NO 
generation, the data indicated that HA treatment for 24 hours has no effect upon 
TNFa production following LPS /IFNy stimulation. However, post hoc analysis 
highlights the fact that prolonged HA exposure is capable of modulating the ESDM 
phenotype regarding TNFa production with reduced TNFa release observed in 
ESDM exposed to HA during differentiation (p= 0.0155, n =4) (Figure 79). 
5.4.1.5.4 Heme arginate has no impact on TNFa gene expression by embryonic stem cell- 
derived macrophages following LPS and IFNy stimulation 
In addition to measuring release of TNFa we also examined TNFa mRNA 
expression by the various ESDM. LPS /IFNy stimulation induced marked 
upregulation of TNFa mRNA. However, statistical analysis of the relative TNFa 
mRNA levels did not reveal any difference between control ESDM, ESDM exposed 
to HA for 24h and ESDM exposed to HA during the entire differentiation process 
(p= 0.8049) (Figure 80). These data suggested that the prolonged exposure of 
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Figure 79: Prolonged heme arginate exposure of embryonic stem cell - 
derived macrophages significantly downregulates TNFa production 
following LPS and IFNy stimulation. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were exposed to LPS (1 Ng /ml) and IFNy (1000 /ml) for 
24h at which time the production of TNFa was determined by ELISA of cell culture 
supernatants. Non -stimulated ESDM do not produce TNFa. LPS /IFNy markedly 
increased TNFa production with 24 hour HA treatment having no effect (p >0.05, 
n =4). ESDM exposed to HA during differentiation exhibit significantly reduced TNFa 
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Figure 80: Heme arginate treatment of embryonic stem cell- derived 
macrophages has no significant impact on TNFa gene expression 
following LPS and IFNy stimulation. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were exposed to LPS (1 pg /ml) and IFNy (1000 /ml) for 
24h at which time the expression of TNFa mRNA was determined. Non -stimulated 
ESDM do not express TNFa mRNA. One -way ANOVA revealed that HA has no 
impact on TNFa gene expression as all the groups have statistically comparable 
means (p= 0.8049) 
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5.4.1.5.5 Embryonic stem cell- derived macrophages treated with heme arginate for 24h 
produce significantly more IL -10 following LPS and IFNy stimulation 
The modulation of anti -inflammatory mediators may also be biologically important. 
We therefore examined the effect of HA upon the production of interleukin -10 (IL- 
10), a potent anti -inflammatory cytokine released primarily by monocytes and Mcp. 
Following LPS and IFN? stimulation, an ELISA was performed on the ESDM 
supernatants to detect IL -10. The previous data regarding NO and TNFa indicated 
that the inclusion of HA during ESDM differentiation exerted a comparable or more 
anti -inflammatory marked effect compared to 24h treatment with HA. Intriguingly, 
this was not the case for IL -10 as only the 24h HA treatment resulted in a significant 
increase in IL -10 production (both Control ESDM vs. 24h HA ESDM and 24h HA 
ESDM vs. HA differentiation ESDM: p <0.001, n =4) (Figure 81). 
5.4.1.5.6 Prolonged heme arginate exposure significantly downregulates IL -10 gene 
expression by embryonic stem cell -derived macrophages following LPS and IFNy 
stimulation 
In addition to measuring release of IL -10 we also examined IL -10 mRNA expression 
by the various ESDM. LPS /IFNy stimulation induced marked upregulation of IL -10 
mRNA (Figure 82). Interestingly, despite increasing IL -10 release into the 
supernatant, 24 hour treatment with HA had no significant effect upon IL -10 mRNA 
expression. Furthermore, prolonged exposure to HA during the ESDM differentiation 
process significantly reduced IL -10 gene expression following LPS and IFNy 
stimulation compared to control ESDM (p <0.05, n =4) despite that fact that 
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Figure 81: Embryonic stem cell- derived macrophages treated with 
heme arginate for 24h produce significantly more IL -10 following LPS 
and IFNy stimulation. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were exposed to LPS (1pg /m1) and IFNy (1000 /ml) for 
24h at which time the production of IL -10 was determined by ELISA of cell culture 
supernatants. Non -stimulated ESDM do not produce IL -10. 24h HA treated ESDM 
release significantly more IL -10 than both Control ESDM and HA differentiation 
ESDM (p <0.001, n =4). There is no statistical difference in 110 production from Ctrl 
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Figure 82: Prolonged heme arginate exposure of embryonic stem cell - 
derived macrophages significantly downregulates IL -10 gene 
expression following LPS and IFNy stimulation. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were exposed to LPS (1pg /mI) and IFNy (1000 /ml) for 
24h at which time the expression of IL -10 mRNA was determined. Non -stimulated 
ESDM do not express IL -10 mRNA. HA differentiated ESDM exhibited a significantly 
decrease in IL -10 gene expression following LPS and IFNy stimulation compared to 
Control ESDM (p <0.05, n =4). No statistical differences were noted between Control 
ESDM and 24h HA ESDM or between 24h HA ESDM and HA differentiation ESDM 
(all p >0.05, n =4). 
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5.4.1.5.7 Heme arginate exposure of embryonic stem cell- derived macrophages 
downregulates IL -6 and IL -1(3 mRNA expression following LPS and IFNy stimulation but 
does not modulate IL -12 mRNA expression 
We also explored the effect of short or long -term HA treatment of ESDM upon the 
mRNA expression of cytokines relevant to inflammation including IL -6, IL -1(3 and IL- 
12. Non -activated ESDM did not exhibit expression of IL -6, 1L-1p or IL -12 mRNA. 
Both 24h HA treatment and exposure to HA during ESDM differentiation resulted in 
a very significant downregulation of both IL -6 (both p <0.01, n =4) and IL -1(3 mRNA 
expression (p <0.05, n =4) following LPS and IFNy stimulation compared to Control 
ESDM. No statistically significant differences in IL -6 or IL -113 mRNA levels were 
noted between 24h HA ESDM and HA differentiation ESDM (p >0.05, n =4) indicating 
that HA exposure alone is enough to have an impact on the expression of these 
cytokine genes. In contrast, HA treatment has no impact on IL -12 gene expression 
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Figure 83: Heme arginate exposure downregulates IL -6 and IL -1ß gene 
expression following LPS +IFNy stimulation but has no effect on IL -12. 
Control embryonic stem cell- derived macrophages (ESDM) (Ctrl), ESDM exposed to 
HA for 24h (24hr HA) and ESDM exposed to HA during the entire differentiation 
process (HA differentiation) were exposed to LPS (1pg /ml) and IFNy (1000/m1) for 
24h at which time the mRNA expression for IL -6, IL -113 and IL -12 was determined. 
Non -stimulated ESDM do not express IL -6, IL -113 and IL -12 mRNA. HA treatment 
significantly downregulated both IL -6 and IL -1ß gene expression following LPS and 
IFNy stimulation but has no effect on IL -12 gene expression. 
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5.5 Summary 
In this chapter, we investigated the effect of HA induced HO -1 upregulation upon 
both the behaviour of ESC and subsequent ESDM phenotype. Using various 
techniques, we have shown that HA treatment: 
Exerts a mild though significant effect upon embryonic stem cell self renewal 
Significantly upregulates ESDM HO -1 protein and gene expression 
Does not influence ESDM yield or morphology 
Enhances the ability of ESDM to phagocytose apoptotic cells 
Modulates the pro- and anti -inflammatory response of ESDM following LPS and 
IFN? stimulation regarding NO, TNFa and IL -10 production 
Modulates the expression of pro -inflammatory and anti -inflammatory genes by 
significantly upregulating HO -1 gene expression and downregulating iNOS, IL- 
10, IL -6 and IL -113 gene expression following LPS and IFNy stimulation. 
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Chapter 6. Development of a model of acute kidney 
injury in 129/P2 mice and the localisation of 
embryonic stem cell derived macrophages in vivo 
6.1 Introduction 
One of our aims was to administer control and HO -1 over -expressing ESDM to mice 
with acute kidney injury (AKI) in order to determine their effect upon renal injury and 
dysfunction. The embryonic stem cells used for our experiments have been 
generated using the 129/P2 mouse strain. Previous work in the group had used the 
FVB /NJ mouse strain for experiments involving AKI and this raised the issue of 
whether it was possible to administer 129/P2 ESDM to FVB /NJ mice without 
detrimental effects upon the administered cells that would be discerned as 'foreign'. 
Rather then exploring whether this strain mismatch was possible in the relatively 
short time frame of the proposed experiments, we decided to avoid the possibility of 
inducing an inflammatory and immunological response and cellular rejection by 
establishing the model of renal ischaemia /reperfusion injury (IRI) in 129/P2 mice. It 
was thus necessary to determine the period of ischaemia that resulted in the 
appropriate level of AKI in 129/P2 mice. 
In this chapter, we outline the initial development and validation of an in vivo model 
of renal IRI in the 129/P2 mouse strain. This model will enable us to study the 
potential anti -inflammatory properties of control and HO -1 over- expressing ESDM in 
AKI. 
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6.2 The severity of acute kidney injury in 129/P2 mice is influenced by 
gender and duration of ischaemia. 
Initial experiments determined the effect of gender and duration of ischaemia upon 
the severity of AKI in 129/P2 mice aged 6 to 8 weeks. The ideal model would exhibit 
clear and reproducible injury with demonstrable acute tubular necrosis (ATN) and 
significant elevation of the serum creatinine. However, the level of injury would be 
important as the induction of very severe injury might make it difficult to see the 
beneficial impact of the administered cells. The unilateral surgical model of IRI was 
adopted. This includes performing a right nephrectomy at the time of the operation 
such that the mouse develops an elevated serum creatinine that is used to quantify 
the severity of acute renal failure. Following a right nephrectomy, the left renal 
pedicle that contains the renal artery and vein is clamped for varying periods of time. 
The clamp is removed and the kidney reperfused for 24h. 24 hours following 
reperfusion, the kidney was harvested to determine the extent of tissue injury by 
determining the ATN score and blood was collected to determine the serum 
creatinine to assess renal function (Figure 84). This model of renal injury is 
temperature sensitive with increased body temperature of the mouse being 
associated with increased injury. Therefore the temperature of the mouse was 
maintained at 37 °C throughout the procedure using a rectal probe and a 
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Figure 84: The Ischaemia /reperfusion injury model in the 129/P2 strain: 
determining the effects of gender and the duration of ischaemia. 
The surgical model of renal ischaemia reperfusion injury (IRI) consisted of a right 
nephrectomy followed by clamping of the left renal pedicle. A: male or female mice 
were used and B: the duration of ischaemia was varied (i.e. how long the left renal 
pedicle is clamped). Following renal ischaemia, the left kidney was reperfused for 
24h and harvested to determine the severity of acute tubular necrosis. Blood was 
collected for the measurement of serum creatinine as an indicator of the severity of 
renal failure. Temperature was maintained at 37 °C throughout the procedure using 
a rectal probe and a homeothermic blanket system. 
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6.2.1 The severity of acute tubular necrosis is dependent on gender and the 
duration of the ischaemic period 
Firstly, we analysed the impact of clamping the left renal pedicle for 20 minutes on 
kidney injury for both female and male mice. The right kidney tissue represented 
baseline renal histology and the pre- and post -IRI tissue appearances are depicted 
in Figure 85. Quantification of the extent of ATN indicated that 20 minutes of renal 
IRI had a greater impact on male 129/P2 mice as they exhibited worse ATN than 
female mice (7.8 ±6.2% vs. 39±7% ATN; females vs. males; p= 0.025, n =6 vs. n =4) 
(Figure 86). However, compared to experimental models used in the field of acute 
kidney injury, this is a low level of ATN and insufficient to see the effect of potentially 
renoprotective interventions such as the administration of HO -1 over- expressing 
ESDM. We therefore increased the ischaemic period to 30 minutes for female mice 
and 25 minutes for male mice (Figure 87). This resulted in a significant 8 -fold 
increase in the extent of ATN in female mice (7.8 ±6.2% vs. 67.4 ±3.6% ATN; 20 min 
vs. 30 min; p <0.001, n =6 /group vs. n =4 /group). The ATN score of male mice was 
also aggravated following an increase in the duration of the ischaemic period but, as 
expected, it was less pronounced than that evident in female mice with a 1.5 -fold 
increase in ATN score (39 ±7% vs. 68.1 ±2.94% ATN; 20 min vs. 25 min; p =0.02, n =4 
per group). There was no difference in the severity of structural kidney injury 




Figure 85: Representative renal histology of normal kidneys and 
kidneys 24 hours following renal ischaemia reperfusion injury. 
H &E staining of kidney sections from 129/P2 male mice showing the outer stripe of 
the outer medulla (OSOM) region of the kidney before and 24 hours following renal 
ischaemia reperfusion injury (IRI). A: pre -IRI the intact renal tubules exhibit a 
healthy simple cuboidal epithelium. B: post -IRI (25 min ischaemia followed by 24h 
reperfusion) many the tubules are necrotic with abnormal nuclear morphology, loss 









Figure 86: The severity of kidney injury following 20 minutes of renal 
ischaemia reperfusion injury is dependent on gender. 
At the time of the operation, the 6 -8 week old mice underwent a right nephrectomy. 
The left kidney was subsequently clamped for 20 minutes and reperfused for 24h 
prior to being harvested. The ATN score was used to determine the severity of 
tissue injury. Male mice exhibit worse kidney injury than the female mice (females 
















Figure 87: Acute tubular necrosis increases with the duration of renal 
ischaemia reperfusion injury 
At the time of the operation, mice underwent a right nephrectomy and the left kidney 
was clamped for the designated period. Kidneys were harvested after 24h 
reperfusion and the ATN score determined. A: Increasing the ischaemic period from 
20min to 30min resulted in a highly significant 8 -fold increase in the ATN score in 
female mice (p <0.001, n =6). B: The ATN score in male mice was modestly 
augmented with a 1.5 -fold increase in ATN score (p= 0.0192, n =4) following an 
increase of the ischaemic period from 20min to 25min. There was no difference in 
kidney injury between females following the 30min IRI and males following 25min 
IRI. 
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6.2.2 The severity of renal failure is dependent on mouse gender and the 
duration of the ischaemic insult. 
The ATN score is a measure of structural kidney damage but does not provide any 
indication of the level of renal failure following injury. The measurement of serum 
creatinine is the standard method of assessing renal function and ischaemic and 
toxic experimental models of AKI are characterised by both marked ATN and a 
significant increase in the serum creatinine. In addition, from a clinical perspective, 
the severity of renal failure in patients with AKI is based on the serum creatinine 
level, as a renal biopsy is often not undertaken such that the extent of ATN is not 
determined. Consequently, the serum creatinine was a key read -out in the renal IRI 
model employed in these studies. Following the 24h reperfusion phase, blood 
samples were collected under terminal anaesthesia and analysed for serum 
creatinine. Baseline serum creatinine levels in 129/P2 mice were determined 2 
weeks prior to renal IRI following a tail bleed. Interestingly, the baseline serum 
creatinine is significantly higher for 129/P2 females compared to males (21.5 ±2.28 
vs. 9.5 ±3.01 pmol /I serum creatinine; females vs. males; p= 0.0114, n =8 vs. n =4) 
(Figure 88). Initial experiments using 20 minutes of renal ischaemia followed by 24h 
reperfusion revealed a trend towards an increased serum creatinine in males and 
females (Figure 89) but this was not statistically significant despite the fact that 
tissue injury was induced as reflected in the ATN scores (Figure 87). However, 
when the ischaemic period was increased to 30 minutes for female mice, serum 
creatinine levels increased significantly (21.5 ±2.3 vs. 46.8 ±5.6 pmol /I serum 
creatinine; baseline vs. 30min IRI females; p= 0.0006, n =8 vs. n =6). Also, an 
increase in the ischaemic period to 25 minutes for male mice resulted in a significant 
increase in serum creatinine levels (10.3±4.1 vs. 71.5 ±8.3 pmol /I serum creatinine; 
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baseline vs. 25min IRI males; p= 0.002, n =4). Our results reveal that male mice are 
more vulnerable to IRI compared to female mice as they exhibit worse renal function 
following a shorter period of ischaemia, (46.8 ±5.6 vs. 71.5 ±8.3 pmol /I serum 
creatinine; 30min IRI females vs. 25min IRI males; p= 0.033, n =6 vs. n =4). 
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Figure 88: 129/P2 females exhibit higher baseline serum creatinine 
levels than male mice. 
Blood samples were collected via tail vein 2 weeks prior to renal ischaemia 
reperfusion injury and analysed for baseline serum creatinine levels. Results 
indicate that 129/P2 females exhibit higher serum creatinine levels than the males at 
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Figure 89: Severity of renal function impairment is dependent on the 
duration of the ischaemic insult. 
Blood samples were collected via tail vein either 2 weeks prior (pre IRI) or 24h 
following IRI (20, 25 or 30 min ischaemia) and analysed for serum creatinine levels. 
Results indicate that an increase in the ischaemic period results in an increase of 
serum creatinine for both 129/P2 females and males. 
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The above studies indicated that 129/P2 male mice that underwent 25 minutes of 
renal ischaemia followed by 24 hours reperfusion exhibited significant ATN 
accompanied by marked elevation of the serum creatinine indicating acute renal 
failure. These results met the requirements for our future studies employing the 
administration of HO -1 over -expressing and control ESDM and we therefore 
adopted the model featuring 25 minutes ischaemia in male 129/P2 mice followed by 
24h reperfusion for all our further in vivo experiments. 
6.2.3 The number of F4/80 positive interstitial macrophages in the medulla of 
129/P2 mice is dependent on gender 
Immunohistochemistry was undertaken to identify and quantify F4/80 positive MT in 
baseline renal tissue (right kidney) of both male and female 129/P2 mice (Figure 
90). Quantification of the number of resident F4/80 positive Mcp (pre -IRI) indicated a 
striking difference in the cell count between males and female mice. Indeed, the 
resident Mcp population of 129/P2 males is at least 8 times more than females' 
(Figure 91). 
6.2.4 Medullary influx of F4/80 positive macrophages is not evident in 129/P2 
mice 24 hours following renal ischaemia reperfusion 
Immunohistochemistry was undertaken to identify and quantify F4/80 positive Mcp in 
the left kidney of both male and female 129/P2 mice 24 hours after renal ischaemia 
reperfusion injury. There was no detectable change in number of F4 /80 positive MT 
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Figure 90: Immunohistochemistry staining of F4/80 positive resident 
macrophages in the non-injured medulla of 129/P2 mice. 
Representative fields of baseline medulla immunohistochemistry for F4/80 positive 
resident macrophages. A: Female 129/P2 mice have few F4/80 positive resident 
macrophages in the medulla. B: In contrast, male 129/P2 mice exhibit relatively high 
numbers of F4/80 positive interstitial macrophages. Arrowheads indicate some 
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Figure 91: Medullas of 129/P2 male mice exhibit significantly higher 
numbers of F4 /80 positive interstitial macrophages than female mice. 
At the time of the operation, the right kidney was removed and served as baseline 
renal tissue (`no IRI control'). The left kidney was subsequently clamped for variable 
periods of ischaemia and the left kidney was removed 24 hours later. 
Immunohistochemistry was undertaken to identify and quantify F4/80 positive 
macrophages in baseline and injured kidney. 5 pictures of non -overlapping fields 
were taken per section (x200 magnification) and F4/80 positive cells were counted. 
The medulla of 129/P2 male mice contains significantly more F4/80 positive 
macrophages than female mice at baseline. There was no significant change in the 
number of medullary F4/80 positive macrophages at 24h post IRI in male or female 
mice. 
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6.3 In vivo localisation of embryonic stem cell derived macrophages 
In order to track ESDM in vivo, cells were labelled with the dye PKH -26. In order to 
determine whether the injected ESDM exhibited the ability to home selectively to the 
injured kidney in vivo, experiments were conducted with a unilateral clamp of the left 
kidney (injured kidney) with the right kidney (contralateral kidney) left in situ to act as 
an uninjured control kidney. 5x106 PKH -26 labelled ESDM were injected 
intravenously to 129/P2 male mice aged 6 to 8 weeks. The cells were injected at the 
time of reperfusion of the kidney. The mice were culled 1 hour following the 
administration of ESDM and the kidneys, spleen, liver and lungs were snap frozen in 
liquid nitrogen. The localisation of ESDM was assessed on frozen sections mounted 
with DAPI mounting medium and analysed by fluorescent microscopy. 
6.3.1 Embryonic stem cell- derived macrophages localise to solid organs one 
hour post renal ischaemia reperfusion injury 
ESDM rapidly infiltrated multiple major organs following ischaemic renal injury. 
Indeed, 1h post injection, PHK -26 positive ESDM were already visible in the lungs, 





Figure 92: Embryonic stem cell derived macrophages localise to solid 
organs 1h post ischaemia /reperfusion injury. 
Embryonic stem cell derived macrophages (ESDM) were labelled in vitro by PKH -26 
red fluorescent dye. The left kidney of 129/P2 male mice was clamped for 25 
minutes to induce a unilateral ischaemic lesion. The cells were injected via the tail 
vein at the time of kidney reperfusion. The mice were culled 1h post injection and 
organs snap frozen. Frozen sections were mounted with DAPI mounting medium 
and analysed by fluorescent microscopy. Representative fields of A: Lung B: Liver 
C: Spleen (x100 magnification) D: non -injured right kidney and E: injured left kidney 
(both x400 magnification). Blue: nuclei stained by DAPI; red: PKH -26 labelled 
ESDM; green: autofluorescence; white arrowheads: PKH -26 positive macrophages. 
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6.3.2 Control and heme arginate treated embryonic stem cell -derived 
macrophages preferentially home to the injured kidney one hour post renal 
ischaemia reperfusion injury 
In chapter 5, we demonstrated that 24h incubation of ESDM with heme arginate 
(HA) significantly induced HO -1 expression. In addition, the in vitro analysis of HA 
treated ESDM indicated that they were more phagocytic and exhibited a reduced 
inflammatory response following LPS and IFNy stimulation (,j, NO and T IL10 
production). 
In order to study the potential anti -inflammatory properties of HA treated HO -1 
expressing ESDM in vivo, we injected control and 24h HA treated ESDM in our 
model of renal ischaemia reperfusion injury in 129/P2 mice. Initial experiments 
explored whether HA treated ESDM exhibited a similar capacity as control ESDM to 
selectively localise to the injured kidney in vivo. Therefore, as previously, the left 
kidney was clamped (injured kidney) and the right kidney left in situ as an uninjured 
control (contralateral kidney). 5x106 control or HA treated ESDM were injected at the 
time of reperfusion 25 minutes after the ischaemic insult. The mice were culled at 1h 
post injection and kidneys snap frozen in liquid nitrogen. Localisation was assessed 
on frozen sections mounted with DAPI mounting medium and analysed by 
fluorescent microscopy. 
Greater numbers of control or HA treated PKH -26+ ESDM were seen within the 
medulla of the injured kidney (IRI) compared to the contralateral control (Control 
ESDM: 0.48 ±0.07 vs. 0.73 ±0.03 PKH+ ESDM /hpf; contralateral kidney vs. IRI 
kidney; p= 0.023, n =3 and HA ESDM: 0.33 ±0.07 vs. 0.8 ±0.06 PKH+ ESDM /hpf; 
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contralateral kidney vs. IRI kidney; p= 0.0061, n =3) (Figure 93). These results 
suggest that ESDM have the ability to sense the injury in vivo and home 
preferentially towards an inflamed site. In addition, the induction of HO -1 expression 































Figure 93: Control and hemeoxygenase -1 overexpressing embryonic 
stem cell- derived macrophages home to the injured kidney 1h post 
renal ischaemia reperfusion injury. 
Embryonic stem cell- derived macrophages (ESDM) were either exposed to 10pM 
heme arginate (HA) for 24h (HA ESDM) or cultured in control medium (Ctrl ESDM). 
ESDM were labelled in vitro by PKH -26 dye. On the day of surgery, 129/P2 male 
mice underwent left renal ischaemia reperfusion injury. The right kidney of the mice 
was left intact (contralateral control) whilst the left kidney was clamped for 25min 
(IRI). 5x106 PKH -26 labelled ESDM were injected via tail vein at the time of kidney 
reperfusion. 1h later, the mice were culled and kidneys snap frozen in liquid 
nitrogen. Frozen sections were mounted with DAPI mounting medium and analysed 
by fluorescent microscopy. 10 pictures of non -overlapping fields were taken per 




In this chapter, we describe the development and validation of an in vivo model of 
renal ischaemia reperfusion injury in the 129/P2 mouse strain and explored the 
localising capacity of control and HA treated HO -1 expressing ESDM in a setting of 
acute kidney injury. We show that: 
In the 129/P2 mouse strain, acute tubular necrosis and severity of renal 
function impairment are dependent on gender and duration of the ischaemic 
period with males being more vulnerable to injury than females. 
The number of F4/80 positive My) is significantly higher in the medulla of 
129/P2 male mice compared to female mice. 
Influx of F4/80 positive Mg) in the medulla is not a feature of renal ischaemia 
reperfusion injury for 129/P2 male or female mice 
ESDM localise to solid organs 1h post IRI 
Control and HA treated HO -1 expressing ESDM preferentially home to the 
injured kidney 1h post renal ischaemia reperfusion injury. 
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Chapter 7. Discussion & Future Work 
7.1 Deriving and phenotyping embryonic stem cell- derived 
macrophages. 
In this thesis we present data demonstrating the successful generation of murine 
ESDM in vitro. Using various parameters including cell morphology, cell surface 
markers and multiple functional assays, we have shown that ESDM are comparable 
to BMDM for all properties tested. Specifically, ESDM are large mononuclear cells 
that express well -established M4 cell surface markers (F4 /80h'gh CD11 b high CD11chigh 
MHC class II10w). ESDM are readily phagocytic for apoptotic cells and beads and 
produce NO when activated by LPS and IFN -y. 
Our results are consistent with the available literature on murine ESDM (Table 5, 
Chapter 1. Introduction). However, one could argue that we did not fully investigate 
the stability or the plasticity of the ESDM phenotype as Mcp are able to adapt their 
phenotype for microbicidal, anti -inflammatory or tissue repair activity depending on 
their microenvironment (M1 /M2 activation). Our work only explored ESDM ability to 
respond to an inflammatory stimulus, namely LPS /IFN -y, and thus become 
`classically activated' (M1). It would be interesting to test ESDM ability to adopt a 
wound -healing (M2) or a regulatory MO phenotype (Mreg) by treating them with IL- 
4/IL-13 and IL -10 respectively. These studies would also enable us to assess the 
phenotypic stability of ESDM. Also, testing different passages of ESC prior to 
performing the ESDM differentiation would be useful as it could potentially support 
the robustness of the protocol. It would also be interesting to simply follow ESDM in 
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culture in the absence of M -CSF and other growth factors in order to determine 
whether they revert to a stem cell phenotype or remain as ESDM. The stability of 
the ESDM phenotype per se represents an important safety concern, as a reversion 
to a stem cell phenotype would be potentially tumourigenic. 
Regarding the flow cytometry and microscopy analysis of ESDM phagocytosis, our 
results are qualitatively similar in that there was no difference between ESDM and 
BMDM. However, the different methodologies did generate markedly different levels 
of phagocytosis with flow cytometry demonstrating -30% phagocytosis compared 
with -70% phagocytosis for the microscopy analysis. Our results highlight the fact 
that different methodologies do not necessarily give similar results. We suspect that 
cell surface binding of beads to M4, can confound the interpretation and therefore, 
that flow cytometry is more reliable than microscopy as it examines a higher number 
of detached cells that are less likely to have adherent beads. Several aspects that 
might explain the result discrepancies differed between the assays. Firstly, although 
all M4 were washed extensively, flow cytometric analysis required Md to be 
physically removed from the plate for processing by both washing and scraping and 
this manoeuvre might act to remove any beads that were tightly adherent to the Mp 
cell surface. Also, the very strong brightness of the green fluorescent latex beads 
and the comparatively weak cytoplasmic staining of Md with Cell Tracker Orange 
made it difficult to discern actual phagocytosis of beads from non -specific cell 
surface binding. It would therefore be of interest to repeat this experiment with 
stronger staining of the Md with Cell Tracker Orange and quench the fluorescence 
of any beads that are bound to the cells with trypan blue. In addition, the Mcp could 
undergo microscopy after they have been physically detached and removed from 
the plate (as for flow cytometry). Cytospins of the detached Md could be made for 
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microscopic assessment and quantification of phagocytosis. Further phagocytosis 
assays should also include bacterial pathogens and cellular debris in addition to 
apoptotic cells as these may also require clearance by M(I) in vivo. 
In this thesis, we chose several well -established M4 functions and markers to 
compare and contrast ESDM and BMDM. As MO and other cells are highly complex, 
it would be valuable to perform gene expression profiling by microarray analysis of 
both BMDM and ESDM in order to create a global picture of ESDM and BMDM 
gene expression. Indeed, this inclusive transcriptomic approach could be adopted to 
interrogate the gene changes of ESDM or BMDM induced to adopt particular 
phenotypes to see if similarities are maintained following MO responses to polarising 
stimuli. 
Recently, several groups have reported working with human ESC as sources of 
ESDM for mechanistic studies (Karlsson et al., 2008; Subramanian et al., 2009). In 
addition, MO have been generated from human induced pluripotent stem (IPS) cells 
(Senju et al., 2011). This is an important step forward and the in vitro analysis of 
these human ESDM will indicate whether they are similar to primary human 
monocyte- derived MO in their behaviour. The use of human cells is appealing in the 
clinical setting and there is no doubt that important future work will be undertaken 
using human ESDM. There are, however, caveats to the exclusive use of human 
ESDM. For example, one of the aims of this work was to determine whether the 
administration of HO -1 overexpressing ESDM would be of benefit in a murine model 
of renal IRI and such an experiment could not be undertaken with human ESDM as 
these are xenogeneic cells. It would be possible to test the effect of human ESDM 
(e.g. HO -1 overexpressing ESDM) in immunodeficient mice such as SLID mice that 
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lack T and B cells. However, T and B cells are involved in the pathogenesis of renal 
IRI and such experiments are thus less representative of the clinical condition. It is 
true, however, that the use of ESDM derived from IPS cells would be advantageous, 
as this should overcome any immune response that might be made against the 
administered cells. 
7.2 Constitutive and Inducible overexpression of hemeoxygenase -1 in 
embryonic stem cells and embryonic stem cell- derived macrophages. 
Genetic engineering was employed to generate ESC lines with either constitutive or 
inducible overexpression of HO -1 as a means to subsequently derive HO -1 
overexpressing ESDM for in vivo studies. 
First, we generated genetically manipulated ESC that constitutively overexpressed 
HO -1 and examined the effect upon the behaviour of ESC including their capacity to 
undergo self -renewal and differentiation to ESDM. We generated a panel of clones 
with varying degrees of HO -1 overexpression (so called low' and `high' HO -1 
expressers) and our results differed according to the clone analysed indicating that 
the genetic modification did not result in uniform alteration of cell behaviour. In some 
clones, the constitutive overexpression of HO -1 in ESC with the pCAG system 
adversely impacted upon the yield of ESC following routine ESC culture. It is 
possible that this adverse effect may be secondary to either low levels of ESC 
proliferation or excessive levels of ESC apoptosis (or both). However, some clones 
exhibited reduced self -renewal associated with increased cell differentiation. The 
problem with the ESC cell number was not obviously related to the level of HO -1 
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expression as poor cell yields were seen with both low and high HO -1 expressing 
clones. Similarly, the reduced self -renewal of ESC was also seen in both low and 
high HO -1 expressers and was thus unlikely to be secondary to HO -1 per se. 
It may be that the problem lies with the technique used to constitutively overexpress 
HO -1 as the HO -1 cDNA was cloned into a pCAG vector that was then randomly 
integrated into the genome of the ESC. This random insertion increases the risk of 
inadvertently disrupting key genes such as those involved in ESC self -renewal 
and /or Mil) differentiation. The interrogation of this hypothesis formed the basis of 
further work and it was decided not to study the mechanisms behind this clonal 
variability. We attempted to overcome this problem by developing and testing a 
more precise, targeted tetracycline inducible system to express HO -1 that offered 
numerous potential advantages. 
First, targeting a specific ICE site in the genome of the ESC would allow us to avoid 
silencing of any other genes. Secondly, this system would provide us with tight 
control over the cellular expression of HO -1 thereby allowing us to study the effect 
of HO -1 overexpression upon either ESC biology or M4 differentiation by inducing 
HO -1 expression at different time points. 
Our results indicated successful generation of a genetically modified ESC line with 
tetracycline inducible HO -1 overexpression. Furthermore, we could produce 
functional ESDM from this genetically modified ESC line. However, and rather 
surprisingly, our data indicated that the inducible HO -1 ESDM did not upregulate 
HO -1 following treatment with the inducing agent doxycycline (Dox). Indeed, our 
data indicated a loss of HO -1 inducibility over time during the differentiation process 
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from ESC to ESDM. These findings were somewhat unexpected given the literature 
in this field (lacovino et al., 2011; Wong et al., 2005). Indeed, the A2lox.cre cell line 
used to generate our inducible HO -1 ESC has been specifically engineered so that 
(i) the ICE containing the cDNA of interest has been targeted under a TRE element 
in the genomic region upstream of HPRT and (ii) the ROSA26 locus contains an 
rtTA transgene that results in the expression of the rtTA protein that enables Dox to 
induce the TRE. Both the HPRT and ROSA26 loci were chosen as docking sites 
because of their presumed ubiquitous and constitutive transcriptional activity 
(Bäckman et al., 2009; Chen et al., 2011; lacovino et al., 2011) with work showing 
that ROSA26 and HPRT have been identified as silence- resistant sites in transgenic 
mouse studies (Bronson et al., 1996; Zambrowicz et al., 1997). However, none of 
these groups worked with MO and our findings thus required further investigation. 
We explored two potential reasons why the inducible system failed to generate 
mature ESDM that would express HO -1 following Dox exposure. The dosage of Dox 
used to treat the ESDM was varied and increased but did not restore inducible HO -1 
expression in genetically modified ESDM. Dox has a long duration of action and is a 
commonly used tetracycline (Schach von Wittenau, 1968). However, absorption of 
tetracycline and thus Dox has been reported to be impaired by milk products, 
aluminium hydroxide gels, sodium bicarbonate, calcium and magnesium salts and 
interestingly iron preparations due to increased chelation of the compound (Sande 
and Mandell, 1990). A by- product of heme catabolism by HO -1 is iron and we could 
investigate whether this impairs Dox absorption into the cell. This seems unlikely as 
the inducible ESC only express HO -1 and thus potentially release iron following Dox 
exposure. However, the HO -1 Western blot of inducible 'ESC without Dox' and 
'Control ESDM without Dox' reveal an element of constitutive HO -1 expression by 
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control ESDM whilst the inducible ESC did not express constitutive HO -1 prior the 
Dox treatment (no HO -1 band visible on the Western blot). It is thus conceivable that 
the low level of constitutive HO -1 expression by inducible ESDM in the absence of 
Dox treatment might somehow affect the bioavailability of Dox to the ESDM. 
Although further studies could include the study of Dox bioavailability in our ESDM 
cultures over time using HPLC, biological or fluorometric assays (Fourtillan et al., 
1980; Saivin and Houin, 1988; Welling et al., 1977) it is thought unlikely that this is a 
major confounder. 
A series of informative experiments examined an alternative hypothesis and aimed 
to determine whether the loss of inducible HO -1 expression was a feature of ESDM 
differentiation per se (i.e. the result of a specific feature of M(I) differentiation) or 
whether it occurs following differentiation of ESC to non -Mt cells (i.e. the result of a 
generic feature of differentiation to various cell types). We therefore induced HO -1 
inducible ESC towards a non -Mt differentiated state by treating them with retinoic 
acid (RA). We preliminarily show that RA differentiated cells do not induce HO -1. 
However, the n number of experiments requires increasing to generate a robust 
data set. 
Further work should definitely target the underlying molecular biology issues of the 
inducible system. It would be interesting to perform gPCR analysis of ROSA26 and 
HPRT gene expression, as it is possible that unforeseen and adverse silencing of 
one of these loci could explain the loss of HO -1 inducibility in our system. If this is 
the case then this would be an important methodological finding for the field. It 
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would also be of interest to determine whether ESDM are more prone to DNA 
methylation during their differentiation or if they specifically silence target transgene 
expression. 
7.3 Pharmacological induction of hemeoxygenase -1: heme arginate 
treatment of ESDM. 
We investigated the effect of HA induced HO -1 upregulation upon ESC and ESDM 
phenotype. Using various techniques, we demonstrated that HA exerts a mild 
though significant effect upon the potential of ESC to undergo self -renewal. Indeed, 
the presence of HA resulted in a small but significant increase in the percentage of 
pure ESC colonies (p= 0.0499, n =3). However, no differences were evident in the 
proportion of either mixed or differentiated colonies. One should be careful when 
drawing conclusions from these results because, although a p -value of less than 
0.05 was achieved following 3 separate and discrete experiments, it is unlikely that 
this effect would have major biological relevance. 
We demonstrated that HA significantly upregulates ESDM HO -1 protein and mRNA 
expression. Interestingly, ESDM treated with HA for 24h exhibit a more striking 
induction of HO -1 than ESDM differentiated in the constant presence of HA. HO -1 is 
an acute cell stress protein expressed in response to oxidative stress, hypoxia etc 
and would typically rapidly return to basal expression levels. Indeed it has been 
reported that continuous expression of HO -1 may be harmful to the cells 
(Deramaudt et al., 1999). Furthermore, although transient HO -1 overexpression 
provides protection against oxygen toxicity in lung cells, some deleterious effects 
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due to iron accumulation were observed for chronic HO -1 overexpression (Dennery 
et al., 2003). Accordingly, further work should include cell viability and longevity 
experiments by culturing the cells over a prolonged period then staining them with 
Propidium Iodide or Trypan Blue, to determine whether prolonged HA exposure 
affects ESDM survival. Our results showing a lower level of HO -1 in cells exposed 
chronically to the inducing agent HA does suggest some form of negative feedback 
controlling the expression of the enzyme. However, the underlying mechanism 
remains unclear. 
The control ESDM also expressed a low baseline level of HO -1 expression thereby 
indicating that the relatively standard cell culture conditions employed for our studies 
did lead to HO -1 upregulation via hypoxia or cell stress pathways. This should be 
borne in mind in the study of HO -1 and emphasises the importance of utilising 
appropriate controls in experiments. 
ESDM differentiated in the constant presence of HA (HA differentiation ESDM) have 
significantly increased CD11b but reduced CD11c expression. CD11b is known to 
be involved in inflammatory processes by regulating leukocyte adhesion and 
migration and has been implicated in several immune processes such as 
phagocytosis, cell- mediated cytotoxicity, chemotaxis and cell activation (Solovjov et 
al., 2005). Interestingly, our results show that HA treatment significantly increased 
the ability of ESDM to phagocytose apoptotic cells and that 'HA differentiated 
ESDM' tended to phagocytose more apoptotic cells than ESDM treated with HA for 
24 hours, though the difference was not statistically different. 
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The possible mechanism of increased phagocytosis following HA treatment is of 
significant interest as this effect has also been seen following BMDM that have 
undergone adenoviral transduction to overexpress HO -1 (Ferenbach et al., 2010). 
There are several questions that will need to be addressed. A key issue is whether 
HA generally modulates phagocytosis or whether the effect is limited to particular 
particles. Further experiments using various particles such as beads, bacterial 
pathogens, opsonised zymosan and necrotic cell debris would shed light on this. In 
addition, it would be of interest to determine whether HA treatment modulates the 
expression of any ESDM cell surface receptors that are involved in the recognition 
and ingestion of apoptotic cells such as scavenger receptors, CD36 or the a(33 
integrin. This may be ascertained by flow cytometric analysis of the level of cell 
surface expression of these receptors. If an increase in receptor expression is found 
following HA treatment then further work such as antibody inhibition studies might 
suggest whether the relevant receptor is key to the increased phagocytosis. An 
additional possibility is that HA may modulate the intracellular phagocytic machinery 
of the cell. An analysis of the proteins involved in generating phagocytic cups and 
phagolysosomes (e.g. Rho -kinase, Myosin -II) might therefore be of interest. It would 
be equally be interesting to assess if HA treatment and the resultant increased 
phagocytosis augments ESDM phenotypic reprogramming i.e. whether it affects the 
ability of the ESDM to adopt an anti -inflammatory, wound -healing or a regulatory 
phenotype by ELISA analysis of their culture supernatant for relevant cytokines. 
It is also important to note that the role of HO -1 per se remains unanswered by the 
work described in this thesis. It remains possible, albeit unlikely, that the cellular 
effects of HA described may be heme dependent and HO -1 independent. In order to 
address this issue further work would require the analysis of the effects of HA upon 
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BMDM from HO -1 knockout mice and ESDM derived from ESC that lack the HO -1 
gene. An alternative approach would be to employ pharmacological inhibitors of HO- 
1 such as tin protoporphyrin with quantification of the HO -1 enzyme bioactivity to 
ensure effective HO -1 inhibition. A caveat here is that such inhibitors are not specific 
and may have other effects upon cells. A further method to inhibit HO -1 expression 
would be to use HO -1 siRNA (with scrambled siRNA as control) with Western 
blotting being employed to ensure effective inhibition of HO -1 protein expression. 
If these experiments demonstrate that HO -1 is key to the effects we reported, it 
would be interesting to determine if these effects are secondary to the mediators 
generated by HO -1 activity such as bilirubin or CO. This would require experiments 
to be undertaken that use exogenous bilirubin or CO that can be generated from CO 
releasing molecules (CORMs). 
Finally, we show that HA treatment modulates the pro- and anti -inflammatory 
response of ESDM following stimulation with LPS and IFNy. The effects seen were 
somewhat variable and did depend upon whether the ESDM had been treated for 
24 hours with HA or had undergone differentiation to ESDM in the presence of HA. 
However, some experiments did demonstrate modulation of the production of NO, 
TNFa and IL -10 as well as modulation of the expression of pro- and anti - 
inflammatory genes (j(HO -1 gene expression and 4 iNOS, IL -10, IL -6 and IL -1(3 
gene expression) following LPS /IFNy stimulation. The overall effect of the altered 
ESDM phenotype induced by HA treatment remains unanswered i.e. the nature of 
the sum effect of all the cytokine changes. It is important to point out that gene 
expression analysis has only been performed 24h after stimulation, i.e. a time point 
when expression levels could already have returned to baseline. It would thus be 
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interesting to run a timecourse experiment of gene expression following LPS /IFNy 
stimulation including earlier time points than 24h, such as 2h, 4h and 12h post 
stimulation as these could explain the discrepancies between protein and mRNA 
levels for TNFa and IL -10. It would equally be interesting to perform experiments 
involving the transfer of the various ESDM conditioned supernatants (control ESDM, 
LPS /IFNy stimulated ESDM pretreated with HA or vehicle) to a control quiescent cell 
(a parenchymal cell such as a tubular cell or a quiescent MO. The level of activation 
of the 'reporter cell' could be assessed by qPCR analysis of gene expression. This 
would provide insight into the 'totality' of the effects of HA treatment upon ESDM 
activation and suggest the effect that such ESDM could have on adjacent 
parenchymal cells. 
7.4 Development of a model of acute kidney injury in 129/P2 mice and 
the localisation of embryonic stem cell derived macrophages in vivo 
We outlined the development and validation of an in vivo model of unilateral renal 
ischaemia -reperfusion injury in the 129/P2 mouse strain and explored the capacity 
of control and HA treated HO -1 expressing ESDM to localise to the acutely injured 
kidney. 
We show that in the 129/P2 mouse strain, acute tubular necrosis and the severity of 
renal functional impairment depend upon gender and the duration of the ischaemic 
period with males being more vulnerable to injury than females. This is consistent 
with the literature available on gender differences in ischaemic acute kidney injury 
for mice and rats (Fekete et al., 2004; Muller et al., 2002; Wei et al., 2005). 
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However, the mechanism underlying these gender differences remains unclear. 
Interestingly, we show that the number of F4/80 positive resident macrophages is 
significantly higher in the medulla of 129/P2 male mice compared to female mice. 
To our knowledge, no other group has described this difference. However, studies 
on renal macrophage and monocyte depletion by liposomal clodronate (LC) prior to 
experimental IRI provided functional and structural protection from the injury (Day et 
al., 2006; Day et al., 2005; Ferenbach et al., 2012; Jo et al., 2006). The authors 
suggested that resident renal macrophages contributed to the initiation and severity 
of injury in renal IRI, and thus their depletion led to amelioration of renal injury. It is 
thus interesting to speculate that the reduced number of resident macrophages in 
female kidneys may underlie the reduced injury found in female mice. Although we 
found that there was no significant influx of F4/80 positive macrophages in the 
medulla following renal ischemia reperfusion injury in both male and female 129/P2 
mice, it would be interesting to examine whether there were any differences in the 
level of infiltration by F4/801" monocytes. 
One of the aims of this thesis was to undertake studies to determine whether HO -1 
overexpressing ESDM are renoprotective in vivo following renal IRI. We therefore 
intravenously injected PKH -26 labelled control and HA treated ESDM to 129/P2 
male mice and assessed their ability to localise in a setting of acute kidney injury. 
We left the right kidney in situ in these studies in order to provide a non -injured 
control kidney. We demonstrated that ESDM did localise to various organs including 
the liver and lung and that they did preferentially homed to the injured kidney 1h 
post IRI. However, it is interesting to note that the numbers of recruited PKH+ 
ESDM in the kidney 1h following IRI is relatively low compared to the number of 
cells injected. Previous studies using M(1) cell therapy targeted specifically to the 
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kidney via renal artery injection have demonstrated significant amelioration of 
disease with relatively low numbers of labelled cells detectable within the diseased 
organ (Kluth et al., 2001; Wilson et al., 2002; Yamagishi et al., 2001). More 
specifically, David Harris' team showed amelioration of disease after injecting as low 
as 1.106 macrophages (Cao et al., 2010). These results raise the possibility that the 
administered cells could be influencing the phenotype of other resident (or 
'bystander') macrophages. Further work should also include experiments on cell fate 
over longer periods after their injection in vivo. To do so, various organs should be 
harvested and examined at multiple time points after cell administration. 
Key further work would include assessing the potential renoprotective effect of HA 
treated ESDM following renal IRI by looking at functional and structural markers of 
injury such as creatinine and ATN scores compared to control ESDM administration 
and control IRI (no cells injected). The administration of HO -1 overexpressing 
BMDM (induced by adenoviral transduction) to mice with ischaemic AKI reduced the 
serum creatinine but had no effect upon the ATN score (Ferenbach et al., 2010). 
The suggested reason for this was the restoration of microvascular patency and it 
would therefore be important to assess platelet and fibrin deposition within the 
peritubular capillaries of the medulla. 
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8. Conclusion 
At the end of this project, we were able to generate functional My from ESC in 
significant numbers. Our work has shown that the advantages that were envisaged 
for an inducible system of gene expression did not materialise in a way that the 
differentiation of ESC to Mcp resulted in the loss of inducible gene expression. This is 
an important message for the field because inducible gene expression systems are 
often praised for their efficacy in stem cells. It may actually well be the case that our 
strategy of treating ESDM with pharmacological agents, such as HA or cytokines, 
might be optimal. Indeed, we show that HA treated ESDM over- express HO -1, 
present promising anti -inflammatory properties in vitro and home to the injured 
kidney in a model of murine IRI in vivo. Further experiments are still needed to 
determine if HA treated ESDM exert anti -inflammatory properties in vivo. However, 
our findings are a strong platform for future studies of the translational potential of 
using modified ESDM in cell therapy. 
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